| Company | Size | Product Name | CAS No | Price | China | USA | Germany |
|---|---|---|---|---|---|---|---|
| BLDPharm | 100mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid, 97% | 954147-36-5 | USD 135 | Inquiry | 1 | 1 |
| BLDPharm | 250mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid, 97% | 954147-36-5 | USD 229 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid, 97% | 954147-36-5 | USD 617 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 98% | 74163-81-8 | USD 8 | >5 | 3 | 3 |
| BLDPharm | 25g | (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 98% | 74163-81-8 | USD 26 | >5 | 3 | 3 |
| BLDPharm | 100g | (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 98% | 74163-81-8 | USD 95 | 5 | 1 | 1 |
| BLDPharm | 500g | (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 98% | 74163-81-8 | USD 203 | 4 | 1 | Inquiry |
| BLDPharm | 1g | N-(1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 99% HPLC | 67219-55-0 | USD 13 | 4 | 1 | Inquiry |
| BLDPharm | 5g | N-(1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 99% HPLC | 67219-55-0 | USD 51 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | N-(1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 99% HPLC | 67219-55-0 | USD 126 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 69123-94-0 | USD 15 | 5 | 4 | Inquiry |
| BLDPharm | 250mg | 1-((2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 69123-94-0 | USD 32 | >5 | 4 | Inquiry |
| BLDPharm | 1g | 1-((2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 69123-94-0 | USD 70 | >5 | 4 | Inquiry |
| BLDPharm | 5g | 1-((2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 69123-94-0 | USD 302 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, 95% | 56-65-5 | USD 5 | >5 | 5 | 2 |
| BLDPharm | 5g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, 95% | 56-65-5 | USD 9 | >5 | 2 | 1 |
| BLDPharm | 10g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, 95% | 56-65-5 | USD 17 | >5 | 1 | 2 |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, 95% | 56-65-5 | USD 31 | >5 | 1 | Inquiry |
| BLDPharm | 100g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, 95% | 56-65-5 | USD 121 | 2 | Inquiry | 1 |
| BLDPharm | 250mg | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 97% Synonyms:5-Fluorouracil 1β-D-ribofuranoside; FUrd | 316-46-1 | USD 7 | >5 | Inquiry | 1 |
| BLDPharm | 1g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 97% Synonyms:5-Fluorouracil 1β-D-ribofuranoside; FUrd | 316-46-1 | USD 20 | >5 | Inquiry | 2 |
| BLDPharm | 5g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 97% Synonyms:5-Fluorouracil 1β-D-ribofuranoside; FUrd | 316-46-1 | USD 79 | >5 | 2 | Inquiry |
| BLDPharm | 10g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 97% Synonyms:5-Fluorouracil 1β-D-ribofuranoside; FUrd | 316-46-1 | USD 96 | 1 | Inquiry | 1 |
| BLDPharm | 25g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 97% Synonyms:5-Fluorouracil 1β-D-ribofuranoside; FUrd | 316-46-1 | USD 239 | 2 | Inquiry | Inquiry |
| BLDPharm | 100g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 97% Synonyms:5-Fluorouracil 1β-D-ribofuranoside; FUrd | 316-46-1 | USD 633 | 4 | 1 | Inquiry |
| BLDPharm | 250mg | 4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one, 95% Synonyms:5-Iodo-2′-deoxycytidine | 611-53-0 | USD 7 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one, 95% Synonyms:5-Iodo-2′-deoxycytidine | 611-53-0 | USD 10 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one, 95% Synonyms:5-Iodo-2′-deoxycytidine | 611-53-0 | USD 42 | >5 | 3 | 1 |
| BLDPharm | 25g | 4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one, 95% Synonyms:5-Iodo-2′-deoxycytidine | 611-53-0 | USD 140 | >5 | 1 | 1 |
| BLDPharm | 100g | 4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one, 95% Synonyms:5-Iodo-2′-deoxycytidine | 611-53-0 | USD 462 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | Adenosine 5'-diphosphate, 95% | 58-64-0 | USD 18 | >5 | 2 | Inquiry |
| BLDPharm | 5g | Adenosine 5'-diphosphate, 95% | 58-64-0 | USD 65 | >5 | 2 | Inquiry |
| BLDPharm | 25g | Adenosine 5'-diphosphate, 95% | 58-64-0 | USD 240 | 3 | Inquiry | Inquiry |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 98% +(Loss on drying≤12%) | 5550-12-09 00:00:00 | USD 17 | 2 | Inquiry | 1 |
| BLDPharm | 100g | Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 98% +(Loss on drying≤12%) | 5550-12-09 00:00:00 | USD 44 | >5 | Inquiry | 2 |
| BLDPharm | 500g | Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 98% +(Loss on drying≤12%) | 5550-12-09 00:00:00 | USD 162 | >5 | 3 | 1 |
| BLDPharm | 1kg | Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 98% +(Loss on drying≤12%) | 5550-12-09 00:00:00 | USD 260 | 3 | 1 | 1 |
| BLDPharm | 5g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 95% | 4578-31-8 | USD 23 | 1 | 1 | Inquiry |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 95% | 4578-31-8 | USD 37 | 1 | Inquiry | 1 |
| BLDPharm | 100g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 95% | 4578-31-8 | USD 88 | 4 | Inquiry | 1 |
| BLDPharm | 500g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 95% | 4578-31-8 | USD 177 | 2 | 1 | Inquiry |
| BLDPharm | 1g | Cytidine 5'-(trihydrogen diphosphate),disodium salt, 97% (HPLC)(contains ≤7%H2O) | 54394-90-0 | USD 28 | 4 | 2 | Inquiry |
| BLDPharm | 5g | Cytidine 5'-(trihydrogen diphosphate),disodium salt, 97% (HPLC)(contains ≤7%H2O) | 54394-90-0 | USD 107 | 4 | Inquiry | Inquiry |
| BLDPharm | 10g | Cytidine 5'-(trihydrogen diphosphate),disodium salt, 97% (HPLC)(contains ≤7%H2O) | 54394-90-0 | USD 202 | 4 | Inquiry | Inquiry |
| BLDPharm | 25g | Cytidine 5'-(trihydrogen diphosphate),disodium salt, 97% (HPLC)(contains ≤7%H2O) | 54394-90-0 | USD 386 | 3 | Inquiry | Inquiry |
| BLDPharm | 100g | Cytidine 5'-(trihydrogen diphosphate),disodium salt, 97% (HPLC)(contains ≤7%H2O) | 54394-90-0 | USD 1271 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | ((2R,3S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 95% Synonyms:Deoxycytidylic acid | 1032-65-1 | USD 35 | >5 | 1 | Inquiry |
| BLDPharm | 1g | ((2R,3S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 95% Synonyms:Deoxycytidylic acid | 1032-65-1 | USD 70 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | ((2R,3S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 95% Synonyms:Deoxycytidylic acid | 1032-65-1 | USD 295 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 95% | 5987-73-5 | USD 49 | 1 | 2 | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 95% | 5987-73-5 | USD 77 | 2 | 1 | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 95% | 5987-73-5 | USD 209 | >5 | 1 | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 95% | 5987-73-5 | USD 732 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, trisodium salt, 98% | 36051-31-7 | USD 63 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, trisodium salt, 98% | 36051-31-7 | USD 94 | >5 | Inquiry | 2 |
| BLDPharm | 1g | (((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, trisodium salt, 98% | 36051-31-7 | USD 234 | 2 | 1 | Inquiry |
| BLDPharm | 5g | (((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, trisodium salt, 98% | 36051-31-7 | USD 825 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate, 97% | 36051-68-0 | USD 8 | >5 | 3 | Inquiry |
| BLDPharm | 1g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate, 97% | 36051-68-0 | USD 17 | >5 | 2 | 3 |
| BLDPharm | 5g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate, 97% | 36051-68-0 | USD 68 | >5 | Inquiry | 1 |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate, 97% | 36051-68-0 | USD 296 | 4 | Inquiry | Inquiry |
| BLDPharm | 100g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate, 97% | 36051-68-0 | USD 917 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, 98% | 53-84-9 | USD 5 | >5 | 3 | 1 |
| BLDPharm | 1g | 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, 98% | 53-84-9 | USD 10 | >5 | >5 | >5 |
| BLDPharm | 5g | 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, 98% | 53-84-9 | USD 25 | >5 | >5 | >5 |
| BLDPharm | 10g | 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, 98% | 53-84-9 | USD 30 | >5 | Inquiry | 2 |
| BLDPharm | 25g | 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, 98% | 53-84-9 | USD 74 | 4 | 1 | 4 |
| BLDPharm | 100g | 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, 98% | 53-84-9 | USD 295 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)butanoic acid, 97% | 979-92-0 | USD 105 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)butanoic acid, 97% | 979-92-0 | USD 186 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | (S)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)butanoic acid, 97% | 979-92-0 | USD 295 | >5 | 5 | 1 |
| BLDPharm | 250mg | (S)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)butanoic acid, 97% | 979-92-0 | USD 528 | >5 | Inquiry | 3 |
| BLDPharm | 1g | (S)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)butanoic acid, 97% | 979-92-0 | USD 1427 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | (((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, disodium salt trihydrate, 99% | 51963-61-2 | USD 9 | 2 | 5 | Inquiry |
| BLDPharm | 25g | (((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, disodium salt trihydrate, 99% | 51963-61-2 | USD 30 | >5 | 1 | Inquiry |
| BLDPharm | 100g | (((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, disodium salt trihydrate, 99% | 51963-61-2 | USD 85 | 1 | Inquiry | Inquiry |
| BLDPharm | 500g | (((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid, disodium salt trihydrate, 99% | 51963-61-2 | USD 340 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt, 99% | 987-65-5 | USD 5 | >5 | 2 | 2 |
| BLDPharm | 5g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt, 99% | 987-65-5 | USD 6 | >5 | >5 | 2 |
| BLDPharm | 10g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt, 99% | 987-65-5 | USD 8 | >5 | 1 | 2 |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt, 99% | 987-65-5 | USD 19 | >5 | 1 | 1 |
| BLDPharm | 100g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt, 99% | 987-65-5 | USD 23 | >5 | 3 | 1 |
| BLDPharm | 500g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt, 99% | 987-65-5 | USD 114 | 5 | Inquiry | Inquiry |
| BLDPharm | 1kg | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt, 99% | 987-65-5 | USD 225 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate, disodium salt, 90% (HPLC) | 7415-69-2 | USD 28 | >5 | 1 | Inquiry |
| BLDPharm | 1g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate, disodium salt, 90% (HPLC) | 7415-69-2 | USD 69 | >5 | 3 | Inquiry |
| BLDPharm | 5g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate, disodium salt, 90% (HPLC) | 7415-69-2 | USD 131 | 5 | Inquiry | Inquiry |
| BLDPharm | 10g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate, disodium salt, 90% (HPLC) | 7415-69-2 | USD 222 | 3 | Inquiry | Inquiry |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate, disodium salt, 90% (HPLC) | 7415-69-2 | USD 554 | >5 | 1 | 1 |
| BLDPharm | 100mg | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 118380-84-0 | USD 93 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 118380-84-0 | USD 140 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 118380-84-0 | USD 348 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-Amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% Synonyms:5-Bromo-D-cytidine | 3066-86-2 | USD 5 | 3 | 1 | Inquiry |
| BLDPharm | 250mg | 4-Amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% Synonyms:5-Bromo-D-cytidine | 3066-86-2 | USD 10 | 3 | 1 | 1 |
| BLDPharm | 1g | 4-Amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% Synonyms:5-Bromo-D-cytidine | 3066-86-2 | USD 15 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 4-Amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% Synonyms:5-Bromo-D-cytidine | 3066-86-2 | USD 64 | 4 | 1 | Inquiry |
| BLDPharm | 25g | 4-Amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% Synonyms:5-Bromo-D-cytidine | 3066-86-2 | USD 224 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Sodium ((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate, 98% | 13085-50-2 | USD 18 | 4 | 2 | Inquiry |
| BLDPharm | 250mg | Sodium ((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate, 98% | 13085-50-2 | USD 44 | 3 | 1 | Inquiry |
| BLDPharm | 1g | Sodium ((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate, 98% | 13085-50-2 | USD 53 | 5 | 2 | Inquiry |
| BLDPharm | 5g | Sodium ((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate, 98% | 13085-50-2 | USD 264 | 1 | 1 | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98% | 7387-57-7 | USD 5 | 1 | 1 | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98% | 7387-57-7 | USD 7 | >5 | 1 | 1 |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98% | 7387-57-7 | USD 23 | 5 | Inquiry | 1 |
| BLDPharm | 100g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98% | 7387-57-7 | USD 65 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | Sodium ((2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate, 95% | 2922-74-9 | USD 96 | >5 | 1 | Inquiry |
| BLDPharm | 1g | Sodium ((2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate, 95% | 2922-74-9 | USD 203 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Sodium ((2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate, 95% | 2922-74-9 | USD 848 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidine-2,4(1H,3H)-dione, 95% | 35542-01-9 | USD 11 | >5 | 3 | 1 |
| BLDPharm | 250mg | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidine-2,4(1H,3H)-dione, 95% | 35542-01-9 | USD 27 | >5 | 1 | 1 |
| BLDPharm | 1g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidine-2,4(1H,3H)-dione, 95% | 35542-01-9 | USD 38 | >5 | Inquiry | 3 |
| BLDPharm | 5g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidine-2,4(1H,3H)-dione, 95% | 35542-01-9 | USD 189 | >5 | 1 | 2 |
| BLDPharm | 25g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidine-2,4(1H,3H)-dione, 95% | 35542-01-9 | USD 944 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,4S,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione, 97% | 134218-81-8 | USD 25 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,4S,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione, 97% | 134218-81-8 | USD 42 | Inquiry | Inquiry | 1 |
| BLDPharm | 1g | 1-((2R,4S,5R)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione, 97% | 134218-81-8 | USD 113 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 8-Amino-1,4-dioxaspiro[4.5]decane-8-carboxylic Acid, 98% | 54621-18-0 | USD 18 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | 8-Amino-1,4-dioxaspiro[4.5]decane-8-carboxylic Acid, 98% | 54621-18-0 | USD 30 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 8-Amino-1,4-dioxaspiro[4.5]decane-8-carboxylic Acid, 98% | 54621-18-0 | USD 46 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 8-Amino-1,4-dioxaspiro[4.5]decane-8-carboxylic Acid, 98% | 54621-18-0 | USD 229 | >5 | 1 | Inquiry |
| BLDPharm | 25g | 8-Amino-1,4-dioxaspiro[4.5]decane-8-carboxylic Acid, 98% | 54621-18-0 | USD 816 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-((3-Chloro-4-fluorophenyl)amino)-7-(methoxy-D3)quinazolin-6-ol, 98% 98%atom%D | 1228665-04-0 | USD 201 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4-((3-Chloro-4-fluorophenyl)amino)-7-(methoxy-D3)quinazolin-6-ol, 98% 98%atom%D | 1228665-04-0 | USD 342 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 4-((3-Chloro-4-fluorophenyl)amino)-7-(methoxy-D3)quinazolin-6-ol, 98% 98%atom%D | 1228665-04-0 | USD 924 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22-hexaoxa-4-azapentacosan-25-oic acid, 95% | 1334177-79-5 | USD 50 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22-hexaoxa-4-azapentacosan-25-oic acid, 95% | 1334177-79-5 | USD 74 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22-hexaoxa-4-azapentacosan-25-oic acid, 95% | 1334177-79-5 | USD 255 | 1 | 1 | Inquiry |
| BLDPharm | 100mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25-heptaoxa-4-azaoctacosan-28-oic acid, 95% | 2112731-42-5 | USD 61 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25-heptaoxa-4-azaoctacosan-28-oic acid, 95% | 2112731-42-5 | USD 104 | >5 | 3 | 1 |
| BLDPharm | 1g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25-heptaoxa-4-azaoctacosan-28-oic acid, 95% | 2112731-42-5 | USD 280 | >5 | 1 | 2 |
| BLDPharm | 100mg | Mal-peg6-acid, 95% | 518044-42-3 | USD 103 | 1 | 1 | Inquiry |
| BLDPharm | 250mg | Mal-peg6-acid, 95% | 518044-42-3 | USD 170 | >5 | Inquiry | 1 |
| BLDPharm | 1g | Mal-peg6-acid, 95% | 518044-42-3 | USD 283 | 5 | Inquiry | 2 |
| BLDPharm | 5g | Mal-peg6-acid, 95% | 518044-42-3 | USD 1414 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16-tetraoxa-4-azanonadecan-19-oic acid, 98% | 1263045-16-4 | USD 60 | 2 | 2 | 1 |
| BLDPharm | 250mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16-tetraoxa-4-azanonadecan-19-oic acid, 98% | 1263045-16-4 | USD 89 | 1 | 2 | Inquiry |
| BLDPharm | 1g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16-tetraoxa-4-azanonadecan-19-oic acid, 98% | 1263045-16-4 | USD 114 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16-tetraoxa-4-azanonadecan-19-oic acid, 98% | 1263045-16-4 | USD 569 | 1 | Inquiry | 1 |
| BLDPharm | 100mg | N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90% | 305372-39-8 | USD 57 | 1 | 1 | Inquiry |
| BLDPharm | 250mg | N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90% | 305372-39-8 | USD 100 | 5 | 1 | Inquiry |
| BLDPharm | 1g | N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90% | 305372-39-8 | USD 398 | 4 | 1 | Inquiry |
| BLDPharm | 100mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid, 95% | 1334177-86-4 | USD 47 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid, 95% | 1334177-86-4 | USD 67 | 5 | 1 | Inquiry |
| BLDPharm | 1g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid, 95% | 1334177-86-4 | USD 131 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid, 95% | 1334177-86-4 | USD 654 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-1-tert-Butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate, 95% (stabilized with TBC) | 74844-93-2 | USD 35 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | (S)-1-tert-Butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate, 95% (stabilized with TBC) | 74844-93-2 | USD 43 | >5 | 1 | 1 |
| BLDPharm | 1g | (S)-1-tert-Butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate, 95% (stabilized with TBC) | 74844-93-2 | USD 65 | >5 | 3 | 4 |
| BLDPharm | 5g | (S)-1-tert-Butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate, 95% (stabilized with TBC) | 74844-93-2 | USD 190 | 3 | 3 | 2 |
| BLDPharm | 25g | (S)-1-tert-Butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate, 95% (stabilized with TBC) | 74844-93-2 | USD 665 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | Sodium (2S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate, 98% Synonyms:GC-376; GC 376 * Cold-chain transportation | 1416992-39-6 | USD 128 | 1 | 2 | Inquiry |
| BLDPharm | 100mg | Sodium (2S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate, 98% Synonyms:GC-376; GC 376 * Cold-chain transportation | 1416992-39-6 | USD 205 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | Sodium (2S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate, 98% Synonyms:GC-376; GC 376 * Cold-chain transportation | 1416992-39-6 | USD 396 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | Sodium (2S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate, 98% Synonyms:GC-376; GC 376 * Cold-chain transportation | 1416992-39-6 | USD 992 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-Hyp(Bom)-OH, 97% | 187223-15-0 | USD 17 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-Hyp(Bom)-OH, 97% | 187223-15-0 | USD 25 | >5 | 2 | 2 |
| BLDPharm | 5g | Fmoc-Hyp(Bom)-OH, 97% | 187223-15-0 | USD 124 | 5 | >5 | Inquiry |
| BLDPharm | 5g | Fmoc-Hyp-OH, 98% | 88050-17-3 | USD 7 | >5 | 2 | 3 |
| BLDPharm | 10g | Fmoc-Hyp-OH, 98% | 88050-17-3 | USD 9 | >5 | Inquiry | 3 |
| BLDPharm | 25g | Fmoc-Hyp-OH, 98% | 88050-17-3 | USD 21 | >5 | 3 | 3 |
| BLDPharm | 100g | Fmoc-Hyp-OH, 98% | 88050-17-3 | USD 83 | >5 | 1 | 2 |
| BLDPharm | 500g | Fmoc-Hyp-OH, 98% | 88050-17-3 | USD 294 | >5 | 1 | 1 |
| BLDPharm | 100mg | 2,5-Dioxopyrrolidin-1-yl hept-6-ynoate, 95+% | 917222-23-2 | USD 15 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,5-Dioxopyrrolidin-1-yl hept-6-ynoate, 95+% | 917222-23-2 | USD 24 | 3 | 1 | Inquiry |
| BLDPharm | 1g | 2,5-Dioxopyrrolidin-1-yl hept-6-ynoate, 95+% | 917222-23-2 | USD 64 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 2,5-Dioxopyrrolidin-1-yl hept-6-ynoate, 95+% | 917222-23-2 | USD 221 | 3 | 1 | Inquiry |
| BLDPharm | 5mg | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:MMAE; Vedotin | 474645-27-7 | USD 19 | >5 | 1 | Inquiry |
| BLDPharm | 25mg | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:MMAE; Vedotin | 474645-27-7 | USD 64 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:MMAE; Vedotin | 474645-27-7 | USD 107 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:MMAE; Vedotin | 474645-27-7 | USD 129 | 4 | 1 | 1 |
| BLDPharm | 250mg | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:MMAE; Vedotin | 474645-27-7 | USD 204 | 2 | 2 | 1 |
| BLDPharm | 1g | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:MMAE; Vedotin | 474645-27-7 | USD 580 | >5 | 4 | 2 |
| BLDPharm | 5g | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:MMAE; Vedotin | 474645-27-7 | USD 2332 | 2 | Inquiry | Inquiry |
| BLDPharm | 2mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Monomethylauristatin-F | 745017-94-1 | USD 16 | >5 | 2 | Inquiry |
| BLDPharm | 5mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Monomethylauristatin-F | 745017-94-1 | USD 32 | >5 | 1 | Inquiry |
| BLDPharm | 10mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Monomethylauristatin-F | 745017-94-1 | USD 54 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Monomethylauristatin-F | 745017-94-1 | USD 214 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Monomethylauristatin-F | 745017-94-1 | USD 321 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Monomethylauristatin-F | 745017-94-1 | USD 641 | 3 | 1 | Inquiry |
| BLDPharm | 1g | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Monomethylauristatin-F | 745017-94-1 | USD 1731 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 99% Synonyms:Auristatin-F | 163768-50-1 | USD 191 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 99% Synonyms:Auristatin-F | 163768-50-1 | USD 305 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 99% Synonyms:Auristatin-F | 163768-50-1 | USD 516 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-((tert-Butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid, 98% | 129423-33-2 | USD 95 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-((tert-Butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid, 98% | 129423-33-2 | USD 159 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-((tert-Butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid, 98% | 129423-33-2 | USD 427 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 4105-38-8 | USD 6 | >5 | 2 | Inquiry |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 4105-38-8 | USD 28 | 4 | 2 | Inquiry |
| BLDPharm | 100g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 4105-38-8 | USD 64 | 3 | 1 | Inquiry |
| BLDPharm | 250mg | Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 98% Synonyms:Uridine-5'-diphosphate | 27821-45-0 | USD 10 | >5 | 3 | Inquiry |
| BLDPharm | 1g | Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 98% Synonyms:Uridine-5'-diphosphate | 27821-45-0 | USD 22 | >5 | >5 | 1 |
| BLDPharm | 5g | Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 98% Synonyms:Uridine-5'-diphosphate | 27821-45-0 | USD 74 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 98% Synonyms:Uridine-5'-diphosphate | 27821-45-0 | USD 128 | >5 | 2 | Inquiry |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 98% Synonyms:Uridine-5'-diphosphate | 27821-45-0 | USD 274 | 4 | Inquiry | 1 |
| BLDPharm | 5g | Disodium uridine-5-monophosphate, 98% | 3387-36-8 | USD 20 | >5 | Inquiry | 1 |
| BLDPharm | 25g | Disodium uridine-5-monophosphate, 98% | 3387-36-8 | USD 73 | >5 | 1 | 1 |
| BLDPharm | 100g | Disodium uridine-5-monophosphate, 98% | 3387-36-8 | USD 151 | >5 | Inquiry | Inquiry |
| BLDPharm | 500g | Disodium uridine-5-monophosphate, 98% | 3387-36-8 | USD 182 | >5 | Inquiry | Inquiry |
| BLDPharm | 1kg | Disodium uridine-5-monophosphate, 98% | 3387-36-8 | USD 312 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-D-4-Pal-OH, 95% | 205528-30-9 | USD 12 | >5 | 1 | 1 |
| BLDPharm | 1g | Fmoc-D-4-Pal-OH, 95% | 205528-30-9 | USD 37 | 2 | 1 | 1 |
| BLDPharm | 5g | Fmoc-D-4-Pal-OH, 95% | 205528-30-9 | USD 179 | 1 | 1 | 2 |
| BLDPharm | 10g | Fmoc-D-4-Pal-OH, 95% | 205528-30-9 | USD 276 | 3 | 1 | Inquiry |
| BLDPharm | 25g | Fmoc-D-4-Pal-OH, 95% | 205528-30-9 | USD 687 | 1 | 2 | 2 |
| BLDPharm | 250mg | Fmoc-3-Pal-OH, 97% | 175453-07-3 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 1g | Fmoc-3-Pal-OH, 97% | 175453-07-3 | USD 10 | >5 | 2 | 2 |
| BLDPharm | 5g | Fmoc-3-Pal-OH, 97% | 175453-07-3 | USD 47 | >5 | 2 | 2 |
| BLDPharm | 10g | Fmoc-3-Pal-OH, 97% | 175453-07-3 | USD 93 | >5 | 1 | Inquiry |
| BLDPharm | 25g | Fmoc-3-Pal-OH, 97% | 175453-07-3 | USD 231 | >5 | Inquiry | 4 |
| BLDPharm | 100g | Fmoc-3-Pal-OH, 97% | 175453-07-3 | USD 923 | 2 | Inquiry | 1 |
| BLDPharm | 100mg | 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide, 98% 98%atom%D | 1609393-89-6 | USD 13 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide, 98% 98%atom%D | 1609393-89-6 | USD 26 | >5 | 1 | Inquiry |
| BLDPharm | 1g | 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide, 98% 98%atom%D | 1609393-89-6 | USD 69 | >5 | 1 | 1 |
| BLDPharm | 5g | 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide, 98% 98%atom%D | 1609393-89-6 | USD 343 | >5 | 1 | Inquiry |
| BLDPharm | 1g | Inosine-5'-monophosphate Disodium Salt octahydrate, 98% | 20813-76-7 | USD 7 | 5 | 1 | 1 |
| BLDPharm | 5g | Inosine-5'-monophosphate Disodium Salt octahydrate, 98% | 20813-76-7 | USD 9 | 3 | Inquiry | 1 |
| BLDPharm | 25g | Inosine-5'-monophosphate Disodium Salt octahydrate, 98% | 20813-76-7 | USD 11 | 3 | 1 | 1 |
| BLDPharm | 100g | Inosine-5'-monophosphate Disodium Salt octahydrate, 98% | 20813-76-7 | USD 43 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Adenosine-5'-diphosphate trilithium salt, 98% | 31008-64-7 | USD 24 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Adenosine-5'-diphosphate trilithium salt, 98% | 31008-64-7 | USD 29 | 4 | Inquiry | Inquiry |
| BLDPharm | 10g | Adenosine-5'-diphosphate trilithium salt, 98% | 31008-64-7 | USD 35 | 2 | Inquiry | Inquiry |
| BLDPharm | 25g | Adenosine-5'-diphosphate trilithium salt, 98% | 31008-64-7 | USD 75 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 2004-07-01 00:00:00 | USD 5 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 2004-07-01 00:00:00 | USD 10 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | (2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 2004-07-01 00:00:00 | USD 19 | 1 | Inquiry | 1 |
| BLDPharm | 25g | (2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 2004-07-01 00:00:00 | USD 29 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | (2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 2004-07-01 00:00:00 | USD 112 | >5 | Inquiry | Inquiry |
| BLDPharm | 500g | (2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 2004-07-01 00:00:00 | USD 559 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | Potassium (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-4-hydroxy-5-(((hydroxy(phosphonooxy)phosphoryl)oxy)methyl)tetrahydrofuran-3-olate dihydrate, 97% | 72696-48-1 | USD 5 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Potassium (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-4-hydroxy-5-(((hydroxy(phosphonooxy)phosphoryl)oxy)methyl)tetrahydrofuran-3-olate dihydrate, 97% | 72696-48-1 | USD 10 | >5 | Inquiry | 2 |
| BLDPharm | 5g | Potassium (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-4-hydroxy-5-(((hydroxy(phosphonooxy)phosphoryl)oxy)methyl)tetrahydrofuran-3-olate dihydrate, 97% | 72696-48-1 | USD 26 | >5 | 1 | 1 |
| BLDPharm | 25g | Potassium (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-4-hydroxy-5-(((hydroxy(phosphonooxy)phosphoryl)oxy)methyl)tetrahydrofuran-3-olate dihydrate, 97% | 72696-48-1 | USD 75 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | trans-Zeatinriboside, 96% | 6025-53-2 | USD 18 | >5 | 2 | Inquiry |
| BLDPharm | 100mg | trans-Zeatinriboside, 96% | 6025-53-2 | USD 84 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | trans-Zeatinriboside, 96% | 6025-53-2 | USD 138 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | trans-Zeatinriboside, 96% | 6025-53-2 | USD 370 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | trans-Zeatinriboside, 96% | 6025-53-2 | USD 1295 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 2',3',5'-Tri-O-acetyl-2-fluoroadenosine, 98% | 15811-32-2 | USD 22 | Inquiry | Inquiry | 1 |
| BLDPharm | 5g | 2',3',5'-Tri-O-acetyl-2-fluoroadenosine, 98% | 15811-32-2 | USD 70 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | 2',3',5'-Tri-O-acetyl-2-fluoroadenosine, 98% | 15811-32-2 | USD 114 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4S,5R)-2-(6-Amino-2-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97% | 35109-88-7 | USD 11 | >5 | 1 | 1 |
| BLDPharm | 250mg | (2R,3R,4S,5R)-2-(6-Amino-2-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97% | 35109-88-7 | USD 19 | >5 | 1 | 1 |
| BLDPharm | 1g | (2R,3R,4S,5R)-2-(6-Amino-2-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97% | 35109-88-7 | USD 61 | 1 | Inquiry | 1 |
| BLDPharm | 5g | (2R,3R,4S,5R)-2-(6-Amino-2-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97% | 35109-88-7 | USD 304 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | (2R,3R,4S,5R)-2-(2-Chloro-6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 13276-43-2 | USD 38 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4S,5R)-2-(2-Chloro-6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% | 13276-43-2 | USD 67 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | xSodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate, 95% | 20398-34-9 | USD 11 | 3 | 1 | Inquiry |
| BLDPharm | 1g | xSodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate, 95% | 20398-34-9 | USD 24 | >5 | 3 | Inquiry |
| BLDPharm | 5g | xSodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate, 95% | 20398-34-9 | USD 86 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | xSodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate, 95% | 20398-34-9 | USD 368 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate xsodium salt, 98+% | 13474-03-8 | USD 10 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate xsodium salt, 98+% | 13474-03-8 | USD 36 | >5 | 2 | Inquiry |
| BLDPharm | 500g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate xsodium salt, 98+% | 13474-03-8 | USD 176 | 4 | 1 | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98+% | 16321-99-6 | USD 20 | >5 | 4 | 1 |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98+% | 16321-99-6 | USD 44 | 1 | 2 | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98+% | 16321-99-6 | USD 145 | 1 | 2 | Inquiry |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 98+% | 16321-99-6 | USD 504 | 1 | 3 | 1 |
| BLDPharm | 100mg | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 3056-18-6 | USD 8 | 5 | 1 | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 3056-18-6 | USD 13 | >5 | 2 | 1 |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 3056-18-6 | USD 34 | >5 | 2 | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 3056-18-6 | USD 107 | >5 | 2 | 1 |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate, 97% | 3056-18-6 | USD 370 | >5 | 1 | Inquiry |
| BLDPharm | 1g | (S)-3-Methyl-1-(2-piperidinophenyl)butylamine N-Acetyl-L-glutamate, 95% | 219921-94-5 | USD 14 | >5 | 2 | 2 |
| BLDPharm | 5g | (S)-3-Methyl-1-(2-piperidinophenyl)butylamine N-Acetyl-L-glutamate, 95% | 219921-94-5 | USD 22 | >5 | 1 | 2 |
| BLDPharm | 10g | (S)-3-Methyl-1-(2-piperidinophenyl)butylamine N-Acetyl-L-glutamate, 95% | 219921-94-5 | USD 38 | 1 | 1 | Inquiry |
| BLDPharm | 25g | (S)-3-Methyl-1-(2-piperidinophenyl)butylamine N-Acetyl-L-glutamate, 95% | 219921-94-5 | USD 68 | >5 | 1 | 1 |
| BLDPharm | 100g | (S)-3-Methyl-1-(2-piperidinophenyl)butylamine N-Acetyl-L-glutamate, 95% | 219921-94-5 | USD 225 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | (2R,4R)-Ethyl 1-(2-amino-5-(3-nitroguanidino)pentanoyl)-4-methylpiperidine-2-carboxylate hydrochloride, 95% | 74874-08-1 | USD 11 | >5 | Inquiry | 1 |
| BLDPharm | 1g | (2R,4R)-Ethyl 1-(2-amino-5-(3-nitroguanidino)pentanoyl)-4-methylpiperidine-2-carboxylate hydrochloride, 95% | 74874-08-1 | USD 33 | 5 | 2 | Inquiry |
| BLDPharm | 5g | (2R,4R)-Ethyl 1-(2-amino-5-(3-nitroguanidino)pentanoyl)-4-methylpiperidine-2-carboxylate hydrochloride, 95% | 74874-08-1 | USD 91 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | (2R,4R)-Ethyl 1-(2-amino-5-(3-nitroguanidino)pentanoyl)-4-methylpiperidine-2-carboxylate hydrochloride, 95% | 74874-08-1 | USD 237 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-(2,5-Difluorobenzoyl)piperidine hydrochloride, 95% | 1172297-96-9 | USD 99 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4-(2,5-Difluorobenzoyl)piperidine hydrochloride, 95% | 1172297-96-9 | USD 150 | >5 | 1 | Inquiry |
| BLDPharm | 1g | 4-(2,5-Difluorobenzoyl)piperidine hydrochloride, 95% | 1172297-96-9 | USD 371 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-(Boc-amino)-1-Fmoc-piperidine-4-carboxylic Acid, 95% | 368866-07-3 | USD 12 | >5 | 1 | 1 |
| BLDPharm | 250mg | 4-(Boc-amino)-1-Fmoc-piperidine-4-carboxylic Acid, 95% | 368866-07-3 | USD 15 | >5 | 2 | 1 |
| BLDPharm | 1g | 4-(Boc-amino)-1-Fmoc-piperidine-4-carboxylic Acid, 95% | 368866-07-3 | USD 34 | 5 | 2 | 1 |
| BLDPharm | 5g | 4-(Boc-amino)-1-Fmoc-piperidine-4-carboxylic Acid, 95% | 368866-07-3 | USD 142 | >5 | 2 | 2 |
| BLDPharm | 25g | 4-(Boc-amino)-1-Fmoc-piperidine-4-carboxylic Acid, 95% | 368866-07-3 | USD 709 | >5 | 1 | 1 |
| BLDPharm | 100mg | 2-(4-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)piperazin-1-yl)acetic acid dihydrochloride, 97% | 204320-65-0 | USD 65 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-(4-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)piperazin-1-yl)acetic acid dihydrochloride, 97% | 204320-65-0 | USD 125 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(4-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)piperazin-1-yl)acetic acid dihydrochloride, 97% | 204320-65-0 | USD 250 | 3 | Inquiry | Inquiry |
| BLDPharm | 5mg | 1,4-Dihydrazinylphthalazine sulfate, 98% | 7327-87-9 | USD 37 | >5 | 2 | Inquiry |
| BLDPharm | 10mg | 1,4-Dihydrazinylphthalazine sulfate, 98% | 7327-87-9 | USD 55 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 1,4-Dihydrazinylphthalazine sulfate, 98% | 7327-87-9 | USD 155 | 4 | 2 | Inquiry |
| BLDPharm | 100mg | 1,4-Dihydrazinylphthalazine sulfate, 98% | 7327-87-9 | USD 262 | 1 | 1 | 1 |
| BLDPharm | 250mg | 1,4-Dihydrazinylphthalazine sulfate, 98% | 7327-87-9 | USD 444 | 1 | Inquiry | 1 |
| BLDPharm | 100mg | (2S,3aS,7aS)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid, 98% | 130309-37-4 | USD 5 | >5 | 2 | 1 |
| BLDPharm | 250mg | (2S,3aS,7aS)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid, 98% | 130309-37-4 | USD 10 | >5 | 2 | 2 |
| BLDPharm | 1g | (2S,3aS,7aS)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid, 98% | 130309-37-4 | USD 18 | >5 | 1 | 3 |
| BLDPharm | 5g | (2S,3aS,7aS)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid, 98% | 130309-37-4 | USD 42 | >5 | 1 | 5 |
| BLDPharm | 10g | (2S,3aS,7aS)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid, 98% | 130309-37-4 | USD 51 | >5 | 3 | 1 |
| BLDPharm | 25g | (2S,3aS,7aS)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid, 98% | 130309-37-4 | USD 126 | >5 | 3 | 1 |
| BLDPharm | 100g | (2S,3aS,7aS)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid, 98% | 130309-37-4 | USD 469 | >5 | >5 | 2 |
| BLDPharm | 5g | Fmoc-D-Trp-OH, 97% | 86123-11-7 | USD 6 | >5 | 1 | 2 |
| BLDPharm | 10g | Fmoc-D-Trp-OH, 97% | 86123-11-7 | USD 9 | >5 | 1 | 1 |
| BLDPharm | 25g | Fmoc-D-Trp-OH, 97% | 86123-11-7 | USD 14 | 4 | Inquiry | 1 |
| BLDPharm | 100g | Fmoc-D-Trp-OH, 97% | 86123-11-7 | USD 48 | 1 | 1 | 2 |
| BLDPharm | 500g | Fmoc-D-Trp-OH, 97% | 86123-11-7 | USD 239 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-3-(5-Bromo-1H-indol-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 97% | 114873-17-5 | USD 101 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-(5-Bromo-1H-indol-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 97% | 114873-17-5 | USD 171 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-(5-Bromo-1H-indol-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 97% | 114873-17-5 | USD 460 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-4-Nitrophenyl 2-((tert-butoxycarbonyl)amino)-3-(1H-indol-3-yl)propanoate, 95% | 15160-31-3 | USD 15 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-4-Nitrophenyl 2-((tert-butoxycarbonyl)amino)-3-(1H-indol-3-yl)propanoate, 95% | 15160-31-3 | USD 68 | 4 | Inquiry | Inquiry |
| BLDPharm | 25g | (S)-4-Nitrophenyl 2-((tert-butoxycarbonyl)amino)-3-(1H-indol-3-yl)propanoate, 95% | 15160-31-3 | USD 207 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | ACetylene-PEG4-biotin conjugate, 95% | 1262681-31-1 | USD 245 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | ACetylene-PEG4-biotin conjugate, 95% | 1262681-31-1 | USD 469 | 1 | 2 | Inquiry |
| BLDPharm | 1g | ACetylene-PEG4-biotin conjugate, 95% | 1262681-31-1 | USD 1604 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% | 663171-32-2 | USD 35 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% | 663171-32-2 | USD 48 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% | 663171-32-2 | USD 139 | >5 | 1 | Inquiry |
| BLDPharm | 5g | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% | 663171-32-2 | USD 611 | 2 | 1 | Inquiry |
| BLDPharm | 5g | Diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate, 95% | 144689-94-1 | USD 5 | 2 | Inquiry | 1 |
| BLDPharm | 10g | Diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate, 95% | 144689-94-1 | USD 6 | 2 | Inquiry | 2 |
| BLDPharm | 25g | Diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate, 95% | 144689-94-1 | USD 9 | >5 | 2 | 1 |
| BLDPharm | 100g | Diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate, 95% | 144689-94-1 | USD 25 | >5 | 1 | 2 |
| BLDPharm | 500g | Diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate, 95% | 144689-94-1 | USD 122 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | 2-Amino-2-(furan-2-yl)acetic acid, 95% | 17119-54-9 | USD 108 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-2-(furan-2-yl)acetic acid, 95% | 17119-54-9 | USD 182 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-2-(furan-2-yl)acetic acid, 95% | 17119-54-9 | USD 490 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-Methyl 3-amino-3-(benzo[d][1,3]dioxol-5-yl)propanoate hydrochloride, 95% | 2061996-64-1 | USD 211 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-Methyl 3-amino-3-(benzo[d][1,3]dioxol-5-yl)propanoate hydrochloride, 95% | 2061996-64-1 | USD 315 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-Methyl 3-amino-3-(benzo[d][1,3]dioxol-5-yl)propanoate hydrochloride, 95% | 2061996-64-1 | USD 787 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 2',3'-o-Isopropylideneadenosine, 98% | 362-75-4 | USD 5 | >5 | 2 | 1 |
| BLDPharm | 1g | 2',3'-o-Isopropylideneadenosine, 98% | 362-75-4 | USD 9 | >5 | 5 | 3 |
| BLDPharm | 5g | 2',3'-o-Isopropylideneadenosine, 98% | 362-75-4 | USD 14 | >5 | 1 | Inquiry |
| BLDPharm | 10g | 2',3'-o-Isopropylideneadenosine, 98% | 362-75-4 | USD 23 | >5 | 1 | 2 |
| BLDPharm | 25g | 2',3'-o-Isopropylideneadenosine, 98% | 362-75-4 | USD 45 | >5 | 4 | 4 |
| BLDPharm | 100g | 2',3'-o-Isopropylideneadenosine, 98% | 362-75-4 | USD 69 | 1 | Inquiry | 1 |
| BLDPharm | 500g | 2',3'-o-Isopropylideneadenosine, 98% | 362-75-4 | USD 344 | 2 | Inquiry | 1 |
| BLDPharm | 100mg | H-Arg(Pbf)-OH, 97% | 200115-86-2 | USD 5 | >5 | 1 | 1 |
| BLDPharm | 250mg | H-Arg(Pbf)-OH, 97% | 200115-86-2 | USD 6 | >5 | 1 | 2 |
| BLDPharm | 1g | H-Arg(Pbf)-OH, 97% | 200115-86-2 | USD 8 | >5 | 2 | 1 |
| BLDPharm | 5g | H-Arg(Pbf)-OH, 97% | 200115-86-2 | USD 13 | >5 | 4 | 1 |
| BLDPharm | 10g | H-Arg(Pbf)-OH, 97% | 200115-86-2 | USD 25 | >5 | 2 | 1 |
| BLDPharm | 25g | H-Arg(Pbf)-OH, 97% | 200115-86-2 | USD 52 | >5 | 3 | 2 |
| BLDPharm | 100g | H-Arg(Pbf)-OH, 97% | 200115-86-2 | USD 164 | >5 | 1 | 1 |
| BLDPharm | 250mg | Fmoc-D-Arg(Pbf)-OH, 97% | 187618-60-6 | USD 5 | >5 | 5 | 2 |
| BLDPharm | 1g | Fmoc-D-Arg(Pbf)-OH, 97% | 187618-60-6 | USD 6 | >5 | Inquiry | 2 |
| BLDPharm | 5g | Fmoc-D-Arg(Pbf)-OH, 97% | 187618-60-6 | USD 23 | >5 | >5 | >5 |
| BLDPharm | 10g | Fmoc-D-Arg(Pbf)-OH, 97% | 187618-60-6 | USD 32 | >5 | 1 | 4 |
| BLDPharm | 25g | Fmoc-D-Arg(Pbf)-OH, 97% | 187618-60-6 | USD 76 | >5 | 5 | 3 |
| BLDPharm | 100g | Fmoc-D-Arg(Pbf)-OH, 97% | 187618-60-6 | USD 302 | >5 | >5 | 3 |
| BLDPharm | 500g | Fmoc-D-Arg(Pbf)-OH, 97% | 187618-60-6 | USD 1347 | >5 | Inquiry | 1 |
| BLDPharm | 50mg | 2-Amino-3-(benzofuran-3-yl)propanoic acid, 95% | 72071-49-9 | USD 146 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-Amino-3-(benzofuran-3-yl)propanoic acid, 95% | 72071-49-9 | USD 247 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-3-(benzofuran-3-yl)propanoic acid, 95% | 72071-49-9 | USD 420 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-3-(benzofuran-3-yl)propanoic acid, 95% | 72071-49-9 | USD 1132 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | H-Cys(Trt)-OH, 95% Synonyms:S-Trityl-L-cysteine | 2799-07-07 00:00:00 | USD 5 | >5 | 2 | Inquiry |
| BLDPharm | 5g | H-Cys(Trt)-OH, 95% Synonyms:S-Trityl-L-cysteine | 2799-07-07 00:00:00 | USD 7 | >5 | 1 | >5 |
| BLDPharm | 10g | H-Cys(Trt)-OH, 95% Synonyms:S-Trityl-L-cysteine | 2799-07-07 00:00:00 | USD 10 | >5 | 1 | 1 |
| BLDPharm | 25g | H-Cys(Trt)-OH, 95% Synonyms:S-Trityl-L-cysteine | 2799-07-07 00:00:00 | USD 24 | >5 | 1 | 1 |
| BLDPharm | 100g | H-Cys(Trt)-OH, 95% Synonyms:S-Trityl-L-cysteine | 2799-07-07 00:00:00 | USD 95 | >5 | 1 | 3 |
| BLDPharm | 500g | H-Cys(Trt)-OH, 95% Synonyms:S-Trityl-L-cysteine | 2799-07-07 00:00:00 | USD 422 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | 2,5,8,11,14-Pentaoxahexadecane-16-thiol, 98+% | 524030-00-0 | USD 48 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 2,5,8,11,14-Pentaoxahexadecane-16-thiol, 98+% | 524030-00-0 | USD 80 | >5 | Inquiry | 1 |
| BLDPharm | 1g | 2,5,8,11,14-Pentaoxahexadecane-16-thiol, 98+% | 524030-00-0 | USD 96 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 2,5,8,11,14-Pentaoxahexadecane-16-thiol, 98+% | 524030-00-0 | USD 479 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,5,8,11-Tetraoxatridecane-13-thiol, 95% | 52190-55-3 | USD 77 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,5,8,11-Tetraoxatridecane-13-thiol, 95% | 52190-55-3 | USD 134 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | 2,5,8,11-Tetraoxatridecane-13-thiol, 95% | 52190-55-3 | USD 349 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | L-Leucine benzyl ester p-toluenesulfonate salt, 98% | 1738-77-8 | USD 13 | >5 | 2 | 1 |
| BLDPharm | 25g | L-Leucine benzyl ester p-toluenesulfonate salt, 98% | 1738-77-8 | USD 16 | >5 | 2 | Inquiry |
| BLDPharm | 100g | L-Leucine benzyl ester p-toluenesulfonate salt, 98% | 1738-77-8 | USD 20 | >5 | 2 | Inquiry |
| BLDPharm | 500g | L-Leucine benzyl ester p-toluenesulfonate salt, 98% | 1738-77-8 | USD 99 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | TRiethylene glycol dimethanesulfonate, 95% | 80322-82-3 | USD 41 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | TRiethylene glycol dimethanesulfonate, 95% | 80322-82-3 | USD 107 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | TRiethylene glycol dimethanesulfonate, 95% | 80322-82-3 | USD 370 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl 2-(2-(2-(tosyloxy)ethoxy)ethoxy)acetate, 97% | 882518-89-0 | USD 89 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl 2-(2-(2-(tosyloxy)ethoxy)ethoxy)acetate, 97% | 882518-89-0 | USD 133 | >5 | 1 | Inquiry |
| BLDPharm | 1g | tert-Butyl 2-(2-(2-(tosyloxy)ethoxy)ethoxy)acetate, 97% | 882518-89-0 | USD 449 | >5 | 1 | 1 |
| BLDPharm | 1g | (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 19249-03-7 | USD 5 | >5 | 3 | 2 |
| BLDPharm | 5g | (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 19249-03-7 | USD 8 | >5 | Inquiry | 1 |
| BLDPharm | 10g | (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 19249-03-7 | USD 14 | >5 | >5 | 3 |
| BLDPharm | 25g | (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 19249-03-7 | USD 19 | >5 | 3 | 3 |
| BLDPharm | 100g | (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 19249-03-7 | USD 49 | >5 | 4 | 1 |
| BLDPharm | 500g | (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 19249-03-7 | USD 244 | >5 | 1 | 1 |
| BLDPharm | 1kg | (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 19249-03-7 | USD 415 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Pentaethylene glycol di-p-toluenesulfonate, 98% | 41024-91-3 | USD 17 | >5 | 1 | 1 |
| BLDPharm | 5g | Pentaethylene glycol di-p-toluenesulfonate, 98% | 41024-91-3 | USD 36 | >5 | 3 | 4 |
| BLDPharm | 25g | Pentaethylene glycol di-p-toluenesulfonate, 98% | 41024-91-3 | USD 167 | >5 | 1 | Inquiry |
| BLDPharm | 100g | Pentaethylene glycol di-p-toluenesulfonate, 98% | 41024-91-3 | USD 552 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | ((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 37860-51-8 | USD 5 | >5 | >5 | 1 |
| BLDPharm | 5g | ((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 37860-51-8 | USD 8 | >5 | 1 | 2 |
| BLDPharm | 10g | ((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 37860-51-8 | USD 15 | >5 | 1 | 5 |
| BLDPharm | 25g | ((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 37860-51-8 | USD 21 | >5 | 5 | 3 |
| BLDPharm | 100g | ((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 37860-51-8 | USD 83 | >5 | 1 | 1 |
| BLDPharm | 500g | ((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate), 97% | 37860-51-8 | USD 414 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | L-Tyrosine benzyl ester p-toluenesulfonate salt, 98% | 53587-11-4 | USD 5 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | L-Tyrosine benzyl ester p-toluenesulfonate salt, 98% | 53587-11-4 | USD 6 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | L-Tyrosine benzyl ester p-toluenesulfonate salt, 98% | 53587-11-4 | USD 17 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | L-Tyrosine benzyl ester p-toluenesulfonate salt, 98% | 53587-11-4 | USD 41 | >5 | Inquiry | Inquiry |
| BLDPharm | 500g | L-Tyrosine benzyl ester p-toluenesulfonate salt, 98% | 53587-11-4 | USD 148 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-Cys(tBu)-OH, 98% | 67436-13-9 | USD 5 | >5 | 1 | 1 |
| BLDPharm | 5g | Fmoc-Cys(tBu)-OH, 98% | 67436-13-9 | USD 17 | >5 | 2 | 1 |
| BLDPharm | 10g | Fmoc-Cys(tBu)-OH, 98% | 67436-13-9 | USD 21 | >5 | 1 | 1 |
| BLDPharm | 25g | Fmoc-Cys(tBu)-OH, 98% | 67436-13-9 | USD 51 | >5 | 1 | 4 |
| BLDPharm | 100g | Fmoc-Cys(tBu)-OH, 98% | 67436-13-9 | USD 87 | >5 | 1 | 2 |
| BLDPharm | 100mg | 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine, 95% | 81265-93-2 | USD 16 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine, 95% | 81265-93-2 | USD 26 | >5 | 1 | 1 |
| BLDPharm | 1g | 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine, 95% | 81265-93-2 | USD 37 | >5 | 3 | 1 |
| BLDPharm | 5g | 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine, 95% | 81265-93-2 | USD 126 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine, 95% | 81265-93-2 | USD 441 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 81279-39-2 | USD 25 | >5 | 3 | 1 |
| BLDPharm | 1g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 81279-39-2 | USD 67 | >5 | 2 | 1 |
| BLDPharm | 5g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 81279-39-2 | USD 172 | >5 | 5 | Inquiry |
| BLDPharm | 25g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 81279-39-2 | USD 620 | >5 | 3 | Inquiry |
| BLDPharm | 100mg | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81256-88-4 | USD 17 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81256-88-4 | USD 35 | >5 | 1 | Inquiry |
| BLDPharm | 1g | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81256-88-4 | USD 104 | >5 | Inquiry | 1 |
| BLDPharm | 5g | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81256-88-4 | USD 519 | 5 | 1 | 2 |
| BLDPharm | 250mg | Fmoc-Ser(TBDMS)-OH, 97% | 146346-81-8 | USD 5 | 3 | 1 | 1 |
| BLDPharm | 1g | Fmoc-Ser(TBDMS)-OH, 97% | 146346-81-8 | USD 17 | Inquiry | Inquiry | 1 |
| BLDPharm | 5g | Fmoc-Ser(TBDMS)-OH, 97% | 146346-81-8 | USD 61 | Inquiry | 1 | Inquiry |
| BLDPharm | 10g | Fmoc-Ser(TBDMS)-OH, 97% | 146346-81-8 | USD 74 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | Fmoc-Ser(TBDMS)-OH, 97% | 146346-81-8 | USD 184 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-Isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate, 98% | 1334513-02-8 | USD 6 | >5 | 4 | 1 |
| BLDPharm | 10g | (S)-Isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate, 98% | 1334513-02-8 | USD 11 | >5 | 1 | 1 |
| BLDPharm | 25g | (S)-Isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate, 98% | 1334513-02-8 | USD 24 | >5 | 1 | 1 |
| BLDPharm | 100g | (S)-Isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate, 98% | 1334513-02-8 | USD 69 | >5 | >5 | 2 |
| BLDPharm | 500g | (S)-Isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate, 98% | 1334513-02-8 | USD 303 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | Methyl ((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-L-valinate hydrochloride, 97% | 482577-59-3 | USD 12 | >5 | 1 | 1 |
| BLDPharm | 100g | Methyl ((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-L-valinate hydrochloride, 97% | 482577-59-3 | USD 39 | 1 | 2 | Inquiry |
| BLDPharm | 500g | Methyl ((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-L-valinate hydrochloride, 97% | 482577-59-3 | USD 139 | 1 | 1 | 1 |
| BLDPharm | 250mg | (S)-2-Amino-3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoic acid, 95% | 1041-01-6 | USD 28 | >5 | 1 | Inquiry |
| BLDPharm | 1g | (S)-2-Amino-3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoic acid, 95% | 1041-01-6 | USD 46 | 5 | 3 | Inquiry |
| BLDPharm | 5g | (S)-2-Amino-3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoic acid, 95% | 1041-01-6 | USD 148 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | (S)-2-Amino-3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoic acid, 95% | 1041-01-6 | USD 248 | 2 | Inquiry | Inquiry |
| BLDPharm | 25g | (S)-2-Amino-3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoic acid, 95% | 1041-01-6 | USD 618 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | Sodium N-carbamimidoyl-N-methylglycinate dihydrogen phosphate tetrahydrate, 99% | 71519-72-7 | USD 26 | >5 | 4 | 1 |
| BLDPharm | 25g | Sodium N-carbamimidoyl-N-methylglycinate dihydrogen phosphate tetrahydrate, 99% | 71519-72-7 | USD 58 | >5 | 2 | 1 |
| BLDPharm | 100g | Sodium N-carbamimidoyl-N-methylglycinate dihydrogen phosphate tetrahydrate, 99% | 71519-72-7 | USD 195 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid, 97% | 200124-22-7 | USD 5 | >5 | 1 | 1 |
| BLDPharm | 1g | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid, 97% | 200124-22-7 | USD 6 | >5 | >5 | 1 |
| BLDPharm | 5g | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid, 97% | 200124-22-7 | USD 16 | >5 | 1 | 2 |
| BLDPharm | 10g | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid, 97% | 200124-22-7 | USD 24 | >5 | 2 | 1 |
| BLDPharm | 25g | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid, 97% | 200124-22-7 | USD 54 | >5 | 3 | 5 |
| BLDPharm | 100g | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid, 97% | 200124-22-7 | USD 115 | >5 | 1 | 2 |
| BLDPharm | 500g | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid, 97% | 200124-22-7 | USD 573 | 3 | Inquiry | 1 |
| BLDPharm | 250mg | Boc-Arg(Z)2-OH, 97% | 51219-19-3 | USD 12 | >5 | 2 | 1 |
| BLDPharm | 1g | Boc-Arg(Z)2-OH, 97% | 51219-19-3 | USD 24 | >5 | 4 | 1 |
| BLDPharm | 5g | Boc-Arg(Z)2-OH, 97% | 51219-19-3 | USD 80 | >5 | 3 | 1 |
| BLDPharm | 25g | Boc-Arg(Z)2-OH, 97% | 51219-19-3 | USD 350 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | H-D-Arg-OMe.2HCl, 98% | 78851-84-0 | USD 7 | 5 | 3 | 1 |
| BLDPharm | 5g | H-D-Arg-OMe.2HCl, 98% | 78851-84-0 | USD 34 | 4 | 2 | Inquiry |
| BLDPharm | 25g | H-D-Arg-OMe.2HCl, 98% | 78851-84-0 | USD 52 | 1 | Inquiry | 1 |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)hexanoic acid, 96% | 401915-53-5 | USD 12 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)hexanoic acid, 96% | 401915-53-5 | USD 21 | >5 | 1 | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)hexanoic acid, 96% | 401915-53-5 | USD 83 | >5 | 2 | 3 |
| BLDPharm | 5g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)hexanoic acid, 96% | 401915-53-5 | USD 167 | 4 | Inquiry | 1 |
| BLDPharm | 10g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)hexanoic acid, 96% | 401915-53-5 | USD 333 | 2 | 1 | Inquiry |
| BLDPharm | 50mg | 2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl methacrylate, 95% | 21217-75-4 | USD 159 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 100mg | 2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl methacrylate, 95% | 21217-75-4 | USD 269 | 4 | Inquiry | 0 1 2 3 4 |
| BLDPharm | 250mg | 2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl methacrylate, 95% | 21217-75-4 | USD 458 | 1 | Inquiry | 0 1 |
| BLDPharm | 1g | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid, 98+% | 180181-93-5 | USD 28 | >5 | 1 | 2 |
| BLDPharm | 5g | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid, 98+% | 180181-93-5 | USD 131 | >5 | 1 | 1 |
| BLDPharm | 25g | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid, 98+% | 180181-93-5 | USD 260 | >5 | 1 | 1 |
| BLDPharm | 100g | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid, 98+% | 180181-93-5 | USD 853 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Boc-Tyr(Boc)-OH, 98% | 20866-48-2 | USD 18 | >5 | 3 | Inquiry |
| BLDPharm | 5g | Boc-Tyr(Boc)-OH, 98% | 20866-48-2 | USD 36 | >5 | 2 | 1 |
| BLDPharm | 25g | Boc-Tyr(Boc)-OH, 98% | 20866-48-2 | USD 152 | >5 | 2 | 1 |
| BLDPharm | 100g | Boc-Tyr(Boc)-OH, 98% | 20866-48-2 | USD 459 | 2 | 1 | 1 |
| BLDPharm | 5g | Fmoc-Thr(tBu)-OH, 97% | 71989-35-0 | USD 7 | >5 | 4 | 4 |
| BLDPharm | 10g | Fmoc-Thr(tBu)-OH, 97% | 71989-35-0 | USD 11 | >5 | 5 | 2 |
| BLDPharm | 25g | Fmoc-Thr(tBu)-OH, 97% | 71989-35-0 | USD 24 | >5 | >5 | >5 |
| BLDPharm | 100g | Fmoc-Thr(tBu)-OH, 97% | 71989-35-0 | USD 73 | >5 | >5 | 5 |
| BLDPharm | 500g | Fmoc-Thr(tBu)-OH, 97% | 71989-35-0 | USD 355 | >5 | 3 | 2 |
| BLDPharm | 250mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid, 98% | 77128-73-5 | USD 5 | 1 | Inquiry | 1 |
| BLDPharm | 1g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid, 98% | 77128-73-5 | USD 6 | >5 | 2 | 2 |
| BLDPharm | 5g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid, 98% | 77128-73-5 | USD 10 | 4 | 1 | 1 |
| BLDPharm | 10g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid, 98% | 77128-73-5 | USD 18 | 4 | 4 | Inquiry |
| BLDPharm | 25g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid, 98% | 77128-73-5 | USD 44 | 1 | Inquiry | Inquiry |
| BLDPharm | 100g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid, 98% | 77128-73-5 | USD 175 | >5 | 3 | 1 |
| BLDPharm | 1g | Fmoc-1-Nal-OH, 98% | 96402-49-2 | USD 6 | >5 | 4 | 2 |
| BLDPharm | 5g | Fmoc-1-Nal-OH, 98% | 96402-49-2 | USD 19 | 1 | 2 | 2 |
| BLDPharm | 10g | Fmoc-1-Nal-OH, 98% | 96402-49-2 | USD 35 | 2 | 1 | Inquiry |
| BLDPharm | 25g | Fmoc-1-Nal-OH, 98% | 96402-49-2 | USD 80 | 1 | Inquiry | 1 |
| BLDPharm | 100g | Fmoc-1-Nal-OH, 98% | 96402-49-2 | USD 313 | 4 | 1 | Inquiry |
| BLDPharm | 500g | Fmoc-1-Nal-OH, 98% | 96402-49-2 | USD 1564 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(Naphthalen-2-yl)pyrrolidine-2-carboxamide hydrochloride, 97% | 97216-16-5 | USD 25 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(Naphthalen-2-yl)pyrrolidine-2-carboxamide hydrochloride, 97% | 97216-16-5 | USD 99 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | N-(Naphthalen-2-yl)pyrrolidine-2-carboxamide hydrochloride, 97% | 97216-16-5 | USD 494 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Triethylene Glycol Mono(2-propynyl) Ether, 95% | 208827-90-1 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 250mg | Triethylene Glycol Mono(2-propynyl) Ether, 95% | 208827-90-1 | USD 14 | >5 | 1 | 1 |
| BLDPharm | 1g | Triethylene Glycol Mono(2-propynyl) Ether, 95% | 208827-90-1 | USD 27 | >5 | 4 | 5 |
| BLDPharm | 5g | Triethylene Glycol Mono(2-propynyl) Ether, 95% | 208827-90-1 | USD 125 | >5 | 1 | 2 |
| BLDPharm | 25g | Triethylene Glycol Mono(2-propynyl) Ether, 95% | 208827-90-1 | USD 438 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-(tert-butyl)phenyl)butanoic acid, 98% | 403661-86-9 | USD 78 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-(tert-butyl)phenyl)butanoic acid, 98% | 403661-86-9 | USD 130 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-(tert-butyl)phenyl)butanoic acid, 98% | 403661-86-9 | USD 348 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (Z)-7-(((R)-2-Amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid, 95% Synonyms:MK791 | 82009-34-5 | USD 67 | >5 | 1 | 1 |
| BLDPharm | 1g | (Z)-7-(((R)-2-Amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid, 95% Synonyms:MK791 | 82009-34-5 | USD 168 | >5 | 5 | Inquiry |
| BLDPharm | 5g | (Z)-7-(((R)-2-Amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid, 95% Synonyms:MK791 | 82009-34-5 | USD 506 | 3 | 1 | Inquiry |
| BLDPharm | 10g | (Z)-7-(((R)-2-Amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid, 95% Synonyms:MK791 | 82009-34-5 | USD 810 | 3 | 1 | Inquiry |
| BLDPharm | 25g | (Z)-7-(((R)-2-Amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid, 95% Synonyms:MK791 | 82009-34-5 | USD 1620 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (all-E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 97% | 303-98-0 | USD 5 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (all-E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 97% | 303-98-0 | USD 14 | >5 | Inquiry | 1 |
| BLDPharm | 5g | (all-E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 97% | 303-98-0 | USD 27 | >5 | 2 | 1 |
| BLDPharm | 10g | (all-E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 97% | 303-98-0 | USD 43 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | (all-E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 97% | 303-98-0 | USD 86 | 2 | 1 | Inquiry |
| BLDPharm | 100g | (all-E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 97% | 303-98-0 | USD 266 | Inquiry | Inquiry | 2 |
| BLDPharm | 1kg | 2-(2-(2-Ethoxyethoxy)ethoxy)ethanol, 98% | 112-50-5 | USD 57 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (1S,2S,3S,4R)-Methyl 3-((R)-1-amino-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentanecarboxylate, 98+% | 1988779-13-0 | USD 63 | 1 | Inquiry | 2 |
| BLDPharm | 5g | (1S,2S,3S,4R)-Methyl 3-((R)-1-amino-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentanecarboxylate, 98+% | 1988779-13-0 | USD 76 | 2 | Inquiry | 1 |
| BLDPharm | 25g | (1S,2S,3S,4R)-Methyl 3-((R)-1-amino-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentanecarboxylate, 98+% | 1988779-13-0 | USD 256 | Inquiry | Inquiry | 1 |
| BLDPharm | 250mg | Phenyl-d5-boronic acid, 98% 98atom%D | 215527-70-1 | USD 36 | >5 | 2 | Inquiry |
| BLDPharm | 1g | Phenyl-d5-boronic acid, 98% 98atom%D | 215527-70-1 | USD 63 | >5 | 3 | 2 |
| BLDPharm | 5g | Phenyl-d5-boronic acid, 98% 98atom%D | 215527-70-1 | USD 76 | >5 | 1 | Inquiry |
| BLDPharm | 25g | Phenyl-d5-boronic acid, 98% 98atom%D | 215527-70-1 | USD 348 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | Phenyl-d5-boronic acid, 98% 98atom%D | 215527-70-1 | USD 1149 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | B-[10-(Phenyl-2,3,4,5,6-d5)-9-anthracenyl]boronic acid, 97% | 1453199-87-5 | USD 63 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | B-[10-(Phenyl-2,3,4,5,6-d5)-9-anthracenyl]boronic acid, 97% | 1453199-87-5 | USD 107 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | B-[10-(Phenyl-2,3,4,5,6-d5)-9-anthracenyl]boronic acid, 97% | 1453199-87-5 | USD 287 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 5-(Methyl-d3)-dibenzothiophenium, 1,1,1-trifluoromethanesulfonate, 98% +99.8atom%D | 2251781-83-4 | USD 42 | 1 | 1 | Inquiry |
| BLDPharm | 250mg | 5-(Methyl-d3)-dibenzothiophenium, 1,1,1-trifluoromethanesulfonate, 98% +99.8atom%D | 2251781-83-4 | USD 60 | >5 | 1 | Inquiry |
| BLDPharm | 1g | 5-(Methyl-d3)-dibenzothiophenium, 1,1,1-trifluoromethanesulfonate, 98% +99.8atom%D | 2251781-83-4 | USD 165 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 5-(Methyl-d3)-dibenzothiophenium, 1,1,1-trifluoromethanesulfonate, 98% +99.8atom%D | 2251781-83-4 | USD 488 | >5 | 1 | Inquiry |
| BLDPharm | 25g | 5-(Methyl-d3)-dibenzothiophenium, 1,1,1-trifluoromethanesulfonate, 98% +99.8atom%D | 2251781-83-4 | USD 2010 | 1 | 1 | Inquiry |
| BLDPharm | 1mg | (((S)-1-Carboxy-5-((S)-3-(naphthalen-2-yl)-2-((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)-L-glutamic acid, 99% Synonyms:PSMA-617 * Cold-chain transportation | 1702967-37-0 | USD 61 | >5 | Inquiry | Inquiry |
| BLDPharm | 5mg | (((S)-1-Carboxy-5-((S)-3-(naphthalen-2-yl)-2-((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)-L-glutamic acid, 99% Synonyms:PSMA-617 * Cold-chain transportation | 1702967-37-0 | USD 183 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | (((S)-1-Carboxy-5-((S)-3-(naphthalen-2-yl)-2-((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)-L-glutamic acid, 99% Synonyms:PSMA-617 * Cold-chain transportation | 1702967-37-0 | USD 310 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | (((S)-1-Carboxy-5-((S)-3-(naphthalen-2-yl)-2-((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)-L-glutamic acid, 99% Synonyms:PSMA-617 * Cold-chain transportation | 1702967-37-0 | USD 621 | 3 | Inquiry | Inquiry |
| BLDPharm | 50mg | (((S)-1-Carboxy-5-((S)-3-(naphthalen-2-yl)-2-((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)-L-glutamic acid, 99% Synonyms:PSMA-617 * Cold-chain transportation | 1702967-37-0 | USD 1117 | 1 | Inquiry | Inquiry |
| BLDPharm | 5mg | 2,5-Dioxopyrrolidin-1-yl 4-((5-(((S)-1-(((14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl)oxy)-1-oxopropan-2-yl)(methyl)amino)-2-methyl-5-oxopentan-2-yl)disulfaneyl)butanoate, 99% Synonyms:SPDB-DM4 * Cold-chain transportation | 1626359-62-3 | USD 1320 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | 2,5-Dioxopyrrolidin-1-yl 4-((3-((3-(((S)-1-(((14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl)oxy)-1-oxopropan-2-yl)(methyl)amino)-3-oxopropyl)thio)-2,5-dioxopyrrolidin-1-yl)methyl)cyclohexane-1-carboxylate, 98% Synonyms:SMCC-DM1 * Cold-chain transportation | 1228105-51-8 | USD 1523 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Fmoc-Gly-Gly-OH, 98% | 35665-38-4 | USD 5 | >5 | 3 | 1 |
| BLDPharm | 10g | Fmoc-Gly-Gly-OH, 98% | 35665-38-4 | USD 7 | >5 | 2 | 2 |
| BLDPharm | 25g | Fmoc-Gly-Gly-OH, 98% | 35665-38-4 | USD 16 | >5 | >5 | 2 |
| BLDPharm | 100g | Fmoc-Gly-Gly-OH, 98% | 35665-38-4 | USD 41 | >5 | 4 | 5 |
| BLDPharm | 500g | Fmoc-Gly-Gly-OH, 98% | 35665-38-4 | USD 169 | >5 | 1 | 3 |
| BLDPharm | 100mg | Sodium 1-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate, 98% | 92921-24-9 | USD 30 | >5 | 3 | 1 |
| BLDPharm | 250mg | Sodium 1-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate, 98% | 92921-24-9 | USD 59 | >5 | 1 | 1 |
| BLDPharm | 1g | Sodium 1-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate, 98% | 92921-24-9 | USD 227 | >5 | 2 | 3 |
| BLDPharm | 5g | Sodium 1-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate, 98% | 92921-24-9 | USD 1134 | 1 | 1 | Inquiry |
| BLDPharm | 100mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 98% Synonyms:Fmoc-15-amino-4,7,1,13-tetraoxapentadecanoic acid | 557756-85-1 | USD 59 | >5 | 3 | 3 |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 98% Synonyms:Fmoc-15-amino-4,7,1,13-tetraoxapentadecanoic acid | 557756-85-1 | USD 92 | >5 | 5 | 1 |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 98% Synonyms:Fmoc-15-amino-4,7,1,13-tetraoxapentadecanoic acid | 557756-85-1 | USD 111 | >5 | 5 | >5 |
| BLDPharm | 5g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 98% Synonyms:Fmoc-15-amino-4,7,1,13-tetraoxapentadecanoic acid | 557756-85-1 | USD 134 | >5 | 1 | 5 |
| BLDPharm | 10g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 98% Synonyms:Fmoc-15-amino-4,7,1,13-tetraoxapentadecanoic acid | 557756-85-1 | USD 161 | >5 | Inquiry | 1 |
| BLDPharm | 25g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 98% Synonyms:Fmoc-15-amino-4,7,1,13-tetraoxapentadecanoic acid | 557756-85-1 | USD 314 | 2 | Inquiry | Inquiry |
| BLDPharm | 100g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 98% Synonyms:Fmoc-15-amino-4,7,1,13-tetraoxapentadecanoic acid | 557756-85-1 | USD 1156 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Boc-21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid, 95% | 882847-13-4 | USD 17 | >5 | 1 | 1 |
| BLDPharm | 250mg | Boc-21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid, 95% | 882847-13-4 | USD 29 | >5 | Inquiry | 1 |
| BLDPharm | 1g | Boc-21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid, 95% | 882847-13-4 | USD 63 | >5 | 5 | 1 |
| BLDPharm | 5g | Boc-21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid, 95% | 882847-13-4 | USD 249 | 3 | 1 | 1 |
| BLDPharm | 25g | Boc-21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid, 95% | 882847-13-4 | USD 1215 | 1 | 1 | 1 |
| BLDPharm | 100mg | 2,5-Dioxopyrrolidin-1-yl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19-pentaoxa-4-azadocosan-22-oate, 98% | 1315355-92-0 | USD 68 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | 2,5-Dioxopyrrolidin-1-yl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19-pentaoxa-4-azadocosan-22-oate, 98% | 1315355-92-0 | USD 88 | >5 | 3 | Inquiry |
| BLDPharm | 1g | 2,5-Dioxopyrrolidin-1-yl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19-pentaoxa-4-azadocosan-22-oate, 98% | 1315355-92-0 | USD 106 | 2 | 2 | Inquiry |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid, 97% | 437655-95-3 | USD 29 | >5 | 4 | Inquiry |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid, 97% | 437655-95-3 | USD 115 | >5 | 4 | 2 |
| BLDPharm | 5g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid, 97% | 437655-95-3 | USD 456 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22-heptaoxa-4-azatetracosan-24-oic acid, 95% | 437655-96-4 | USD 50 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22-heptaoxa-4-azatetracosan-24-oic acid, 95% | 437655-96-4 | USD 68 | >5 | 1 | Inquiry |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22-heptaoxa-4-azatetracosan-24-oic acid, 95% | 437655-96-4 | USD 256 | 5 | Inquiry | Inquiry |
| BLDPharm | 5g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22-heptaoxa-4-azatetracosan-24-oic acid, 95% | 437655-96-4 | USD 1131 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate, 95% | 955094-26-5 | USD 20 | >5 | 3 | 1 |
| BLDPharm | 250mg | 2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate, 95% | 955094-26-5 | USD 34 | 5 | 2 | Inquiry |
| BLDPharm | 1g | 2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate, 95% | 955094-26-5 | USD 90 | >5 | 3 | Inquiry |
| BLDPharm | 5g | 2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate, 95% | 955094-26-5 | USD 353 | >5 | 3 | Inquiry |
| BLDPharm | 100mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 97% | 756526-02-0 | USD 20 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 97% | 756526-02-0 | USD 25 | >5 | 3 | Inquiry |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 97% | 756526-02-0 | USD 68 | >5 | 3 | 3 |
| BLDPharm | 5g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 97% | 756526-02-0 | USD 339 | >5 | 1 | Inquiry |
| BLDPharm | 10g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 97% | 756526-02-0 | USD 677 | 1 | 2 | 1 |
| BLDPharm | 25g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 97% | 756526-02-0 | USD 1398 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 5 | >5 | Inquiry | 2 |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 8 | >5 | 3 | 1 |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 10 | >5 | >5 | 3 |
| BLDPharm | 5g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 17 | >5 | 5 | 2 |
| BLDPharm | 10g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 32 | >5 | >5 | 1 |
| BLDPharm | 25g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 67 | >5 | >5 | 5 |
| BLDPharm | 100g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 265 | >5 | >5 | 2 |
| BLDPharm | 500g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid, 98% Synonyms:Fmoc-NH-PEG2-CH2COOH | 166108-71-0 | USD 1319 | >5 | 5 | 1 |
| BLDPharm | 50mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(3-mercaptopropanoyl)-N-methyl-L-alaninate, 99% Synonyms:DM1 | 139504-50-0 | USD 292 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(3-mercaptopropanoyl)-N-methyl-L-alaninate, 99% Synonyms:DM1 | 139504-50-0 | USD 526 | 5 | 1 | Inquiry |
| BLDPharm | 250mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(3-mercaptopropanoyl)-N-methyl-L-alaninate, 99% Synonyms:DM1 | 139504-50-0 | USD 1053 | 3 | 4 | Inquiry |
| BLDPharm | 1g | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(3-mercaptopropanoyl)-N-methyl-L-alaninate, 99% Synonyms:DM1 | 139504-50-0 | USD 2632 | 3 | 1 | Inquiry |
| BLDPharm | 100mg | 4,7,10,13,16,19,22,25,28-Nonaoxahentriacontane-1,31-dioic acid, 97% | 1268488-70-5 | USD 61 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4,7,10,13,16,19,22,25,28-Nonaoxahentriacontane-1,31-dioic acid, 97% | 1268488-70-5 | USD 102 | 2 | 1 | Inquiry |
| BLDPharm | 1g | 4,7,10,13,16,19,22,25,28-Nonaoxahentriacontane-1,31-dioic acid, 97% | 1268488-70-5 | USD 174 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 4,7,10,13,16,19,22,25,28-Nonaoxahentriacontane-1,31-dioic acid, 97% | 1268488-70-5 | USD 869 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-ol, 95% Synonyms:Decaethylene glycol monomethyl ether | 27425-92-9 | USD 8 | >5 | 1 | 1 |
| BLDPharm | 250mg | 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-ol, 95% Synonyms:Decaethylene glycol monomethyl ether | 27425-92-9 | USD 18 | 4 | 2 | 1 |
| BLDPharm | 1g | 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-ol, 95% Synonyms:Decaethylene glycol monomethyl ether | 27425-92-9 | USD 48 | >5 | 4 | 2 |
| BLDPharm | 5g | 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-ol, 95% Synonyms:Decaethylene glycol monomethyl ether | 27425-92-9 | USD 168 | 1 | Inquiry | Inquiry |
| BLDPharm | 10mg | (2S,5S)-2,5-Diamino-6-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)hexanoic acid, 98% | 58944-73-3 | USD 585 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | (2S,5S)-2,5-Diamino-6-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)hexanoic acid, 98% | 58944-73-3 | USD 993 | 4 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2S,5S)-2,5-Diamino-6-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)hexanoic acid, 98% | 58944-73-3 | USD 1687 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | N-(3-Amino-3-oxoprop-1-en-2-yl)-2-((11S,14Z,21S,23S,29S)-14-ethylidene-3,23-dihydroxy-11-((1R)-(1-hydroxyethyl))-31-methyl-9,12,19,24,33,43-hexaoxo-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-21,36-([2,4]-endo-thiazolomethanimino)-5,8:15,18:37,40-tri(azeno)-30,32-epiminobenzo[h1]pyrido[3,2-v][1]oxa[10,20,26,30]tetrathia[6,13,16]triazacyclohexatriacontin-2-yl)thiazole-4-carboxamide, 90% Synonyms:Multhiomycin; RP 9671 | 56377-79-8 | USD 144 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(3-Amino-3-oxoprop-1-en-2-yl)-2-((11S,14Z,21S,23S,29S)-14-ethylidene-3,23-dihydroxy-11-((1R)-(1-hydroxyethyl))-31-methyl-9,12,19,24,33,43-hexaoxo-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-21,36-([2,4]-endo-thiazolomethanimino)-5,8:15,18:37,40-tri(azeno)-30,32-epiminobenzo[h1]pyrido[3,2-v][1]oxa[10,20,26,30]tetrathia[6,13,16]triazacyclohexatriacontin-2-yl)thiazole-4-carboxamide, 90% Synonyms:Multhiomycin; RP 9671 | 56377-79-8 | USD 258 | 3 | 1 | Inquiry |
| BLDPharm | 250mg | N-(3-Amino-3-oxoprop-1-en-2-yl)-2-((11S,14Z,21S,23S,29S)-14-ethylidene-3,23-dihydroxy-11-((1R)-(1-hydroxyethyl))-31-methyl-9,12,19,24,33,43-hexaoxo-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-21,36-([2,4]-endo-thiazolomethanimino)-5,8:15,18:37,40-tri(azeno)-30,32-epiminobenzo[h1]pyrido[3,2-v][1]oxa[10,20,26,30]tetrathia[6,13,16]triazacyclohexatriacontin-2-yl)thiazole-4-carboxamide, 90% Synonyms:Multhiomycin; RP 9671 | 56377-79-8 | USD 504 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(3-Amino-3-oxoprop-1-en-2-yl)-2-((11S,14Z,21S,23S,29S)-14-ethylidene-3,23-dihydroxy-11-((1R)-(1-hydroxyethyl))-31-methyl-9,12,19,24,33,43-hexaoxo-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-21,36-([2,4]-endo-thiazolomethanimino)-5,8:15,18:37,40-tri(azeno)-30,32-epiminobenzo[h1]pyrido[3,2-v][1]oxa[10,20,26,30]tetrathia[6,13,16]triazacyclohexatriacontin-2-yl)thiazole-4-carboxamide, 90% Synonyms:Multhiomycin; RP 9671 | 56377-79-8 | USD 1260 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | (6R,7R)-3-(Acetoxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 98% Synonyms:7-ACA | 957-68-6 | USD 19 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | (6R,7R)-3-(Acetoxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 98% Synonyms:7-ACA | 957-68-6 | USD 75 | >5 | Inquiry | Inquiry |
| BLDPharm | 500g | (6R,7R)-3-(Acetoxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 98% Synonyms:7-ACA | 957-68-6 | USD 179 | >5 | Inquiry | Inquiry |
| BLDPharm | 1kg | (6R,7R)-3-(Acetoxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 98% Synonyms:7-ACA | 957-68-6 | USD 305 | 2 | Inquiry | Inquiry |
| BLDPharm | 1mg | (4S,7S,10S,13S)-7-(2-Carboxyethyl)-4-(carboxymethyl)-13-formyl-10-isopropyl-2,5,8,11-tetraoxo-3,6,9,12-tetraazapentadecan-15-oic acid, 97% Synonyms:Caspase-3 Inhibitor I; N-Ac-Asp-Glu-Val-Asp-CHO | 169332-60-9 | USD 78 | >5 | 2 | Inquiry |
| BLDPharm | 5mg | (4S,7S,10S,13S)-7-(2-Carboxyethyl)-4-(carboxymethyl)-13-formyl-10-isopropyl-2,5,8,11-tetraoxo-3,6,9,12-tetraazapentadecan-15-oic acid, 97% Synonyms:Caspase-3 Inhibitor I; N-Ac-Asp-Glu-Val-Asp-CHO | 169332-60-9 | USD 255 | >5 | 2 | Inquiry |
| BLDPharm | 10mg | (4S,7S,10S,13S)-7-(2-Carboxyethyl)-4-(carboxymethyl)-13-formyl-10-isopropyl-2,5,8,11-tetraoxo-3,6,9,12-tetraazapentadecan-15-oic acid, 97% Synonyms:Caspase-3 Inhibitor I; N-Ac-Asp-Glu-Val-Asp-CHO | 169332-60-9 | USD 340 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol, 98% Synonyms:Octaethyleneglycol monododecyl ether | 3055-98-9 | USD 86 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol, 98% Synonyms:Octaethyleneglycol monododecyl ether | 3055-98-9 | USD 145 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol, 98% Synonyms:Octaethyleneglycol monododecyl ether | 3055-98-9 | USD 389 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol, 98% Synonyms:Octaethyleneglycol monododecyl ether | 3055-98-9 | USD 1380 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | Sodium (S)-2-amino-3-((((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)oxy)propanoate, 98% * Cold-chain transportation | 208757-51-1 | USD 145 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Sodium (S)-2-amino-3-((((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)oxy)propanoate, 98% * Cold-chain transportation | 208757-51-1 | USD 231 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Sodium (S)-2-amino-3-((((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)oxy)propanoate, 98% * Cold-chain transportation | 208757-51-1 | USD 404 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4S,5R)-2-(5,6-Dichloro-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98% Synonyms:5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole | 53-85-0 | USD 112 | 4 | 1 | Inquiry |
| BLDPharm | 250mg | (2R,3R,4S,5R)-2-(5,6-Dichloro-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98% Synonyms:5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole | 53-85-0 | USD 213 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4S,5R)-2-(5,6-Dichloro-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98% Synonyms:5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole | 53-85-0 | USD 617 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2'-Deoxyguanosine-5'-monophosphoric acid disodium salt, 98% | 33430-61-4 | USD 32 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | 2'-Deoxyguanosine-5'-monophosphoric acid disodium salt, 98% | 33430-61-4 | USD 55 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 2'-Deoxyguanosine-5'-monophosphoric acid disodium salt, 98% | 33430-61-4 | USD 149 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 2'-Deoxyguanosine-5'-monophosphoric acid disodium salt, 98% | 33430-61-4 | USD 522 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 223777-16-0 | USD 22 | 3 | 2 | 1 |
| BLDPharm | 250mg | 4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 223777-16-0 | USD 35 | >5 | Inquiry | 1 |
| BLDPharm | 1g | 4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 223777-16-0 | USD 83 | >5 | Inquiry | 2 |
| BLDPharm | 5g | 4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 223777-16-0 | USD 290 | 1 | 1 | Inquiry |
| BLDPharm | 100mg | N4-Methylcytidine, 98% | 10578-79-7 | USD 70 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N4-Methylcytidine, 98% | 10578-79-7 | USD 119 | >5 | 1 | Inquiry |
| BLDPharm | 1g | N4-Methylcytidine, 98% | 10578-79-7 | USD 425 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | Sodium ((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl phosphate, 95% Synonyms:Thymidine-5′-monophosphate disodium salt | 33430-62-5 | USD 72 | 1 | Inquiry | 1 |
| BLDPharm | 1g | Sodium ((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl phosphate, 95% Synonyms:Thymidine-5′-monophosphate disodium salt | 33430-62-5 | USD 144 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | Sodium ((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl phosphate, 95% Synonyms:Thymidine-5′-monophosphate disodium salt | 33430-62-5 | USD 558 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-hydroxypyrimidine-2,4(1H,3H)-dione, 97% | 957-77-7 | USD 1856 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | 2-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 97% | 62160-23-0 | USD 295 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | 2-Amino-5-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-4(3H)-one, 95% | 57100-18-2 | USD 194 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-Amino-5-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-4(3H)-one, 95% | 57100-18-2 | USD 329 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-5-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-4(3H)-one, 95% | 57100-18-2 | USD 558 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-acetyl-N-methyl-L-alaninate, 98+% Synonyms:Maytansine; NSC-153858; DM-1 | 35846-53-8 | USD 104 | 1 | Inquiry | Inquiry |
| BLDPharm | 10mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-acetyl-N-methyl-L-alaninate, 98+% Synonyms:Maytansine; NSC-153858; DM-1 | 35846-53-8 | USD 176 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-acetyl-N-methyl-L-alaninate, 98+% Synonyms:Maytansine; NSC-153858; DM-1 | 35846-53-8 | USD 352 | 3 | 1 | Inquiry |
| BLDPharm | 50mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-acetyl-N-methyl-L-alaninate, 98+% Synonyms:Maytansine; NSC-153858; DM-1 | 35846-53-8 | USD 598 | 2 | 1 | Inquiry |
| BLDPharm | 100mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-acetyl-N-methyl-L-alaninate, 98+% Synonyms:Maytansine; NSC-153858; DM-1 | 35846-53-8 | USD 1017 | 3 | 1 | Inquiry |
| BLDPharm | 250mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-acetyl-N-methyl-L-alaninate, 98+% Synonyms:Maytansine; NSC-153858; DM-1 | 35846-53-8 | USD 1728 | 1 | Inquiry | Inquiry |
| BLDPharm | 1mg | (S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N-((3R,4S,5S)-3-methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethylbutanamide, 98% Synonyms:DLS 1; NSC-376128 | 110417-88-4 | USD 100 | 1 | Inquiry | Inquiry |
| BLDPharm | 5mg | (S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N-((3R,4S,5S)-3-methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethylbutanamide, 98% Synonyms:DLS 1; NSC-376128 | 110417-88-4 | USD 254 | 1 | Inquiry | Inquiry |
| BLDPharm | 10mg | (S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N-((3R,4S,5S)-3-methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethylbutanamide, 98% Synonyms:DLS 1; NSC-376128 | 110417-88-4 | USD 380 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N-((3R,4S,5S)-3-methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethylbutanamide, 98% Synonyms:DLS 1; NSC-376128 | 110417-88-4 | USD 647 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N-((3R,4S,5S)-3-methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethylbutanamide, 98% Synonyms:DLS 1; NSC-376128 | 110417-88-4 | USD 1035 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethylbutanamide, 99+% Synonyms:Auristatin-E | 160800-57-7 | USD 2550 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-N-((3R,4S,5S)-3-Methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:Demethyldolastatin 1; Monomethylauristatin D; Monomethyl Dolastatin 1 | 203849-91-6 | USD 241 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-N-((3R,4S,5S)-3-Methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:Demethyldolastatin 1; Monomethylauristatin D; Monomethyl Dolastatin 1 | 203849-91-6 | USD 410 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-N-((3R,4S,5S)-3-Methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:Demethyldolastatin 1; Monomethylauristatin D; Monomethyl Dolastatin 1 | 203849-91-6 | USD 697 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-N-((3R,4S,5S)-3-Methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide, 98% Synonyms:Demethyldolastatin 1; Monomethylauristatin D; Monomethyl Dolastatin 1 | 203849-91-6 | USD 1183 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-8-bromo-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 97% Synonyms:8-bromo-guanosine; 2-Amino-8-bromo-6-hydroxypurine riboside | 4016-63-1 | USD 7 | >5 | 2 | 1 |
| BLDPharm | 5g | 2-Amino-8-bromo-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 97% Synonyms:8-bromo-guanosine; 2-Amino-8-bromo-6-hydroxypurine riboside | 4016-63-1 | USD 27 | 4 | 3 | Inquiry |
| BLDPharm | 25g | 2-Amino-8-bromo-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 97% Synonyms:8-bromo-guanosine; 2-Amino-8-bromo-6-hydroxypurine riboside | 4016-63-1 | USD 50 | 5 | 2 | Inquiry |
| BLDPharm | 100g | 2-Amino-8-bromo-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 97% Synonyms:8-bromo-guanosine; 2-Amino-8-bromo-6-hydroxypurine riboside | 4016-63-1 | USD 199 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% Synonyms:N-IbuG; N2-Isobutyryl-D-guanosine | 64350-24-9 | USD 5 | >5 | 3 | 1 |
| BLDPharm | 5g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% Synonyms:N-IbuG; N2-Isobutyryl-D-guanosine | 64350-24-9 | USD 12 | >5 | 2 | 2 |
| BLDPharm | 10g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% Synonyms:N-IbuG; N2-Isobutyryl-D-guanosine | 64350-24-9 | USD 21 | >5 | 2 | 2 |
| BLDPharm | 25g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% Synonyms:N-IbuG; N2-Isobutyryl-D-guanosine | 64350-24-9 | USD 29 | >5 | Inquiry | 4 |
| BLDPharm | 100g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% Synonyms:N-IbuG; N2-Isobutyryl-D-guanosine | 64350-24-9 | USD 109 | >5 | 1 | 5 |
| BLDPharm | 500g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% Synonyms:N-IbuG; N2-Isobutyryl-D-guanosine | 64350-24-9 | USD 544 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97% | 40733-27-5 | USD 58 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97% | 40733-27-5 | USD 82 | >5 | 1 | Inquiry |
| BLDPharm | 1g | 1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97% | 40733-27-5 | USD 113 | >5 | 5 | 2 |
| BLDPharm | 5g | 1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97% | 40733-27-5 | USD 444 | >5 | 5 | Inquiry |
| BLDPharm | 25g | 1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97% | 40733-27-5 | USD 1554 | 3 | 1 | Inquiry |
| BLDPharm | 100mg | 5-Iodo-cytidine, 98% | 1147-23-5 | USD 7 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 5-Iodo-cytidine, 98% | 1147-23-5 | USD 10 | >5 | 2 | 1 |
| BLDPharm | 1g | 5-Iodo-cytidine, 98% | 1147-23-5 | USD 28 | >5 | 1 | 1 |
| BLDPharm | 5g | 5-Iodo-cytidine, 98% | 1147-23-5 | USD 73 | 4 | 5 | Inquiry |
| BLDPharm | 25g | 5-Iodo-cytidine, 98% | 1147-23-5 | USD 294 | 4 | 1 | Inquiry |
| BLDPharm | 25mg | (2R,3R,4S,5R)-2-(6-Amino-8-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98% | 34408-14-5 | USD 462 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-((3R,11S,17S,20S,25aS)-20-((1H-Indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2]dithia[5,8,11,14,17,20]hexaazacyclotricosin-17-yl)acetic acid acetic acid (1:x), 98% * Cold-chain transportation | 881997-86-0 | USD 122 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-((3R,11S,17S,20S,25aS)-20-((1H-Indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2]dithia[5,8,11,14,17,20]hexaazacyclotricosin-17-yl)acetic acid acetic acid (1:x), 98% * Cold-chain transportation | 881997-86-0 | USD 207 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-((3R,11S,17S,20S,25aS)-20-((1H-Indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2]dithia[5,8,11,14,17,20]hexaazacyclotricosin-17-yl)acetic acid acetic acid (1:x), 98% * Cold-chain transportation | 881997-86-0 | USD 556 | 3 | Inquiry | Inquiry |
| BLDPharm | 10mg | (2S,4R)-N-((S)-2-(tert-Butyl)-24-chloro-4-oxo-6,9,12,15,18-pentaoxa-3-azatetracosanoyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98% | 1799506-06-1 | USD 846 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide, 98% | 1957236-22-4 | USD 444 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid, 95% | 2138440-81-8 | USD 115 | 4 | 4 | Inquiry |
| BLDPharm | 100mg | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid, 95% | 2138440-81-8 | USD 229 | 3 | 3 | Inquiry |
| BLDPharm | 250mg | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid, 95% | 2138440-81-8 | USD 341 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid, 95% | 2138440-81-8 | USD 931 | 2 | 1 | Inquiry |
| BLDPharm | 50mg | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 99% | 2225148-49-0 | USD 115 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 99% | 2225148-49-0 | USD 229 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 99% | 2225148-49-0 | USD 571 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 99% | 2225148-49-0 | USD 931 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S,R,S)-AHPC-PEG3-NH2, 95% | 2010159-56-3 | USD 845 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S,R,S)-AHPC-PEG2-NH2, 99% | 2010159-60-9 | USD 2254 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,4R)-1-((S)-17-Amino-2-(tert-butyl)-4-oxo-6,9,12,15-tetraoxa-3-azaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98% | 2010159-57-4 | USD 1837 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | PAC, 98+% * Cold-chain transportation | 2158322-33-7 | USD 2894 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-((S)-N-(2,3-Dihydro-1H-inden-2-yl)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanamido)acetic acid hydrochloride, 97% | 83435-67-0 | USD 124 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 2-((S)-N-(2,3-Dihydro-1H-inden-2-yl)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanamido)acetic acid hydrochloride, 97% | 83435-67-0 | USD 618 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | (2S,3aS,6aS)-1-(((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid, 95% Synonyms:Ramipril Diacid | 87269-97-4 | USD 118 | Inquiry | 1 | Inquiry |
| BLDPharm | 50mg | (2S,3aS,6aS)-1-(((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid, 95% Synonyms:Ramipril Diacid | 87269-97-4 | USD 200 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,3aS,6aS)-1-(((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid, 95% Synonyms:Ramipril Diacid | 87269-97-4 | USD 340 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | (1-(Cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycine, 98% | 1616690-16-4 | USD 101 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (1-(Cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycine, 98% | 1616690-16-4 | USD 161 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (1-(Cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycine, 98% | 1616690-16-4 | USD 257 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | (1-(Cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycine, 98% | 1616690-16-4 | USD 437 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (1-(Cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycine, 98% | 1616690-16-4 | USD 1181 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | (S)-1-(L-Alanyl-L-tyrosyl)-N-(2-(((S)-6-amino-1-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-1-oxohexan-2-yl)amino)-2-oxoethyl)pyrrolidine-2-carboxamide, 99+% Synonyms:H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2 | 352017-71-1 | USD 459 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | L-Arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine, 98% | 60482-95-3 | USD 90 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | L-Arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine, 98% | 60482-95-3 | USD 144 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | L-Arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine, 98% | 60482-95-3 | USD 230 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | L-Arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine, 98% | 60482-95-3 | USD 390 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | (R)-2-Acetamido-3-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)thio)propanoic acid, 97% Synonyms:Arazine | 135304-07-3 | USD 331 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | (Glp1)-Apelin-13, 97% Synonyms:(pGlu1)Apelin-13; [Pyr1]-Apelin-13; Pyr-Apelin-13 | 217082-60-5 | USD 59 | >5 | 2 | Inquiry |
| BLDPharm | 5mg | (Glp1)-Apelin-13, 97% Synonyms:(pGlu1)Apelin-13; [Pyr1]-Apelin-13; Pyr-Apelin-13 | 217082-60-5 | USD 233 | 5 | 1 | Inquiry |
| BLDPharm | 10mg | (Glp1)-Apelin-13, 97% Synonyms:(pGlu1)Apelin-13; [Pyr1]-Apelin-13; Pyr-Apelin-13 | 217082-60-5 | USD 437 | 1 | Inquiry | Inquiry |
| BLDPharm | 5mg | N-(2-Aminoethyl)-2-(4-(2-(4-((9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)amino)phenyl)acetamido)phenyl)acetamide, 98+% Synonyms:ADAC | 96760-69-9 | USD 74 | 1 | 4 | Inquiry |
| BLDPharm | 10mg | N-(2-Aminoethyl)-2-(4-(2-(4-((9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)amino)phenyl)acetamido)phenyl)acetamide, 98+% Synonyms:ADAC | 96760-69-9 | USD 111 | Inquiry | 4 | Inquiry |
| BLDPharm | 25mg | N-(2-Aminoethyl)-2-(4-(2-(4-((9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)amino)phenyl)acetamido)phenyl)acetamide, 98+% Synonyms:ADAC | 96760-69-9 | USD 188 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | N-(2-Aminoethyl)-2-(4-(2-(4-((9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)amino)phenyl)acetamido)phenyl)acetamide, 98+% Synonyms:ADAC | 96760-69-9 | USD 301 | Inquiry | 4 | Inquiry |
| BLDPharm | 100mg | N-(2-Aminoethyl)-2-(4-(2-(4-((9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)amino)phenyl)acetamido)phenyl)acetamide, 98+% Synonyms:ADAC | 96760-69-9 | USD 481 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4S,5R)-2-(2-Chloro-6-(cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98% Synonyms:2-Chloro-N-cyclopentyladenosine; CCPA | 37739-05-2 | USD 898 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (2R,3R,4S,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98+% Synonyms:CPA | 41552-82-3 | USD 1409 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | 4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 95% | 606-58-6 | USD 100 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 95% | 606-58-6 | USD 169 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 95% | 606-58-6 | USD 287 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 95% | 606-58-6 | USD 862 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-Amino-4-(guanidinooxy)butanoic acid sulfuric acid salt, 98% | 2219-31-0 | USD 145 | Inquiry | Inquiry | |
| BLDPharm | 100mg | (6S,9S,12S,15S,18S)-1,6-Diamino-9-(4-aminobutyl)-12-(carboxymethyl)-18-(4-hydroxybenzyl)-1-imino-15-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecan-19-oic acid, 99% Synonyms:TP5 | 69558-55-0 | USD 92 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (6S,9S,12S,15S,18S)-1,6-Diamino-9-(4-aminobutyl)-12-(carboxymethyl)-18-(4-hydroxybenzyl)-1-imino-15-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecan-19-oic acid, 99% Synonyms:TP5 | 69558-55-0 | USD 155 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (6S,9S,12S,15S,18S)-1,6-Diamino-9-(4-aminobutyl)-12-(carboxymethyl)-18-(4-hydroxybenzyl)-1-imino-15-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecan-19-oic acid, 99% Synonyms:TP5 | 69558-55-0 | USD 263 | 1 | Inquiry | Inquiry |
| BLDPharm | 1mg | (S)-N-((S)-1-(((S)-1-(((S)-1-(((S)-1-Amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-5-gua, 98% * Cold-chain transportation | 878557-55-2 | USD 105 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (6S,9S,12S)-12-Benzyl-9-isobutyl-2,2-dimethyl-6-(2-(methylthio)ethyl)-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oic acid, 98% Synonyms:Boc-Met-Leu-Phe-OH | 67247-12-5 | USD 431 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | Beta-elemonicacid, 95% | 28282-25-9 | USD 105 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Beta-elemonicacid, 95% | 28282-25-9 | USD 178 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | Beta-elemonicacid, 95% | 28282-25-9 | USD 302 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-(2-(2-(2-(Aminooxy)ethoxy)ethoxy)ethoxy)ethanol, 95% * Cold-chain transportation | 106492-60-8 | USD 40 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-(2-(2-(2-(Aminooxy)ethoxy)ethoxy)ethoxy)ethanol, 95% * Cold-chain transportation | 106492-60-8 | USD 60 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 2-(2-(2-(2-(Aminooxy)ethoxy)ethoxy)ethoxy)ethanol, 95% * Cold-chain transportation | 106492-60-8 | USD 150 | >5 | 3 | Inquiry |
| BLDPharm | 5g | 2-(2-(2-(2-(Aminooxy)ethoxy)ethoxy)ethoxy)ethanol, 95% * Cold-chain transportation | 106492-60-8 | USD 523 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | O-(3,6,9,12-Tetraoxapentadec-14-yn-1-yl)hydroxylamine, 95% | 1835759-78-8 | USD 15 | >5 | 4 | 1 |
| BLDPharm | 250mg | O-(3,6,9,12-Tetraoxapentadec-14-yn-1-yl)hydroxylamine, 95% | 1835759-78-8 | USD 19 | >5 | 5 | 1 |
| BLDPharm | 1g | O-(3,6,9,12-Tetraoxapentadec-14-yn-1-yl)hydroxylamine, 95% | 1835759-78-8 | USD 75 | 5 | 5 | 1 |
| BLDPharm | 100mg | 5,8,11-Trioxa-2-azatridecan-13-ol, 97% | 90430-59-4 | USD 29 | >5 | 2 | 1 |
| BLDPharm | 250mg | 5,8,11-Trioxa-2-azatridecan-13-ol, 97% | 90430-59-4 | USD 43 | >5 | 2 | 1 |
| BLDPharm | 1g | 5,8,11-Trioxa-2-azatridecan-13-ol, 97% | 90430-59-4 | USD 52 | 2 | Inquiry | 1 |
| BLDPharm | 5g | 5,8,11-Trioxa-2-azatridecan-13-ol, 97% | 90430-59-4 | USD 259 | 1 | 1 | 1 |
| BLDPharm | 100mg | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid, 97% | 1451362-51-8 | USD 27 | 5 | 1 | 1 |
| BLDPharm | 250mg | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid, 97% | 1451362-51-8 | USD 46 | >5 | 3 | 1 |
| BLDPharm | 1g | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid, 97% | 1451362-51-8 | USD 125 | >5 | 3 | 1 |
| BLDPharm | 5g | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid, 97% | 1451362-51-8 | USD 434 | >5 | 2 | 1 |
| BLDPharm | 100mg | tert-Butyl 1-bromo-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate, 97% | 1807521-00-1 | USD 13 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl 1-bromo-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate, 97% | 1807521-00-1 | USD 24 | >5 | 2 | 1 |
| BLDPharm | 1g | tert-Butyl 1-bromo-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate, 97% | 1807521-00-1 | USD 34 | >5 | 2 | 2 |
| BLDPharm | 5g | tert-Butyl 1-bromo-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate, 97% | 1807521-00-1 | USD 134 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate, 95% | 169751-73-9 | USD 27 | >5 | 2 | 1 |
| BLDPharm | 250mg | tert-Butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate, 95% | 169751-73-9 | USD 60 | 2 | 2 | 1 |
| BLDPharm | 1g | tert-Butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate, 95% | 169751-73-9 | USD 114 | 5 | 3 | 1 |
| BLDPharm | 5g | tert-Butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate, 95% | 169751-73-9 | USD 410 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl 20-hydroxy-3,6,9,12,15,18-hexaoxaicosanoate, 98% | 297162-47-1 | USD 27 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl 20-hydroxy-3,6,9,12,15,18-hexaoxaicosanoate, 98% | 297162-47-1 | USD 33 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | tert-Butyl 20-hydroxy-3,6,9,12,15,18-hexaoxaicosanoate, 98% | 297162-47-1 | USD 112 | >5 | 1 | Inquiry |
| BLDPharm | 5g | tert-Butyl 20-hydroxy-3,6,9,12,15,18-hexaoxaicosanoate, 98% | 297162-47-1 | USD 559 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | HOOCCH2CH2O-PEG7-CH2CH2COOH, 95% | 1246189-43-4 | USD 20 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | HOOCCH2CH2O-PEG7-CH2CH2COOH, 95% | 1246189-43-4 | USD 49 | >5 | 1 | Inquiry |
| BLDPharm | 1g | HOOCCH2CH2O-PEG7-CH2CH2COOH, 95% | 1246189-43-4 | USD 195 | >5 | 3 | Inquiry |
| BLDPharm | 5g | HOOCCH2CH2O-PEG7-CH2CH2COOH, 95% | 1246189-43-4 | USD 974 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silahexadecan-16-oic acid, 95% | 1807540-77-7 | USD 58 | >5 | 1 | 1 |
| BLDPharm | 250mg | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silahexadecan-16-oic acid, 95% | 1807540-77-7 | USD 86 | >5 | 2 | 1 |
| BLDPharm | 1g | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silahexadecan-16-oic acid, 95% | 1807540-77-7 | USD 215 | >5 | 2 | 1 |
| BLDPharm | 5g | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silahexadecan-16-oic acid, 95% | 1807540-77-7 | USD 750 | 2 | 1 | 1 |
| BLDPharm | 100mg | 20-Amino-3,6,9,12,15,18-hexaoxaicosan-1-ol, 98% | 1425973-14-3 | USD 22 | >5 | 1 | 2 |
| BLDPharm | 250mg | 20-Amino-3,6,9,12,15,18-hexaoxaicosan-1-ol, 98% | 1425973-14-3 | USD 27 | >5 | 1 | 1 |
| BLDPharm | 1g | 20-Amino-3,6,9,12,15,18-hexaoxaicosan-1-ol, 98% | 1425973-14-3 | USD 80 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 20-Amino-3,6,9,12,15,18-hexaoxaicosan-1-ol, 98% | 1425973-14-3 | USD 331 | 2 | 1 | Inquiry |
| BLDPharm | 100mg | Benzyl (2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl)carbamate, 95% | 206265-31-8 | USD 133 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Benzyl (2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl)carbamate, 95% | 206265-31-8 | USD 225 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Benzyl (2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl)carbamate, 95% | 206265-31-8 | USD 607 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silapentadecan-15-ol, 95% | 134179-40-1 | USD 20 | >5 | 3 | Inquiry |
| BLDPharm | 1g | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silapentadecan-15-ol, 95% | 134179-40-1 | USD 27 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silapentadecan-15-ol, 95% | 134179-40-1 | USD 134 | >5 | 1 | Inquiry |
| BLDPharm | 25g | 2,2,3,3-Tetramethyl-4,7,10,13-tetraoxa-3-silapentadecan-15-ol, 95% | 134179-40-1 | USD 469 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | 14-Hydroxy-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate, 98% | 155130-15-7 | USD 12 | >5 | 5 | 1 |
| BLDPharm | 250mg | 14-Hydroxy-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate, 98% | 155130-15-7 | USD 29 | >5 | 5 | 1 |
| BLDPharm | 1g | 14-Hydroxy-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate, 98% | 155130-15-7 | USD 49 | >5 | 4 | 1 |
| BLDPharm | 5g | 14-Hydroxy-3,6,9,12-tetraoxatetradecyl 4-methylbenzenesulfonate, 98% | 155130-15-7 | USD 216 | >5 | 4 | 1 |
| BLDPharm | 100mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 97% | 756525-91-4 | USD 9 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 97% | 756525-91-4 | USD 12 | 4 | 1 | 3 |
| BLDPharm | 1g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 97% | 756525-91-4 | USD 32 | 1 | 3 | Inquiry |
| BLDPharm | 5g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 97% | 756525-91-4 | USD 159 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 97% | 756525-91-4 | USD 489 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,2,3,3-Tetramethyl-4,7,10-trioxa-3-siladodecan-12-ol, 98% | 201037-95-8 | USD 13 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | 2,2,3,3-Tetramethyl-4,7,10-trioxa-3-siladodecan-12-ol, 98% | 201037-95-8 | USD 20 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 2,2,3,3-Tetramethyl-4,7,10-trioxa-3-siladodecan-12-ol, 98% | 201037-95-8 | USD 74 | >5 | 1 | 2 |
| BLDPharm | 5g | 2,2,3,3-Tetramethyl-4,7,10-trioxa-3-siladodecan-12-ol, 98% | 201037-95-8 | USD 285 | >5 | 1 | Inquiry |
| BLDPharm | 25g | 2,2,3,3-Tetramethyl-4,7,10-trioxa-3-siladodecan-12-ol, 98% | 201037-95-8 | USD 998 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4,7,10,13-Tetraoxahexadec-15-yn-1-oic acid, 97% | 1415800-32-6 | USD 15 | >5 | 1 | 1 |
| BLDPharm | 250mg | 4,7,10,13-Tetraoxahexadec-15-yn-1-oic acid, 97% | 1415800-32-6 | USD 20 | >5 | 3 | 1 |
| BLDPharm | 1g | 4,7,10,13-Tetraoxahexadec-15-yn-1-oic acid, 97% | 1415800-32-6 | USD 43 | >5 | 4 | 2 |
| BLDPharm | 5g | 4,7,10,13-Tetraoxahexadec-15-yn-1-oic acid, 97% | 1415800-32-6 | USD 190 | >5 | 4 | 1 |
| BLDPharm | 25g | 4,7,10,13-Tetraoxahexadec-15-yn-1-oic acid, 97% | 1415800-32-6 | USD 784 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | O-(2-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)hydroxylamine, 95% * Cold-chain transportation | 1807537-27-4 | USD 53 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | O-(2-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)hydroxylamine, 95% * Cold-chain transportation | 1807537-27-4 | USD 79 | >5 | 3 | Inquiry |
| BLDPharm | 1g | O-(2-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)hydroxylamine, 95% * Cold-chain transportation | 1807537-27-4 | USD 197 | >5 | 3 | Inquiry |
| BLDPharm | 5g | O-(2-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)hydroxylamine, 95% * Cold-chain transportation | 1807537-27-4 | USD 688 | 3 | 1 | Inquiry |
| BLDPharm | 100mg | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, 95% * Cold-chain transportation | 1246999-33-6 | USD 24 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, 95% * Cold-chain transportation | 1246999-33-6 | USD 36 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, 95% * Cold-chain transportation | 1246999-33-6 | USD 59 | 2 | >5 | 1 |
| BLDPharm | 5g | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, 95% * Cold-chain transportation | 1246999-33-6 | USD 294 | >5 | 3 | Inquiry |
| BLDPharm | 25g | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, 95% * Cold-chain transportation | 1246999-33-6 | USD 1182 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl (2-(2-(2-(2-(aminooxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 95% | 2062663-65-2 | USD 56 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl (2-(2-(2-(2-(aminooxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 95% | 2062663-65-2 | USD 95 | >5 | 2 | Inquiry |
| BLDPharm | 1g | tert-Butyl (2-(2-(2-(2-(aminooxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 95% | 2062663-65-2 | USD 256 | 3 | 5 | Inquiry |
| BLDPharm | 5g | tert-Butyl (2-(2-(2-(2-(aminooxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 95% | 2062663-65-2 | USD 895 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12-Tetraoxapentadec-14-yn-1-yl 4-methylbenzenesulfonate, 98% | 875770-32-4 | USD 22 | >5 | 4 | 1 |
| BLDPharm | 250mg | 3,6,9,12-Tetraoxapentadec-14-yn-1-yl 4-methylbenzenesulfonate, 98% | 875770-32-4 | USD 27 | >5 | 5 | 1 |
| BLDPharm | 1g | 3,6,9,12-Tetraoxapentadec-14-yn-1-yl 4-methylbenzenesulfonate, 98% | 875770-32-4 | USD 64 | >5 | Inquiry | 1 |
| BLDPharm | 5g | 3,6,9,12-Tetraoxapentadec-14-yn-1-yl 4-methylbenzenesulfonate, 98% | 875770-32-4 | USD 318 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-yl 4-methylbenzenesulfonate, 98% * Cold-chain transportation | 1404111-69-8 | USD 32 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-yl 4-methylbenzenesulfonate, 98% * Cold-chain transportation | 1404111-69-8 | USD 47 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-yl 4-methylbenzenesulfonate, 98% * Cold-chain transportation | 1404111-69-8 | USD 118 | >5 | 1 | 1 |
| BLDPharm | 5g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-yl 4-methylbenzenesulfonate, 98% * Cold-chain transportation | 1404111-69-8 | USD 422 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate, 95% * Cold-chain transportation | 1415329-20-2 | USD 54 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate, 95% * Cold-chain transportation | 1415329-20-2 | USD 89 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate, 95% * Cold-chain transportation | 1415329-20-2 | USD 307 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(methyl-d3)picolinamide, 98% 98%atom%D Synonyms:Sorafenib (D3); Bay 43-96 (D3) | 1130115-44-4 | USD 95 | >5 | 3 | Inquiry |
| BLDPharm | 100mg | 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(methyl-d3)picolinamide, 98% 98%atom%D Synonyms:Sorafenib (D3); Bay 43-96 (D3) | 1130115-44-4 | USD 152 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(methyl-d3)picolinamide, 98% 98%atom%D Synonyms:Sorafenib (D3); Bay 43-96 (D3) | 1130115-44-4 | USD 257 | 4 | 3 | Inquiry |
| BLDPharm | 10mg | (11R,51R)-16,17,56,57-Tetramethoxy-12,52-dimethyl-11,12,13,14,51,52,53,54-octahydro-2,6-dioxa-1(8,1),5(1,8)-diisoquinolina-3,7(1,4)-dibenzenacyclooctaphane, 98+% | 518-94-5 | USD 129 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)diphosphate Sodium Salt (1:2), 98% | 148296-46-2 | USD 180 | Inquiry | >5 | Inquiry |
| BLDPharm | 5mg | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)diphosphate Sodium Salt (1:2), 98% | 148296-46-2 | USD 306 | Inquiry | 4 | Inquiry |
| BLDPharm | 25mg | D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine, 97% Synonyms:D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine | 673202-67-0 | USD 100 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine, 97% Synonyms:D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine | 673202-67-0 | USD 159 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine, 97% Synonyms:D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine | 673202-67-0 | USD 255 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine, 97% Synonyms:D-Argininamide D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-alanine | 673202-67-0 | USD 432 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | (2S)-2-Amino-3-(4-(2-amino-6-(2,2,2-trifluoro-1-(3'-fluoro-[1,1'-biphenyl]-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid hydrochloride, 97% | 1040526-12-2 | USD 109 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | (S)-2-(4-(4-((6-Aminopyridin-3-yl)sulfonyl)-2-(prop-1-yn-1-yl)piperazin-1-yl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol, 99% | 1361224-53-4 | USD 45 | >5 | 4 | Inquiry |
| BLDPharm | 5mg | (S)-2-(4-(4-((6-Aminopyridin-3-yl)sulfonyl)-2-(prop-1-yn-1-yl)piperazin-1-yl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol, 99% | 1361224-53-4 | USD 112 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2,5-Diamino-2-(difluoromethyl)pentanoic acid, 97% Synonyms:L-DFMO;L-RMI71782;L-α-difluoromethylornithine | 66640-93-5 | USD 135 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | N-(4-(4-Amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)-1-(4-((2-(((1R,2R,4S)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)-2-methoxycyclohexyl)oxy)ethoxy)methyl)-1H-1,2,3-triazol-1-yl)-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-amide, 95% | 1887095-82-0 | USD 73 | 1 | Inquiry | Inquiry |
| BLDPharm | 5mg | N-(4-(4-Amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)-1-(4-((2-(((1R,2R,4S)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)-2-methoxycyclohexyl)oxy)ethoxy)methyl)-1H-1,2,3-triazol-1-yl)-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-amide, 95% | 1887095-82-0 | USD 219 | >5 | 3 | Inquiry |
| BLDPharm | 100mg | 5-Ethynyl-2'-dU, 98% Synonyms:5-Ethynyl-2'-deoxyuridine | 61135-33-9 | USD 48 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 5-Ethynyl-2'-dU, 98% Synonyms:5-Ethynyl-2'-deoxyuridine | 61135-33-9 | USD 73 | 2 | Inquiry | 1 |
| BLDPharm | 1g | 5-Ethynyl-2'-dU, 98% Synonyms:5-Ethynyl-2'-deoxyuridine | 61135-33-9 | USD 88 | >5 | 5 | 1 |
| BLDPharm | 5g | 5-Ethynyl-2'-dU, 98% Synonyms:5-Ethynyl-2'-deoxyuridine | 61135-33-9 | USD 399 | 3 | 1 | 1 |
| BLDPharm | 10mg | MZP-55, 98% | 2010159-48-3 | USD 1181 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | (2S,4R)-N-((S)-2-(tert-Butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98% | 1797406-69-9 | USD 117 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2S,4R)-N-((S)-2-(tert-Butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98% | 1797406-69-9 | USD 233 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,4R)-N-((S)-2-(tert-Butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98% | 1797406-69-9 | USD 336 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,4R)-N-((S)-2-(tert-Butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98% | 1797406-69-9 | USD 570 | 3 | 3 | Inquiry |
| BLDPharm | 1g | (2S,4R)-N-((S)-2-(tert-Butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-1-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98% | 1797406-69-9 | USD 1539 | 1 | Inquiry | Inquiry |
| BLDPharm | 10mg | (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid, 95% | 199850-67-4 | USD 89 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid, 95% | 199850-67-4 | USD 151 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid, 95% | 199850-67-4 | USD 257 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid, 95% | 199850-67-4 | USD 437 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid, 95% | 199850-67-4 | USD 743 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid, 95% | 199850-67-4 | USD 1263 | 3 | Inquiry | Inquiry |
| BLDPharm | 25mg | (2S,3S)-2-((S)-1-((2S,3S)-2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid, 98% Synonyms:Ile-Pro-Ile | 90614-48-5 | USD 135 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2S,3S)-2-((S)-1-((2S,3S)-2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid, 98% Synonyms:Ile-Pro-Ile | 90614-48-5 | USD 228 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,3S)-2-((S)-1-((2S,3S)-2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid, 98% Synonyms:Ile-Pro-Ile | 90614-48-5 | USD 386 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,3S)-2-((S)-1-((2S,3S)-2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid, 98% Synonyms:Ile-Pro-Ile | 90614-48-5 | USD 734 | 4 | Inquiry | Inquiry |
| BLDPharm | 25mg | (Z)-N-Ethyl-N-methyl-2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indoline-6-carboxamide, 97% | 334951-90-5 | USD 116 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (Z)-N-Ethyl-N-methyl-2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indoline-6-carboxamide, 97% | 334951-90-5 | USD 195 | >5 | 2 | Inquiry |
| BLDPharm | 100mg | (Z)-N-Ethyl-N-methyl-2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indoline-6-carboxamide, 97% | 334951-90-5 | USD 333 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | (Z)-N-Ethyl-N-methyl-2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indoline-6-carboxamide, 97% | 334951-90-5 | USD 564 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (Z)-N-Ethyl-N-methyl-2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indoline-6-carboxamide, 97% | 334951-90-5 | USD 1523 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | Methyltetrazine-PEG5-nhs ester, 95% | 1802907-92-1 | USD 101 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | Methyltetrazine-PEG5-nhs ester, 95% | 1802907-92-1 | USD 201 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Methyltetrazine-PEG5-nhs ester, 95% | 1802907-92-1 | USD 287 | 3 | 1 | Inquiry |
| BLDPharm | 250mg | Methyltetrazine-PEG5-nhs ester, 95% | 1802907-92-1 | USD 716 | 1 | Inquiry | Inquiry |
| BLDPharm | 10mg | (((S)-5-((S)-2-(trans-4-(Aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid, 99% | 1703768-74-4 | USD 119 | 2 | Inquiry | Inquiry |
| BLDPharm | 25mg | (((S)-5-((S)-2-(trans-4-(Aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid, 99% | 1703768-74-4 | USD 238 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | (((S)-5-((S)-2-(trans-4-(Aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid, 99% | 1703768-74-4 | USD 404 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (((S)-5-((S)-2-(trans-4-(Aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid, 99% | 1703768-74-4 | USD 687 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Amino polyethylene glycol monomethyl ether-average M.W. 2000, 95% +(~average M.W. 2000) | 80506-64-5 | USD 20 | >5 | 1 | 2 |
| BLDPharm | 1g | Amino polyethylene glycol monomethyl ether-average M.W. 2000, 95% +(~average M.W. 2000) | 80506-64-5 | USD 47 | >5 | 1 | 1 |
| BLDPharm | 5g | Amino polyethylene glycol monomethyl ether-average M.W. 2000, 95% +(~average M.W. 2000) | 80506-64-5 | USD 158 | >5 | 1 | 1 |
| BLDPharm | 25g | Amino polyethylene glycol monomethyl ether-average M.W. 2000, 95% +(~average M.W. 2000) | 80506-64-5 | USD 503 | 1 | Inquiry | 1 |
| BLDPharm | 100mg | 4-arm-PEG-Mal, 97% average Mw5000 | 357277-62-4 | USD 30 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4-arm-PEG-Mal, 97% average Mw5000 | 357277-62-4 | USD 45 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 4-arm-PEG-Mal, 97% average Mw5000 | 357277-62-4 | USD 111 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | 4-arm-PEG-Mal, 97% average Mw5000 | 357277-62-4 | USD 389 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | NHS-PEG-NHS average Mw2000, 97% average Mw2000 | 122375-06-8 | USD 21 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | NHS-PEG-NHS average Mw2000, 97% average Mw2000 | 122375-06-8 | USD 31 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | NHS-PEG-NHS average Mw2000, 97% average Mw2000 | 122375-06-8 | USD 77 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | NHS-PEG-NHS average Mw2000, 97% average Mw2000 | 122375-06-8 | USD 270 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15-Pentaoxaoctadec-17-yn-1-ol, 95% | 1036204-60-0 | USD 14 | >5 | 2 | 1 |
| BLDPharm | 250mg | 3,6,9,12,15-Pentaoxaoctadec-17-yn-1-ol, 95% | 1036204-60-0 | USD 17 | >5 | 3 | 1 |
| BLDPharm | 1g | 3,6,9,12,15-Pentaoxaoctadec-17-yn-1-ol, 95% | 1036204-60-0 | USD 67 | >5 | 1 | 1 |
| BLDPharm | 5g | 3,6,9,12,15-Pentaoxaoctadec-17-yn-1-ol, 95% | 1036204-60-0 | USD 334 | >5 | 2 | 2 |
| BLDPharm | 50mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29,32,35,38,41-tridecaoxa-5-azatetratetracontan-44-oic acid, 95% | 1415981-79-1 | USD 99 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29,32,35,38,41-tridecaoxa-5-azatetratetracontan-44-oic acid, 95% | 1415981-79-1 | USD 119 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29,32,35,38,41-tridecaoxa-5-azatetratetracontan-44-oic acid, 95% | 1415981-79-1 | USD 162 | 3 | 1 | Inquiry |
| BLDPharm | 1g | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29,32,35,38,41-tridecaoxa-5-azatetratetracontan-44-oic acid, 95% | 1415981-79-1 | USD 545 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | 2,2,5-Trimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 95% | 1260431-01-3 | USD 124 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,2,5-Trimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 95% | 1260431-01-3 | USD 210 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,2,5-Trimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 95% | 1260431-01-3 | USD 356 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2,2,5-Trimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azaicosan-20-oic acid, 95% | 1260431-01-3 | USD 960 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 95% | 1347750-85-9 | USD 92 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-Hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 95% | 1347750-85-9 | USD 208 | 5 | Inquiry | Inquiry |
| BLDPharm | 5g | 1-Hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 95% | 1347750-85-9 | USD 404 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)-3,6,9,12-tetraoxapentadecan-15-oic acid, 99% | 1802907-91-0 | USD 1731 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl (26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 2112731-44-7 | USD 70 | >5 | 4 | 1 |
| BLDPharm | 250mg | tert-Butyl (26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 2112731-44-7 | USD 105 | >5 | 5 | 1 |
| BLDPharm | 1g | tert-Butyl (26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 2112731-44-7 | USD 260 | >5 | 2 | 2 |
| BLDPharm | 5g | tert-Butyl (26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 2112731-44-7 | USD 910 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl (23-hydroxy-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 95% | 1345337-22-5 | USD 67 | >5 | 3 | 1 |
| BLDPharm | 250mg | tert-Butyl (23-hydroxy-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 95% | 1345337-22-5 | USD 113 | >5 | 2 | Inquiry |
| BLDPharm | 1g | tert-Butyl (23-hydroxy-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 95% | 1345337-22-5 | USD 277 | >5 | 2 | 1 |
| BLDPharm | 5g | tert-Butyl (23-hydroxy-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 95% | 1345337-22-5 | USD 971 | 4 | 3 | Inquiry |
| BLDPharm | 25mg | Bis(2,5-dioxopyrrolidin-1-yl) 16-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl)-4,7,10,13,19,22,25,28-octaoxa-16-azahentriacontane-1,31-dioate, 95% * Cold-chain transportation | 2112738-60-8 | USD 142 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | Bis(2,5-dioxopyrrolidin-1-yl) 16-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl)-4,7,10,13,19,22,25,28-octaoxa-16-azahentriacontane-1,31-dioate, 95% * Cold-chain transportation | 2112738-60-8 | USD 241 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Bis(2,5-dioxopyrrolidin-1-yl) 16-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl)-4,7,10,13,19,22,25,28-octaoxa-16-azahentriacontane-1,31-dioate, 95% * Cold-chain transportation | 2112738-60-8 | USD 409 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Bis(2,5-dioxopyrrolidin-1-yl) 16-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl)-4,7,10,13,19,22,25,28-octaoxa-16-azahentriacontane-1,31-dioate, 95% * Cold-chain transportation | 2112738-60-8 | USD 694 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Bis(2,5-dioxopyrrolidin-1-yl) 16-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl)-4,7,10,13,19,22,25,28-octaoxa-16-azahentriacontane-1,31-dioate, 95% * Cold-chain transportation | 2112738-60-8 | USD 1874 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 23-Amino-3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 95% | 352439-37-3 | USD 27 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | 23-Amino-3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 95% | 352439-37-3 | USD 40 | >5 | 1 | 1 |
| BLDPharm | 1g | 23-Amino-3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 95% | 352439-37-3 | USD 159 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 23-Amino-3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 95% | 352439-37-3 | USD 794 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18-Hexaoxaeicosane-1,20-diamine, 95% | 76927-70-3 | USD 34 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18-Hexaoxaeicosane-1,20-diamine, 95% | 76927-70-3 | USD 58 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18-Hexaoxaeicosane-1,20-diamine, 95% | 76927-70-3 | USD 71 | >5 | Inquiry | 2 |
| BLDPharm | 5g | 3,6,9,12,15,18-Hexaoxaeicosane-1,20-diamine, 95% | 76927-70-3 | USD 328 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-Amino-3,6,9,12,15,18,21,24,27-nonaoxatriacontan-30-oic acid, 95% | 1191079-83-0 | USD 73 | 1 | 2 | 1 |
| BLDPharm | 250mg | 1-Amino-3,6,9,12,15,18,21,24,27-nonaoxatriacontan-30-oic acid, 95% | 1191079-83-0 | USD 124 | 3 | 2 | 1 |
| BLDPharm | 1g | 1-Amino-3,6,9,12,15,18,21,24,27-nonaoxatriacontan-30-oic acid, 95% | 1191079-83-0 | USD 256 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diamine, 95% | 928292-69-7 | USD 46 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diamine, 95% | 928292-69-7 | USD 56 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diamine, 95% | 928292-69-7 | USD 82 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diamine, 95% | 928292-69-7 | USD 210 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol, 98% | 24342-68-5 | USD 8 | >5 | 1 | 1 |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol, 98% | 24342-68-5 | USD 10 | >5 | 2 | 1 |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol, 98% | 24342-68-5 | USD 36 | >5 | 2 | 2 |
| BLDPharm | 5g | 1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol, 98% | 24342-68-5 | USD 145 | 1 | 2 | Inquiry |
| BLDPharm | 25g | 1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol, 98% | 24342-68-5 | USD 604 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol, 96% | 957205-14-0 | USD 38 | >5 | 2 | 1 |
| BLDPharm | 250mg | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol, 96% | 957205-14-0 | USD 50 | >5 | >5 | Inquiry |
| BLDPharm | 1g | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol, 96% | 957205-14-0 | USD 111 | >5 | 3 | 1 |
| BLDPharm | 5g | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol, 96% | 957205-14-0 | USD 450 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol, 96% | 957205-14-0 | USD 1350 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1,1'-((Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(1H-pyrrole-2,5-dione), 98% * Cold-chain transportation | 115597-84-7 | USD 22 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 1,1'-((Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(1H-pyrrole-2,5-dione), 98% * Cold-chain transportation | 115597-84-7 | USD 27 | 4 | 1 | Inquiry |
| BLDPharm | 1g | 1,1'-((Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(1H-pyrrole-2,5-dione), 98% * Cold-chain transportation | 115597-84-7 | USD 107 | 1 | 1 | Inquiry |
| BLDPharm | 5g | 1,1'-((Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(1H-pyrrole-2,5-dione), 98% * Cold-chain transportation | 115597-84-7 | USD 534 | 1 | 1 | Inquiry |
| BLDPharm | 100mg | Fmoc-NH-PEG5-CH2COOH, 96% | 635287-26-2 | USD 50 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | Fmoc-NH-PEG5-CH2COOH, 96% | 635287-26-2 | USD 76 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-NH-PEG5-CH2COOH, 96% | 635287-26-2 | USD 244 | >5 | 1 | 1 |
| BLDPharm | 5g | Fmoc-NH-PEG5-CH2COOH, 96% | 635287-26-2 | USD 855 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 17-(Boc-amino)-3,6,9,12,15-pentaoxa-1-heptadecanol, 98% | 331242-61-6 | USD 36 | >5 | 1 | 1 |
| BLDPharm | 250mg | 17-(Boc-amino)-3,6,9,12,15-pentaoxa-1-heptadecanol, 98% | 331242-61-6 | USD 49 | >5 | 3 | 1 |
| BLDPharm | 1g | 17-(Boc-amino)-3,6,9,12,15-pentaoxa-1-heptadecanol, 98% | 331242-61-6 | USD 141 | >5 | 2 | 2 |
| BLDPharm | 5g | 17-(Boc-amino)-3,6,9,12,15-pentaoxa-1-heptadecanol, 98% | 331242-61-6 | USD 462 | 3 | 1 | Inquiry |
| BLDPharm | 100mg | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oate, 95% | 778596-26-2 | USD 15 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oate, 95% | 778596-26-2 | USD 34 | 3 | 1 | Inquiry |
| BLDPharm | 1g | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oate, 95% | 778596-26-2 | USD 125 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid, 97% * Cold-chain transportation | 518044-41-2 | USD 65 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid, 97% * Cold-chain transportation | 518044-41-2 | USD 110 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid, 97% * Cold-chain transportation | 518044-41-2 | USD 186 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid, 97% * Cold-chain transportation | 518044-41-2 | USD 315 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid, 97% * Cold-chain transportation | 518044-41-2 | USD 741 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl 1-amino-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 97% | 756526-06-4 | USD 37 | >5 | 1 | 1 |
| BLDPharm | 250mg | tert-Butyl 1-amino-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 97% | 756526-06-4 | USD 61 | >5 | 1 | 2 |
| BLDPharm | 1g | tert-Butyl 1-amino-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 97% | 756526-06-4 | USD 135 | >5 | 1 | 1 |
| BLDPharm | 5g | tert-Butyl 1-amino-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 97% | 756526-06-4 | USD 535 | >5 | Inquiry | 1 |
| BLDPharm | 1mg | N-(2-(2-(2-(2-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% | 1835759-81-3 | USD 144 | >5 | Inquiry | Inquiry |
| BLDPharm | 5mg | N-(2-(2-(2-(2-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% | 1835759-81-3 | USD 198 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | N-(2-(2-(2-(2-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% | 1835759-81-3 | USD 343 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | H2n-peg13-ch2ch2nh2, 95% | 1228119-65-0 | USD 81 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | H2n-peg13-ch2ch2nh2, 95% | 1228119-65-0 | USD 129 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | H2n-peg13-ch2ch2nh2, 95% | 1228119-65-0 | USD 335 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | H2n-peg13-ch2ch2nh2, 95% | 1228119-65-0 | USD 1270 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Ho-peg5-ch2cooh, 95% | 52026-48-9 | USD 54 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Ho-peg5-ch2cooh, 95% | 52026-48-9 | USD 103 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Ho-peg5-ch2cooh, 95% | 52026-48-9 | USD 256 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Hydroxy-PEG9-t-butyl ester, 95% | 2055042-66-3 | USD 49 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Hydroxy-PEG9-t-butyl ester, 95% | 2055042-66-3 | USD 61 | >5 | 1 | Inquiry |
| BLDPharm | 1g | Hydroxy-PEG9-t-butyl ester, 95% | 2055042-66-3 | USD 163 | >5 | 1 | Inquiry |
| BLDPharm | 5g | Hydroxy-PEG9-t-butyl ester, 95% | 2055042-66-3 | USD 612 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | Hydroxy-PEG9-t-butyl ester, 95% | 2055042-66-3 | USD 844 | 5 | Inquiry | Inquiry |
| BLDPharm | 10mg | Dibenzocyclooctyne-PEG4 maleimide, 95% | 1480516-75-3 | USD 157 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | Dibenzocyclooctyne-PEG4 maleimide, 95% | 1480516-75-3 | USD 313 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | Dibenzocyclooctyne-PEG4 maleimide, 95% | 1480516-75-3 | USD 376 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Dibenzocyclooctyne-PEG4 maleimide, 95% | 1480516-75-3 | USD 751 | >5 | 1 | Inquiry |
| BLDPharm | 10mg | DBCO-PEG4 amine, 95% | 1255942-08-5 | USD 76 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | DBCO-PEG4 amine, 95% | 1255942-08-5 | USD 152 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | DBCO-PEG4 amine, 95% | 1255942-08-5 | USD 258 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | DBCO-PEG4 amine, 95% | 1255942-08-5 | USD 437 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | DBCO-PEG4 amine, 95% | 1255942-08-5 | USD 742 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl (32-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontyl)carbamate, 95% | 1556847-53-0 | USD 24 | 2 | Inquiry | 1 |
| BLDPharm | 250mg | tert-Butyl (32-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontyl)carbamate, 95% | 1556847-53-0 | USD 59 | 1 | Inquiry | 1 |
| BLDPharm | 1g | tert-Butyl (32-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontyl)carbamate, 95% | 1556847-53-0 | USD 193 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | tert-Butyl (17-bromo-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 1392499-33-0 | USD 33 | >5 | Inquiry | 1 |
| BLDPharm | 100mg | tert-Butyl (17-bromo-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 1392499-33-0 | USD 40 | >5 | 2 | 2 |
| BLDPharm | 250mg | tert-Butyl (17-bromo-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 1392499-33-0 | USD 59 | >5 | 5 | 5 |
| BLDPharm | 1g | tert-Butyl (17-bromo-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 1392499-33-0 | USD 235 | >5 | 2 | 5 |
| BLDPharm | 5g | tert-Butyl (17-bromo-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 1392499-33-0 | USD 996 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12,15-pentaoxaoctadecan-18-oic acid, 98% | 1286755-26-7 | USD 79 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12,15-pentaoxaoctadecan-18-oic acid, 98% | 1286755-26-7 | USD 118 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12,15-pentaoxaoctadecan-18-oic acid, 98% | 1286755-26-7 | USD 177 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12,15-pentaoxaoctadecan-18-oic acid, 98% | 1286755-26-7 | USD 301 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12,15-pentaoxaoctadecan-18-oic acid, 98% | 1286755-26-7 | USD 512 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 95% | 756526-00-8 | USD 87 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 95% | 756526-00-8 | USD 261 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid, 95% | 756526-00-8 | USD 914 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-Boc-peg4-bromide, 98% | 1392499-32-9 | USD 23 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | N-Boc-peg4-bromide, 98% | 1392499-32-9 | USD 28 | >5 | Inquiry | 1 |
| BLDPharm | 1g | N-Boc-peg4-bromide, 98% | 1392499-32-9 | USD 67 | 5 | 3 | 5 |
| BLDPharm | 5g | N-Boc-peg4-bromide, 98% | 1392499-32-9 | USD 261 | >5 | 3 | 2 |
| BLDPharm | 100mg | tert-Butyl (20-hydroxy-3,6,9,12,15,18-hexaoxaicosyl)carbamate, 95% | 1292268-13-3 | USD 45 | >5 | 2 | 1 |
| BLDPharm | 250mg | tert-Butyl (20-hydroxy-3,6,9,12,15,18-hexaoxaicosyl)carbamate, 95% | 1292268-13-3 | USD 86 | >5 | 2 | 2 |
| BLDPharm | 1g | tert-Butyl (20-hydroxy-3,6,9,12,15,18-hexaoxaicosyl)carbamate, 95% | 1292268-13-3 | USD 143 | >5 | 5 | 2 |
| BLDPharm | 5g | tert-Butyl (20-hydroxy-3,6,9,12,15,18-hexaoxaicosyl)carbamate, 95% | 1292268-13-3 | USD 607 | 3 | Inquiry | Inquiry |
| BLDPharm | 25g | tert-Butyl (20-hydroxy-3,6,9,12,15,18-hexaoxaicosyl)carbamate, 95% | 1292268-13-3 | USD 2125 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1,1,1-Triphenyl-2,5,8,11-tetraoxatridecan-13-ol, 95% | 125274-16-0 | USD 13 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1,1,1-Triphenyl-2,5,8,11-tetraoxatridecan-13-ol, 95% | 125274-16-0 | USD 29 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1,1,1-Triphenyl-2,5,8,11-tetraoxatridecan-13-ol, 95% | 125274-16-0 | USD 115 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid, 95% | 882847-32-7 | USD 12 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid, 95% | 882847-32-7 | USD 15 | >5 | 1 | 1 |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid, 95% | 882847-32-7 | USD 59 | >5 | Inquiry | 1 |
| BLDPharm | 5g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid, 95% | 882847-32-7 | USD 294 | >5 | 3 | 2 |
| BLDPharm | 25g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid, 95% | 882847-32-7 | USD 1469 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 17-Amino-3,6,9,12,15-pentaoxaheptadecan-1-ol, 96% | 39160-70-8 | USD 31 | >5 | 2 | 1 |
| BLDPharm | 250mg | 17-Amino-3,6,9,12,15-pentaoxaheptadecan-1-ol, 96% | 39160-70-8 | USD 40 | >5 | 1 | 1 |
| BLDPharm | 1g | 17-Amino-3,6,9,12,15-pentaoxaheptadecan-1-ol, 96% | 39160-70-8 | USD 68 | >5 | Inquiry | 1 |
| BLDPharm | 5g | 17-Amino-3,6,9,12,15-pentaoxaheptadecan-1-ol, 96% | 39160-70-8 | USD 324 | >5 | Inquiry | 1 |
| BLDPharm | 100mg | 1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-ol, 97% | 423763-19-3 | USD 11 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-ol, 97% | 423763-19-3 | USD 27 | >5 | Inquiry | 1 |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-ol, 97% | 423763-19-3 | USD 76 | 1 | 1 | Inquiry |
| BLDPharm | 50mg | Boc-NH-PEG6-NH2, 95% | 1091627-77-8 | USD 47 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Boc-NH-PEG6-NH2, 95% | 1091627-77-8 | USD 62 | >5 | 2 | 2 |
| BLDPharm | 250mg | Boc-NH-PEG6-NH2, 95% | 1091627-77-8 | USD 129 | >5 | 1 | 2 |
| BLDPharm | 1g | Boc-NH-PEG6-NH2, 95% | 1091627-77-8 | USD 215 | >5 | 4 | 1 |
| BLDPharm | 5g | Boc-NH-PEG6-NH2, 95% | 1091627-77-8 | USD 655 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | DBCO-PEG4-NHS Ester, 95% | 1427004-19-0 | USD 170 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | DBCO-PEG4-NHS Ester, 95% | 1427004-19-0 | USD 288 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | DBCO-PEG4-NHS Ester, 95% | 1427004-19-0 | USD 490 | >5 | 1 | Inquiry |
| BLDPharm | 1g | DBCO-PEG4-NHS Ester, 95% | 1427004-19-0 | USD 1321 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | DBCO-PEG4-NHS Ester, 95% | 1427004-19-0 | USD 5018 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl 1-amino-3,6,9,12,15,18-hexaoxahenicosan-21-oate, 95% | 1286281-32-0 | USD 47 | >5 | 1 | 1 |
| BLDPharm | 250mg | tert-Butyl 1-amino-3,6,9,12,15,18-hexaoxahenicosan-21-oate, 95% | 1286281-32-0 | USD 69 | >5 | 1 | 1 |
| BLDPharm | 1g | tert-Butyl 1-amino-3,6,9,12,15,18-hexaoxahenicosan-21-oate, 95% | 1286281-32-0 | USD 83 | >5 | Inquiry | 3 |
| BLDPharm | 5g | tert-Butyl 1-amino-3,6,9,12,15,18-hexaoxahenicosan-21-oate, 95% | 1286281-32-0 | USD 378 | >5 | 1 | 1 |
| BLDPharm | 100mg | 3-(2-(3-Methoxy-3-oxopropoxy)ethoxy)propanoic acid, 97% | 2089292-48-6 | USD 91 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3-(2-(3-Methoxy-3-oxopropoxy)ethoxy)propanoic acid, 97% | 2089292-48-6 | USD 155 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 3-(2-(3-Methoxy-3-oxopropoxy)ethoxy)propanoic acid, 97% | 2089292-48-6 | USD 406 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid, 98% | 876345-13-0 | USD 13 | 2 | Inquiry | 2 |
| BLDPharm | 250mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid, 98% | 876345-13-0 | USD 17 | >5 | 1 | 2 |
| BLDPharm | 1g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid, 98% | 876345-13-0 | USD 59 | >5 | 1 | >5 |
| BLDPharm | 5g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid, 98% | 876345-13-0 | USD 293 | 1 | 3 | 2 |
| BLDPharm | 25g | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid, 98% | 876345-13-0 | USD 1043 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1,11-Bis(maleimido)-3,6,9-trioxaundecane, 95% HPLC | 86099-06-1 | USD 20 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1,11-Bis(maleimido)-3,6,9-trioxaundecane, 95% HPLC | 86099-06-1 | USD 49 | 3 | 1 | Inquiry |
| BLDPharm | 1g | 1,11-Bis(maleimido)-3,6,9-trioxaundecane, 95% HPLC | 86099-06-1 | USD 187 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | HO-PEG3-CH2COOH, 95% | 51951-05-4 | USD 40 | >5 | 1 | 1 |
| BLDPharm | 250mg | HO-PEG3-CH2COOH, 95% | 51951-05-4 | USD 68 | >5 | 2 | 1 |
| BLDPharm | 1g | HO-PEG3-CH2COOH, 95% | 51951-05-4 | USD 182 | 2 | 3 | Inquiry |
| BLDPharm | 5g | HO-PEG3-CH2COOH, 95% | 51951-05-4 | USD 637 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12-Tetraoxapentadec-14-yn-1-amine, 97% | 1013921-36-2 | USD 15 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12-Tetraoxapentadec-14-yn-1-amine, 97% | 1013921-36-2 | USD 19 | >5 | >5 | 2 |
| BLDPharm | 1g | 3,6,9,12-Tetraoxapentadec-14-yn-1-amine, 97% | 1013921-36-2 | USD 52 | >5 | 2 | Inquiry |
| BLDPharm | 5g | 3,6,9,12-Tetraoxapentadec-14-yn-1-amine, 97% | 1013921-36-2 | USD 259 | 1 | Inquiry | Inquiry |
| BLDPharm | 1mg | Adibo-NH-peg2-biotin, 98% * Cold-chain transportation | 1255942-07-4 | USD 54 | >5 | Inquiry | Inquiry |
| BLDPharm | 5mg | Adibo-NH-peg2-biotin, 98% * Cold-chain transportation | 1255942-07-4 | USD 162 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | Adibo-NH-peg2-biotin, 98% * Cold-chain transportation | 1255942-07-4 | USD 274 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | Adibo-NH-peg2-biotin, 98% * Cold-chain transportation | 1255942-07-4 | USD 547 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | Adibo-NH-peg2-biotin, 98% * Cold-chain transportation | 1255942-07-4 | USD 929 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Bromo-peg6-bromide, 95% | 72713-23-6 | USD 30 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Bromo-peg6-bromide, 95% | 72713-23-6 | USD 70 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | Bromo-peg6-bromide, 95% | 72713-23-6 | USD 279 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% * Cold-chain transportation | 1778736-18-7 | USD 80 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% * Cold-chain transportation | 1778736-18-7 | USD 183 | 2 | 1 | Inquiry |
| BLDPharm | 1g | N-(2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95% * Cold-chain transportation | 1778736-18-7 | USD 552 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 95% | 1334177-84-2 | USD 16 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 95% | 1334177-84-2 | USD 33 | >5 | 3 | Inquiry |
| BLDPharm | 1g | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 95% | 1334177-84-2 | USD 115 | >5 | 2 | 1 |
| BLDPharm | 5g | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 95% | 1334177-84-2 | USD 385 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 95% | 1334177-84-2 | USD 1348 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 5-((3aR,4R,6aS)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(3,6,9,12-tetraoxapentadec-14-yn-1-yl)pentanamide, 98% | 1458576-00-5 | USD 123 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 5-((3aR,4R,6aS)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(3,6,9,12-tetraoxapentadec-14-yn-1-yl)pentanamide, 98% | 1458576-00-5 | USD 242 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 5-((3aR,4R,6aS)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(3,6,9,12-tetraoxapentadec-14-yn-1-yl)pentanamide, 98% | 1458576-00-5 | USD 661 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76-pentacosaoxa-4-azanonaheptacontan-79-oic acid, 97% | 2170484-59-8 | USD 111 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76-pentacosaoxa-4-azanonaheptacontan-79-oic acid, 97% | 2170484-59-8 | USD 188 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76-pentacosaoxa-4-azanonaheptacontan-79-oic acid, 97% | 2170484-59-8 | USD 506 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-Phenyl-2,5,8,11,14-pentaoxahexadecan-16-yl 4-methylbenzenesulfonate, 97% | 129086-10-8 | USD 7 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11,14-pentaoxahexadecan-16-yl 4-methylbenzenesulfonate, 97% | 129086-10-8 | USD 13 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11,14-pentaoxahexadecan-16-yl 4-methylbenzenesulfonate, 97% | 129086-10-8 | USD 46 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate, 97% | 89346-82-7 | USD 42 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate, 97% | 89346-82-7 | USD 105 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate, 97% | 89346-82-7 | USD 168 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate, 97% | 89346-82-7 | USD 838 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | tert-Butyl (2-(2-(2-(2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 99+% | 2194563-84-1 | USD 82 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | tert-Butyl (2-(2-(2-(2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 99+% | 2194563-84-1 | USD 139 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl (2-(2-(2-(2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 99+% | 2194563-84-1 | USD 236 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl (2-(2-(2-(2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 99+% | 2194563-84-1 | USD 401 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | tert-Butyl (2-(2-(2-(2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 99+% | 2194563-84-1 | USD 1081 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-(2-(2-(2-Chloroethoxy)ethoxy)ethoxy)ethanol, 95% | 5197-66-0 | USD 38 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-(2-(2-(2-Chloroethoxy)ethoxy)ethoxy)ethanol, 95% | 5197-66-0 | USD 56 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 2-(2-(2-(2-Chloroethoxy)ethoxy)ethoxy)ethanol, 95% | 5197-66-0 | USD 139 | >5 | 3 | Inquiry |
| BLDPharm | 5g | 2-(2-(2-(2-Chloroethoxy)ethoxy)ethoxy)ethanol, 95% | 5197-66-0 | USD 487 | 1 | 1 | Inquiry |
| BLDPharm | 100mg | 1-Phenyl-2,5,8,11,14,17,20,23-octaoxapentacosan-25-ol, 95% | 477775-73-8 | USD 5 | 2 | Inquiry | 1 |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11,14,17,20,23-octaoxapentacosan-25-ol, 95% | 477775-73-8 | USD 12 | >5 | 4 | 1 |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11,14,17,20,23-octaoxapentacosan-25-ol, 95% | 477775-73-8 | USD 26 | 1 | 4 | 2 |
| BLDPharm | 5g | 1-Phenyl-2,5,8,11,14,17,20,23-octaoxapentacosan-25-ol, 95% | 477775-73-8 | USD 129 | Inquiry | 1 | 1 |
| BLDPharm | 100mg | 1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol, 98% | 868594-48-3 | USD 19 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol, 98% | 868594-48-3 | USD 43 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol, 98% | 868594-48-3 | USD 168 | 3 | 2 | Inquiry |
| BLDPharm | 5g | 1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol, 98% | 868594-48-3 | USD 755 | 3 | 1 | Inquiry |
| BLDPharm | 100mg | tert-Butyl (17-amino-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 189209-27-6 | USD 33 | >5 | 2 | 2 |
| BLDPharm | 250mg | tert-Butyl (17-amino-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 189209-27-6 | USD 53 | >5 | 1 | Inquiry |
| BLDPharm | 1g | tert-Butyl (17-amino-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 189209-27-6 | USD 139 | >5 | 4 | 1 |
| BLDPharm | 5g | tert-Butyl (17-amino-3,6,9,12,15-pentaoxaheptadecyl)carbamate, 95% | 189209-27-6 | USD 541 | >5 | 2 | 5 |
| BLDPharm | 100mg | I-peg6-oh, 95% | 136399-07-0 | USD 90 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | I-peg6-oh, 95% | 136399-07-0 | USD 152 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | I-peg6-oh, 95% | 136399-07-0 | USD 407 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diyl bis(4-methylbenzenesulfonate), 97% | 109635-64-5 | USD 59 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diyl bis(4-methylbenzenesulfonate), 97% | 109635-64-5 | USD 101 | >5 | 3 | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diyl bis(4-methylbenzenesulfonate), 97% | 109635-64-5 | USD 270 | 2 | 1 | Inquiry |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diyl bis(4-methylbenzenesulfonate), 97% | 109635-64-5 | USD 944 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Propargyl-peg8-alcohol, 95% | 1422023-54-8 | USD 47 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | Propargyl-peg8-alcohol, 95% | 1422023-54-8 | USD 83 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Propargyl-peg8-alcohol, 95% | 1422023-54-8 | USD 414 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18-Hexaoxahenicos-20-yn-1-amine, 97% | 1198080-04-4 | USD 53 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18-Hexaoxahenicos-20-yn-1-amine, 97% | 1198080-04-4 | USD 81 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18-Hexaoxahenicos-20-yn-1-amine, 97% | 1198080-04-4 | USD 206 | >5 | 2 | Inquiry |
| BLDPharm | 5g | 3,6,9,12,15,18-Hexaoxahenicos-20-yn-1-amine, 97% | 1198080-04-4 | USD 460 | 4 | Inquiry | Inquiry |
| BLDPharm | 50mg | 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69-Tricosaoxahenheptacontane-1,71-diol, 95% | 2243942-52-9 | USD 100 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69-Tricosaoxahenheptacontane-1,71-diol, 95% | 2243942-52-9 | USD 170 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69-Tricosaoxahenheptacontane-1,71-diol, 95% | 2243942-52-9 | USD 288 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69-Tricosaoxahenheptacontane-1,71-diol, 95% | 2243942-52-9 | USD 722 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-Mercapto-3,6,9,12-tetraoxapentadecan-15-oic acid, 95% | 749247-06-1 | USD 150 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Mercapto-3,6,9,12-tetraoxapentadecan-15-oic acid, 95% | 749247-06-1 | USD 180 | 2 | Inquiry | 1 |
| BLDPharm | 1g | 1-Mercapto-3,6,9,12-tetraoxapentadecan-15-oic acid, 95% | 749247-06-1 | USD 540 | 4 | Inquiry | 1 |
| BLDPharm | 100mg | tert-Butyl 20-bromo-3,6,9,12,15,18-hexaoxaicosanoate, 95% | 297162-48-2 | USD 111 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | tert-Butyl 20-bromo-3,6,9,12,15,18-hexaoxaicosanoate, 95% | 297162-48-2 | USD 179 | >5 | 3 | Inquiry |
| BLDPharm | 1g | tert-Butyl 20-bromo-3,6,9,12,15,18-hexaoxaicosanoate, 95% | 297162-48-2 | USD 390 | >5 | 2 | Inquiry |
| BLDPharm | 5g | tert-Butyl 20-bromo-3,6,9,12,15,18-hexaoxaicosanoate, 95% | 297162-48-2 | USD 1561 | 1 | Inquiry | Inquiry |
| BLDPharm | 10g | tert-Butyl 20-bromo-3,6,9,12,15,18-hexaoxaicosanoate, 95% | 297162-48-2 | USD 2377 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Thiol-peg6-alcohol, 95% | 194425-46-2 | USD 185 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Thiol-peg6-alcohol, 95% | 194425-46-2 | USD 307 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | Thiol-peg6-alcohol, 95% | 194425-46-2 | USD 419 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 3-Oxo-1-phenyl-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 95% | 1334177-87-5 | USD 60 | >5 | 2 | 1 |
| BLDPharm | 1g | 3-Oxo-1-phenyl-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 95% | 1334177-87-5 | USD 159 | >5 | 3 | 1 |
| BLDPharm | 5g | 3-Oxo-1-phenyl-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 95% | 1334177-87-5 | USD 555 | >5 | 2 | 2 |
| BLDPharm | 100mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid, 95% | 1334169-93-5 | USD 39 | >5 | 5 | 2 |
| BLDPharm | 250mg | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid, 95% | 1334169-93-5 | USD 47 | >5 | 3 | 2 |
| BLDPharm | 1g | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid, 95% | 1334169-93-5 | USD 142 | >5 | 3 | 2 |
| BLDPharm | 5g | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid, 95% | 1334169-93-5 | USD 275 | >5 | 2 | 5 |
| BLDPharm | 25g | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid, 95% | 1334169-93-5 | USD 963 | 3 | Inquiry | Inquiry |
| BLDPharm | 50mg | 4,7,10,13,16,19,22,25,28,31-Decaoxatetratriacontanedioic acid, 95% | 2055023-26-0 | USD 111 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4,7,10,13,16,19,22,25,28,31-Decaoxatetratriacontanedioic acid, 95% | 2055023-26-0 | USD 189 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4,7,10,13,16,19,22,25,28,31-Decaoxatetratriacontanedioic acid, 95% | 2055023-26-0 | USD 321 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | 4,7,10,13,16,19,22,25,28,31-Decaoxatetratriacontanedioic acid, 95% | 2055023-26-0 | USD 864 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | O,O'-(((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl))bis(hydroxylamine), 99% | 98627-70-4 | USD 88 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | O,O'-(((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl))bis(hydroxylamine), 99% | 98627-70-4 | USD 351 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | O,O'-(((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl))bis(hydroxylamine), 99% | 98627-70-4 | USD 1562 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diol, 98% | 6809-70-7 | USD 10 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diol, 98% | 6809-70-7 | USD 12 | >5 | 2 | 1 |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diol, 98% | 6809-70-7 | USD 32 | >5 | 2 | 1 |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diol, 98% | 6809-70-7 | USD 114 | 3 | 3 | Inquiry |
| BLDPharm | 100mg | 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxahentriacontan-31-ol, 98% | 908258-44-6 | USD 144 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxahentriacontan-31-ol, 98% | 908258-44-6 | USD 244 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxahentriacontan-31-ol, 98% | 908258-44-6 | USD 658 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1,14-Dichloro-3,6,9,12-tetraoxatetradecane, 98% | 5197-65-9 | USD 140 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1,14-Dichloro-3,6,9,12-tetraoxatetradecane, 98% | 5197-65-9 | USD 237 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1,14-Dichloro-3,6,9,12-tetraoxatetradecane, 98% | 5197-65-9 | USD 638 | >5 | Inquiry | Inquiry |
| BLDPharm | 1mg | 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 98% Synonyms:MC-Val-Cit-PAB-MMAE | 646502-53-6 | USD 39 | >5 | 4 | Inquiry |
| BLDPharm | 10mg | 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 98% Synonyms:MC-Val-Cit-PAB-MMAE | 646502-53-6 | USD 149 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 98% Synonyms:MC-Val-Cit-PAB-MMAE | 646502-53-6 | USD 223 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 98% Synonyms:MC-Val-Cit-PAB-MMAE | 646502-53-6 | USD 268 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 98% Synonyms:MC-Val-Cit-PAB-MMAE | 646502-53-6 | USD 322 | >5 | 3 | 1 |
| BLDPharm | 250mg | 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 98% Synonyms:MC-Val-Cit-PAB-MMAE | 646502-53-6 | USD 468 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 98% Synonyms:MC-Val-Cit-PAB-MMAE | 646502-53-6 | USD 1402 | 1 | Inquiry | Inquiry |
| BLDPharm | 5mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Maleimidocaproyl Monomethylauristatin F; Mafodotin; SGD 1269 | 863971-19-1 | USD 119 | 3 | 1 | Inquiry |
| BLDPharm | 10mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Maleimidocaproyl Monomethylauristatin F; Mafodotin; SGD 1269 | 863971-19-1 | USD 202 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Maleimidocaproyl Monomethylauristatin F; Mafodotin; SGD 1269 | 863971-19-1 | USD 436 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Maleimidocaproyl Monomethylauristatin F; Mafodotin; SGD 1269 | 863971-19-1 | USD 661 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid, 98% Synonyms:Maleimidocaproyl Monomethylauristatin F; Mafodotin; SGD 1269 | 863971-19-1 | USD 1048 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid, 98% | 1191064-81-9 | USD 21 | >5 | 5 | 1 |
| BLDPharm | 250mg | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid, 98% | 1191064-81-9 | USD 30 | >5 | 5 | 1 |
| BLDPharm | 1g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid, 98% | 1191064-81-9 | USD 115 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid, 98% | 1191064-81-9 | USD 567 | >5 | Inquiry | 1 |
| BLDPharm | 100mg | Fmoc-NH-PEG10-CH2CH2COOH, 97% | 2101563-45-3 | USD 15 | >5 | 2 | 1 |
| BLDPharm | 250mg | Fmoc-NH-PEG10-CH2CH2COOH, 97% | 2101563-45-3 | USD 32 | >5 | 3 | 1 |
| BLDPharm | 1g | Fmoc-NH-PEG10-CH2CH2COOH, 97% | 2101563-45-3 | USD 124 | 4 | 1 | Inquiry |
| BLDPharm | 5g | Fmoc-NH-PEG10-CH2CH2COOH, 97% | 2101563-45-3 | USD 615 | >5 | 2 | 1 |
| BLDPharm | 10g | Fmoc-NH-PEG10-CH2CH2COOH, 97% | 2101563-45-3 | USD 1227 | 1 | 1 | Inquiry |
| BLDPharm | 100mg | tert-Butyl 17-hydroxy-3,6,9,12,15-pentaoxaheptadecan-1-oate, 98% | 1807530-05-7 | USD 19 | >5 | 1 | 1 |
| BLDPharm | 250mg | tert-Butyl 17-hydroxy-3,6,9,12,15-pentaoxaheptadecan-1-oate, 98% | 1807530-05-7 | USD 47 | 4 | 2 | 1 |
| BLDPharm | 1g | tert-Butyl 17-hydroxy-3,6,9,12,15-pentaoxaheptadecan-1-oate, 98% | 1807530-05-7 | USD 81 | 5 | 2 | Inquiry |
| BLDPharm | 5g | tert-Butyl 17-hydroxy-3,6,9,12,15-pentaoxaheptadecan-1-oate, 98% | 1807530-05-7 | USD 304 | 4 | 2 | Inquiry |
| BLDPharm | 25g | tert-Butyl 17-hydroxy-3,6,9,12,15-pentaoxaheptadecan-1-oate, 98% | 1807530-05-7 | USD 1064 | 2 | 1 | Inquiry |
| BLDPharm | 100mg | 3,6,9,12-Tetraoxapentadec-14-yn-1-yl methanesulfonate, 97% | 1233816-83-5 | USD 162 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12-Tetraoxapentadec-14-yn-1-yl methanesulfonate, 97% | 1233816-83-5 | USD 275 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3,6,9,12-Tetraoxapentadec-14-yn-1-yl methanesulfonate, 97% | 1233816-83-5 | USD 739 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-amine, 97% | 868594-43-8 | USD 129 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-amine, 97% | 868594-43-8 | USD 219 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-amine, 97% | 868594-43-8 | USD 590 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24-Octaoxaheptacos-26-yn-1-amine, 97% | 1196732-52-1 | USD 84 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24-Octaoxaheptacos-26-yn-1-amine, 97% | 1196732-52-1 | USD 135 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24-Octaoxaheptacos-26-yn-1-amine, 97% | 1196732-52-1 | USD 278 | 2 | 2 | Inquiry |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24-Octaoxaheptacos-26-yn-1-amine, 97% | 1196732-52-1 | USD 834 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl (26-amino-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 1052207-59-6 | USD 40 | >5 | 5 | Inquiry |
| BLDPharm | 250mg | tert-Butyl (26-amino-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 1052207-59-6 | USD 73 | >5 | 4 | 2 |
| BLDPharm | 1g | tert-Butyl (26-amino-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 1052207-59-6 | USD 263 | >5 | 5 | 5 |
| BLDPharm | 5g | tert-Butyl (26-amino-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate, 95% | 1052207-59-6 | USD 1094 | >5 | Inquiry | 1 |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxaoctatriacontane-1,38-diol, 95% | 17598-96-8 | USD 9 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxaoctatriacontane-1,38-diol, 95% | 17598-96-8 | USD 20 | >5 | 1 | 1 |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxaoctatriacontane-1,38-diol, 95% | 17598-96-8 | USD 52 | >5 | Inquiry | 1 |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxaoctatriacontane-1,38-diol, 95% | 17598-96-8 | USD 246 | 3 | 1 | 2 |
| BLDPharm | 50mg | NHS-PEO4-Biotin, 97% | 459426-22-3 | USD 39 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | NHS-PEO4-Biotin, 97% | 459426-22-3 | USD 47 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | NHS-PEO4-Biotin, 97% | 459426-22-3 | USD 106 | >5 | 2 | 1 |
| BLDPharm | 1g | NHS-PEO4-Biotin, 97% | 459426-22-3 | USD 322 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | NHS-PEO4-Biotin, 97% | 459426-22-3 | USD 1127 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4,7,10,13,16,19,22,25,28,31,34-Undecaoxaheptatriacontanedioic acid, 95% | 2097010-30-3 | USD 150 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4,7,10,13,16,19,22,25,28,31,34-Undecaoxaheptatriacontanedioic acid, 95% | 2097010-30-3 | USD 255 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 4,7,10,13,16,19,22,25,28,31,34-Undecaoxaheptatriacontanedioic acid, 95% | 2097010-30-3 | USD 688 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosane-1,29-diamine, 95% | 474082-35-4 | USD 46 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosane-1,29-diamine, 95% | 474082-35-4 | USD 74 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosane-1,29-diamine, 95% | 474082-35-4 | USD 146 | 5 | 1 | Inquiry |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosane-1,29-diamine, 95% | 474082-35-4 | USD 464 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Tos-peg7-t-butyl ester, 95% | 406213-75-0 | USD 94 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Tos-peg7-t-butyl ester, 95% | 406213-75-0 | USD 124 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | Tos-peg7-t-butyl ester, 95% | 406213-75-0 | USD 310 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2,5-Dioxopyrrolidin-1-yl 4,7,10,13,16,19-hexaoxadocos-21-yn-1-oate, 95% * Cold-chain transportation | 2093153-99-0 | USD 77 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,5-Dioxopyrrolidin-1-yl 4,7,10,13,16,19-hexaoxadocos-21-yn-1-oate, 95% * Cold-chain transportation | 2093153-99-0 | USD 152 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2,5-Dioxopyrrolidin-1-yl 4,7,10,13,16,19-hexaoxadocos-21-yn-1-oate, 95% * Cold-chain transportation | 2093153-99-0 | USD 443 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-Hydroxy-3,6,9,12,15,18,21-heptaoxatetracosan-24-oic acid, 95% | 1797408-46-8 | USD 178 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-Hydroxy-3,6,9,12,15,18,21-heptaoxatetracosan-24-oic acid, 95% | 1797408-46-8 | USD 302 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-Hydroxy-3,6,9,12,15,18,21-heptaoxatetracosan-24-oic acid, 95% | 1797408-46-8 | USD 815 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24,27,30,33,36,39,42-Tetradecaoxatetratetracontane-1,44-diol, 95% | 28821-35-4 | USD 115 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24,27,30,33,36,39,42-Tetradecaoxatetratetracontane-1,44-diol, 95% | 28821-35-4 | USD 183 | >5 | 1 | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24,27,30,33,36,39,42-Tetradecaoxatetratetracontane-1,44-diol, 95% | 28821-35-4 | USD 352 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24,27,30,33,36,39,42-Tetradecaoxatetratetracontane-1,44-diol, 95% | 28821-35-4 | USD 1229 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | Propargyl-peg4-ch2co2tbu, 95% | 888010-02-4 | USD 112 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | Propargyl-peg4-ch2co2tbu, 95% | 888010-02-4 | USD 189 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Propargyl-peg4-ch2co2tbu, 95% | 888010-02-4 | USD 322 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Propargyl-peg4-ch2co2tbu, 95% | 888010-02-4 | USD 546 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Propargyl-peg4-ch2co2tbu, 95% | 888010-02-4 | USD 1474 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | Fmoc-nh-peg8-ch2cooh, 95% | 868594-52-9 | USD 71 | >5 | 1 | 1 |
| BLDPharm | 250mg | Fmoc-nh-peg8-ch2cooh, 95% | 868594-52-9 | USD 86 | >5 | 2 | 1 |
| BLDPharm | 1g | Fmoc-nh-peg8-ch2cooh, 95% | 868594-52-9 | USD 198 | >5 | 4 | 2 |
| BLDPharm | 5g | Fmoc-nh-peg8-ch2cooh, 95% | 868594-52-9 | USD 696 | 1 | 1 | 1 |
| BLDPharm | 25g | Fmoc-nh-peg8-ch2cooh, 95% | 868594-52-9 | USD 2436 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Benzyl-peg5-amine, 95% | 86770-77-6 | USD 132 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Benzyl-peg5-amine, 95% | 86770-77-6 | USD 223 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Benzyl-peg5-amine, 95% | 86770-77-6 | USD 599 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1,23-Dibromo-3,6,9,12,15,18,21-heptaoxatricosane, 97% | 177987-04-1 | USD 58 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1,23-Dibromo-3,6,9,12,15,18,21-heptaoxatricosane, 97% | 177987-04-1 | USD 99 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 1,23-Dibromo-3,6,9,12,15,18,21-heptaoxatricosane, 97% | 177987-04-1 | USD 265 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl 1-(tosyloxy)-3,6,9,12,15-pentaoxaoctadecan-18-oate, 95% | 850090-10-7 | USD 9 | >5 | 1 | 1 |
| BLDPharm | 250mg | tert-Butyl 1-(tosyloxy)-3,6,9,12,15-pentaoxaoctadecan-18-oate, 95% | 850090-10-7 | USD 19 | >5 | 1 | 1 |
| BLDPharm | 1g | tert-Butyl 1-(tosyloxy)-3,6,9,12,15-pentaoxaoctadecan-18-oate, 95% | 850090-10-7 | USD 75 | >5 | 1 | Inquiry |
| BLDPharm | 5g | tert-Butyl 1-(tosyloxy)-3,6,9,12,15-pentaoxaoctadecan-18-oate, 95% | 850090-10-7 | USD 374 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 1,2-Bis(2-propynyloxy)ethane, 98% | 40842-04-4 | USD 13 | >5 | Inquiry | 1 |
| BLDPharm | 1g | 1,2-Bis(2-propynyloxy)ethane, 98% | 40842-04-4 | USD 32 | >5 | 2 | 1 |
| BLDPharm | 5g | 1,2-Bis(2-propynyloxy)ethane, 98% | 40842-04-4 | USD 112 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | 1,2-Bis(2-propynyloxy)ethane, 98% | 40842-04-4 | USD 310 | 1 | Inquiry | Inquiry |
| BLDPharm | 5mg | 4-((S)-2-(4-Aminobutyl)-35-(4-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxamido)methyl)-1H-1,2,3-triazol-1-yl)-4,8-dioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacontanamido)benzyl ((S)-4,11-diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl) carbonate, 98% | 1279680-68-0 | USD 235 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | 4-((S)-2-(4-Aminobutyl)-35-(4-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxamido)methyl)-1H-1,2,3-triazol-1-yl)-4,8-dioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacontanamido)benzyl ((S)-4,11-diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl) carbonate, 98% | 1279680-68-0 | USD 327 | >5 | 2 | Inquiry |
| BLDPharm | 25mg | 4-((S)-2-(4-Aminobutyl)-35-(4-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxamido)methyl)-1H-1,2,3-triazol-1-yl)-4,8-dioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacontanamido)benzyl ((S)-4,11-diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl) carbonate, 98% | 1279680-68-0 | USD 458 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 4-((S)-2-(4-Aminobutyl)-35-(4-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxamido)methyl)-1H-1,2,3-triazol-1-yl)-4,8-dioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacontanamido)benzyl ((S)-4,11-diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl) carbonate, 98% | 1279680-68-0 | USD 641 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-((S)-2-(4-Aminobutyl)-35-(4-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxamido)methyl)-1H-1,2,3-triazol-1-yl)-4,8-dioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacontanamido)benzyl ((S)-4,11-diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl) carbonate, 98% | 1279680-68-0 | USD 897 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol, 95% | 3386-18-3 | USD 5 | 3 | 5 | Inquiry |
| BLDPharm | 250mg | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol, 95% | 3386-18-3 | USD 6 | 1 | 1 | Inquiry |
| BLDPharm | 1g | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol, 95% | 3386-18-3 | USD 15 | >5 | >5 | 1 |
| BLDPharm | 5g | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol, 95% | 3386-18-3 | USD 52 | >5 | 4 | 1 |
| BLDPharm | 10g | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol, 95% | 3386-18-3 | USD 84 | 4 | 1 | 3 |
| BLDPharm | 25g | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol, 95% | 3386-18-3 | USD 168 | >5 | 3 | Inquiry |
| BLDPharm | 100g | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol, 95% | 3386-18-3 | USD 662 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol, 97% | 5117-19-1 | USD 5 | >5 | 2 | 2 |
| BLDPharm | 250mg | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol, 97% | 5117-19-1 | USD 8 | >5 | >5 | 2 |
| BLDPharm | 1g | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol, 97% | 5117-19-1 | USD 11 | >5 | >5 | 3 |
| BLDPharm | 5g | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol, 97% | 5117-19-1 | USD 46 | >5 | 1 | 3 |
| BLDPharm | 10g | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol, 97% | 5117-19-1 | USD 86 | >5 | 2 | Inquiry |
| BLDPharm | 25g | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol, 97% | 5117-19-1 | USD 176 | >5 | 1 | 4 |
| BLDPharm | 100g | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol, 97% | 5117-19-1 | USD 638 | 1 | 1 | 1 |
| BLDPharm | 25mg | 17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenicosanoic acid, 97% | 721431-18-1 | USD 31 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenicosanoic acid, 97% | 721431-18-1 | USD 38 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | 17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenicosanoic acid, 97% | 721431-18-1 | USD 46 | >5 | 2 | 1 |
| BLDPharm | 250mg | 17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenicosanoic acid, 97% | 721431-18-1 | USD 62 | >5 | Inquiry | 2 |
| BLDPharm | 1g | 17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenicosanoic acid, 97% | 721431-18-1 | USD 247 | 5 | Inquiry | 2 |
| BLDPharm | 5g | 17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenicosanoic acid, 97% | 721431-18-1 | USD 1234 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl (23-amino-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 98% | 206265-98-7 | USD 43 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | tert-Butyl (23-amino-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 98% | 206265-98-7 | USD 71 | 5 | 2 | Inquiry |
| BLDPharm | 1g | tert-Butyl (23-amino-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 98% | 206265-98-7 | USD 140 | >5 | 2 | Inquiry |
| BLDPharm | 5g | tert-Butyl (23-amino-3,6,9,12,15,18,21-heptaoxatricosyl)carbamate, 98% | 206265-98-7 | USD 699 | 2 | 1 | Inquiry |
| BLDPharm | 100mg | 14-Amino-3,6,9,12-tetraoxatetradecan-1-oic acid, 96% | 195071-49-9 | USD 56 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | 14-Amino-3,6,9,12-tetraoxatetradecan-1-oic acid, 96% | 195071-49-9 | USD 82 | >5 | 3 | Inquiry |
| BLDPharm | 1g | 14-Amino-3,6,9,12-tetraoxatetradecan-1-oic acid, 96% | 195071-49-9 | USD 172 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | 14-Amino-3,6,9,12-tetraoxatetradecan-1-oic acid, 96% | 195071-49-9 | USD 859 | 1 | Inquiry | Inquiry |
| BLDPharm | 25mg | 4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 99% | 644981-35-1 | USD 152 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 99% | 644981-35-1 | USD 258 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | 4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, 99% | 644981-35-1 | USD 438 | >5 | 3 | Inquiry |
| BLDPharm | 25mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-methyl-N-(3-(methyldisulfaneyl)propanoyl)-L-alaninate, 98% | 138148-68-2 | USD 254 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-methyl-N-(3-(methyldisulfaneyl)propanoyl)-L-alaninate, 98% | 138148-68-2 | USD 432 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-methyl-N-(3-(methyldisulfaneyl)propanoyl)-L-alaninate, 98% | 138148-68-2 | USD 733 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methylpentanoic acid, 98% | 143688-83-9 | USD 21 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | (2R,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methylpentanoic acid, 98% | 143688-83-9 | USD 51 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methylpentanoic acid, 98% | 143688-83-9 | USD 203 | >5 | 1 | Inquiry |
| BLDPharm | 5g | (2R,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methylpentanoic acid, 98% | 143688-83-9 | USD 1014 | >5 | 4 | 2 |
| BLDPharm | 1g | Fmoc-Lys-OH, 97% | 105047-45-8 | USD 6 | >5 | >5 | 2 |
| BLDPharm | 5g | Fmoc-Lys-OH, 97% | 105047-45-8 | USD 21 | >5 | 3 | 5 |
| BLDPharm | 10g | Fmoc-Lys-OH, 97% | 105047-45-8 | USD 26 | >5 | 3 | >5 |
| BLDPharm | 25g | Fmoc-Lys-OH, 97% | 105047-45-8 | USD 64 | >5 | Inquiry | 2 |
| BLDPharm | 100g | Fmoc-Lys-OH, 97% | 105047-45-8 | USD 255 | >5 | Inquiry | 1 |
| BLDPharm | 500g | Fmoc-Lys-OH, 97% | 105047-45-8 | USD 1181 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Fmoc-Lys(Fmoc)-OH, 95% | 78081-87-5 | USD 9 | >5 | 1 | 1 |
| BLDPharm | 10g | Fmoc-Lys(Fmoc)-OH, 95% | 78081-87-5 | USD 16 | >5 | 1 | 1 |
| BLDPharm | 25g | Fmoc-Lys(Fmoc)-OH, 95% | 78081-87-5 | USD 36 | >5 | 2 | 1 |
| BLDPharm | 100g | Fmoc-Lys(Fmoc)-OH, 95% | 78081-87-5 | USD 80 | >5 | 2 | >5 |
| BLDPharm | 500g | Fmoc-Lys(Fmoc)-OH, 95% | 78081-87-5 | USD 393 | 1 | Inquiry | 1 |
| BLDPharm | 250mg | Fmoc-8-Aoc-OH, 97% | 126631-93-4 | USD 17 | >5 | 3 | Inquiry |
| BLDPharm | 1g | Fmoc-8-Aoc-OH, 97% | 126631-93-4 | USD 35 | >5 | 3 | 1 |
| BLDPharm | 5g | Fmoc-8-Aoc-OH, 97% | 126631-93-4 | USD 153 | >5 | 2 | 3 |
| BLDPharm | 25g | Fmoc-8-Aoc-OH, 97% | 126631-93-4 | USD 764 | 4 | Inquiry | 1 |
| BLDPharm | 5g | Fmoc-Ser(tBu)-OH, 98% | 71989-33-8 | USD 6 | >5 | 1 | 2 |
| BLDPharm | 10g | Fmoc-Ser(tBu)-OH, 98% | 71989-33-8 | USD 9 | >5 | 2 | 1 |
| BLDPharm | 25g | Fmoc-Ser(tBu)-OH, 98% | 71989-33-8 | USD 19 | >5 | Inquiry | >5 |
| BLDPharm | 100g | Fmoc-Ser(tBu)-OH, 98% | 71989-33-8 | USD 46 | >5 | >5 | 4 |
| BLDPharm | 500g | Fmoc-Ser(tBu)-OH, 98% | 71989-33-8 | USD 229 | >5 | 4 | 1 |
| BLDPharm | 1kg | Fmoc-Ser(tBu)-OH, 98% | 71989-33-8 | USD 457 | 2 | 1 | 2 |
| BLDPharm | 250mg | (2R)-2-Amino-3-(methylsulfinyl)propanoic acid, 97% | 6853-87-8 | USD 15 | >5 | 2 | 2 |
| BLDPharm | 1g | (2R)-2-Amino-3-(methylsulfinyl)propanoic acid, 97% | 6853-87-8 | USD 19 | >5 | 2 | 2 |
| BLDPharm | 5g | (2R)-2-Amino-3-(methylsulfinyl)propanoic acid, 97% | 6853-87-8 | USD 94 | >5 | 1 | 1 |
| BLDPharm | 250mg | Fmoc-D-Allo-Ile-OH, 98% | 118904-37-3 | USD 7 | 1 | Inquiry | 1 |
| BLDPharm | 1g | Fmoc-D-Allo-Ile-OH, 98% | 118904-37-3 | USD 27 | >5 | 1 | 1 |
| BLDPharm | 5g | Fmoc-D-Allo-Ile-OH, 98% | 118904-37-3 | USD 134 | >5 | >5 | 1 |
| BLDPharm | 10g | Fmoc-D-Allo-Ile-OH, 98% | 118904-37-3 | USD 223 | >5 | 1 | 1 |
| BLDPharm | 25g | Fmoc-D-Allo-Ile-OH, 98% | 118904-37-3 | USD 268 | >5 | 1 | Inquiry |
| BLDPharm | 5g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid, 98% | 71989-26-9 | USD 7 | >5 | 5 | 3 |
| BLDPharm | 10g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid, 98% | 71989-26-9 | USD 9 | >5 | >5 | 2 |
| BLDPharm | 25g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid, 98% | 71989-26-9 | USD 20 | >5 | >5 | >5 |
| BLDPharm | 100g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid, 98% | 71989-26-9 | USD 59 | >5 | >5 | >5 |
| BLDPharm | 500g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid, 98% | 71989-26-9 | USD 199 | >5 | >5 | 2 |
| BLDPharm | 1kg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid, 98% | 71989-26-9 | USD 397 | >5 | 4 | Inquiry |
| BLDPharm | 1g | Fmoc-Nle-OH, 97% | 77284-32-3 | USD 6 | >5 | 3 | 2 |
| BLDPharm | 5g | Fmoc-Nle-OH, 97% | 77284-32-3 | USD 15 | >5 | 3 | 1 |
| BLDPharm | 10g | Fmoc-Nle-OH, 97% | 77284-32-3 | USD 27 | >5 | 1 | 2 |
| BLDPharm | 25g | Fmoc-Nle-OH, 97% | 77284-32-3 | USD 55 | >5 | 3 | 5 |
| BLDPharm | 100g | Fmoc-Nle-OH, 97% | 77284-32-3 | USD 170 | >5 | >5 | 3 |
| BLDPharm | 500g | Fmoc-Nle-OH, 97% | 77284-32-3 | USD 849 | >5 | 2 | 1 |
| BLDPharm | 5g | Fmoc-Gln-OH, 97% | 71989-20-3 | USD 6 | >5 | 3 | 2 |
| BLDPharm | 25g | Fmoc-Gln-OH, 97% | 71989-20-3 | USD 15 | >5 | Inquiry | 3 |
| BLDPharm | 100g | Fmoc-Gln-OH, 97% | 71989-20-3 | USD 36 | >5 | 2 | 5 |
| BLDPharm | 500g | Fmoc-Gln-OH, 97% | 71989-20-3 | USD 179 | >5 | 1 | 1 |
| BLDPharm | 5g | (S)-Methyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate, 95% | 137863-17-3 | USD 12 | >5 | 1 | Inquiry |
| BLDPharm | 25g | (S)-Methyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate, 95% | 137863-17-3 | USD 40 | 4 | Inquiry | 2 |
| BLDPharm | 100mg | 2-Amino-4-mercaptobutanoic acid, 98% | 454-29-5 | USD 25 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-4-mercaptobutanoic acid, 98% | 454-29-5 | USD 35 | >5 | 3 | 2 |
| BLDPharm | 1g | 2-Amino-4-mercaptobutanoic acid, 98% | 454-29-5 | USD 92 | >5 | 3 | Inquiry |
| BLDPharm | 5g | 2-Amino-4-mercaptobutanoic acid, 98% | 454-29-5 | USD 390 | 1 | 1 | Inquiry |
| BLDPharm | 250mg | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-4-methylpentanoic acid, 95% | 88743-98-0 | USD 45 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-4-methylpentanoic acid, 95% | 88743-98-0 | USD 120 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-4-methylpentanoic acid, 95% | 88743-98-0 | USD 420 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | SAMe-1,4-Butanedisulfonate, 95% | 101020-79-5 | USD 12 | >5 | 2 | Inquiry |
| BLDPharm | 1g | SAMe-1,4-Butanedisulfonate, 95% | 101020-79-5 | USD 29 | >5 | 1 | Inquiry |
| BLDPharm | 5g | SAMe-1,4-Butanedisulfonate, 95% | 101020-79-5 | USD 90 | 1 | 1 | Inquiry |
| BLDPharm | 10g | SAMe-1,4-Butanedisulfonate, 95% | 101020-79-5 | USD 140 | 2 | 1 | Inquiry |
| BLDPharm | 25g | SAMe-1,4-Butanedisulfonate, 95% | 101020-79-5 | USD 251 | 1 | 1 | Inquiry |
| BLDPharm | 250mg | Fmoc-D-Tyr(Me)-OH, 97% | 201335-88-8 | USD 5 | >5 | Inquiry | 1 |
| BLDPharm | 1g | Fmoc-D-Tyr(Me)-OH, 97% | 201335-88-8 | USD 19 | >5 | 2 | 2 |
| BLDPharm | 5g | Fmoc-D-Tyr(Me)-OH, 97% | 201335-88-8 | USD 26 | >5 | Inquiry | 1 |
| BLDPharm | 25g | Fmoc-D-Tyr(Me)-OH, 97% | 201335-88-8 | USD 129 | 3 | 2 | Inquiry |
| BLDPharm | 250mg | Fmoc-Tyr(Me)-OH, 95% | 77128-72-4 | USD 5 | 1 | 1 | Inquiry |
| BLDPharm | 1g | Fmoc-Tyr(Me)-OH, 95% | 77128-72-4 | USD 6 | >5 | 1 | 3 |
| BLDPharm | 5g | Fmoc-Tyr(Me)-OH, 95% | 77128-72-4 | USD 14 | >5 | 1 | Inquiry |
| BLDPharm | 10g | Fmoc-Tyr(Me)-OH, 95% | 77128-72-4 | USD 27 | >5 | 2 | Inquiry |
| BLDPharm | 25g | Fmoc-Tyr(Me)-OH, 95% | 77128-72-4 | USD 66 | 1 | Inquiry | 1 |
| BLDPharm | 100g | Fmoc-Tyr(Me)-OH, 95% | 77128-72-4 | USD 263 | 3 | Inquiry | 2 |
| BLDPharm | 5g | Fmoc-D-Phe-OH, 98% | 86123-10-6 | USD 7 | >5 | 1 | 3 |
| BLDPharm | 10g | Fmoc-D-Phe-OH, 98% | 86123-10-6 | USD 9 | >5 | Inquiry | 2 |
| BLDPharm | 25g | Fmoc-D-Phe-OH, 98% | 86123-10-6 | USD 21 | >5 | >5 | >5 |
| BLDPharm | 100g | Fmoc-D-Phe-OH, 98% | 86123-10-6 | USD 31 | >5 | >5 | 1 |
| BLDPharm | 500g | Fmoc-D-Phe-OH, 98% | 86123-10-6 | USD 154 | >5 | 1 | 2 |
| BLDPharm | 1kg | Fmoc-D-Phe-OH, 98% | 86123-10-6 | USD 307 | 3 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid, 98% | 1012341-52-4 | USD 118 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid, 98% | 1012341-52-4 | USD 200 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid, 98% | 1012341-52-4 | USD 339 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid, 98% | 1012341-52-4 | USD 915 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-D-Lys(Boc)-OH, 98% | 92122-45-7 | USD 9 | >5 | 5 | 2 |
| BLDPharm | 5g | Fmoc-D-Lys(Boc)-OH, 98% | 92122-45-7 | USD 21 | >5 | >5 | 2 |
| BLDPharm | 10g | Fmoc-D-Lys(Boc)-OH, 98% | 92122-45-7 | USD 26 | >5 | 4 | 3 |
| BLDPharm | 25g | Fmoc-D-Lys(Boc)-OH, 98% | 92122-45-7 | USD 36 | >5 | 3 | >5 |
| BLDPharm | 100g | Fmoc-D-Lys(Boc)-OH, 98% | 92122-45-7 | USD 143 | >5 | 5 | 2 |
| BLDPharm | 500g | Fmoc-D-Lys(Boc)-OH, 98% | 92122-45-7 | USD 714 | >5 | Inquiry | 1 |
| BLDPharm | 100mg | Fmoc-Gly-Gly-Gly-Gly, 97% | 1001202-16-9 | USD 7 | >5 | 1 | 2 |
| BLDPharm | 250mg | Fmoc-Gly-Gly-Gly-Gly, 97% | 1001202-16-9 | USD 11 | >5 | 2 | 1 |
| BLDPharm | 1g | Fmoc-Gly-Gly-Gly-Gly, 97% | 1001202-16-9 | USD 15 | >5 | 3 | 1 |
| BLDPharm | 5g | Fmoc-Gly-Gly-Gly-Gly, 97% | 1001202-16-9 | USD 50 | >5 | >5 | 3 |
| BLDPharm | 25g | Fmoc-Gly-Gly-Gly-Gly, 97% | 1001202-16-9 | USD 175 | >5 | 1 | Inquiry |
| BLDPharm | 5g | Fmoc-Phe-OH, 98% | 35661-40-6 | USD 9 | >5 | >5 | 3 |
| BLDPharm | 10g | Fmoc-Phe-OH, 98% | 35661-40-6 | USD 12 | >5 | 5 | 2 |
| BLDPharm | 25g | Fmoc-Phe-OH, 98% | 35661-40-6 | USD 19 | >5 | 4 | >5 |
| BLDPharm | 100g | Fmoc-Phe-OH, 98% | 35661-40-6 | USD 59 | >5 | >5 | 5 |
| BLDPharm | 500g | Fmoc-Phe-OH, 98% | 35661-40-6 | USD 172 | >5 | 1 | 1 |
| BLDPharm | 1kg | Fmoc-Phe-OH, 98% | 35661-40-6 | USD 343 | >5 | 2 | 1 |
| BLDPharm | 250mg | Fmoc-D-Arg-OH, 95% | 130752-32-8 | USD 5 | >5 | 1 | 2 |
| BLDPharm | 1g | Fmoc-D-Arg-OH, 95% | 130752-32-8 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 5g | Fmoc-D-Arg-OH, 95% | 130752-32-8 | USD 12 | 4 | Inquiry | 2 |
| BLDPharm | 10g | Fmoc-D-Arg-OH, 95% | 130752-32-8 | USD 22 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | Fmoc-D-Arg-OH, 95% | 130752-32-8 | USD 40 | 3 | Inquiry | 1 |
| BLDPharm | 100g | Fmoc-D-Arg-OH, 95% | 130752-32-8 | USD 139 | 2 | 1 | 1 |
| BLDPharm | 1g | Fmoc-Asn(Trt)-OH, 98% | 132388-59-1 | USD 6 | >5 | >5 | 2 |
| BLDPharm | 5g | Fmoc-Asn(Trt)-OH, 98% | 132388-59-1 | USD 8 | >5 | Inquiry | 1 |
| BLDPharm | 10g | Fmoc-Asn(Trt)-OH, 98% | 132388-59-1 | USD 10 | >5 | 2 | Inquiry |
| BLDPharm | 25g | Fmoc-Asn(Trt)-OH, 98% | 132388-59-1 | USD 24 | >5 | >5 | >5 |
| BLDPharm | 100g | Fmoc-Asn(Trt)-OH, 98% | 132388-59-1 | USD 75 | >5 | >5 | Inquiry |
| BLDPharm | 500g | Fmoc-Asn(Trt)-OH, 98% | 132388-59-1 | USD 374 | 5 | 1 | 2 |
| BLDPharm | 1kg | Fmoc-Asn(Trt)-OH, 98% | 132388-59-1 | USD 747 | >5 | Inquiry | 2 |
| BLDPharm | 1g | (2R,2'R)-3,3'-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid), 96% | 135273-01-7 | USD 29 | >5 | 3 | 1 |
| BLDPharm | 5g | (2R,2'R)-3,3'-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid), 96% | 135273-01-7 | USD 36 | >5 | 2 | Inquiry |
| BLDPharm | 10g | (2R,2'R)-3,3'-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid), 96% | 135273-01-7 | USD 44 | >5 | 1 | Inquiry |
| BLDPharm | 25g | (2R,2'R)-3,3'-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid), 96% | 135273-01-7 | USD 108 | >5 | Inquiry | 1 |
| BLDPharm | 100g | (2R,2'R)-3,3'-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid), 96% | 135273-01-7 | USD 431 | 4 | 1 | 1 |
| BLDPharm | 1g | Fmoc-Cys(Trt)-OH, 98% | 103213-32-7 | USD 5 | >5 | 3 | 1 |
| BLDPharm | 5g | Fmoc-Cys(Trt)-OH, 98% | 103213-32-7 | USD 6 | >5 | 5 | 5 |
| BLDPharm | 10g | Fmoc-Cys(Trt)-OH, 98% | 103213-32-7 | USD 8 | >5 | >5 | Inquiry |
| BLDPharm | 25g | Fmoc-Cys(Trt)-OH, 98% | 103213-32-7 | USD 15 | >5 | 4 | Inquiry |
| BLDPharm | 100g | Fmoc-Cys(Trt)-OH, 98% | 103213-32-7 | USD 35 | >5 | >5 | 2 |
| BLDPharm | 500g | Fmoc-Cys(Trt)-OH, 98% | 103213-32-7 | USD 174 | >5 | 5 | 3 |
| BLDPharm | 1kg | Fmoc-Cys(Trt)-OH, 98% | 103213-32-7 | USD 347 | >5 | 5 | 2 |
| BLDPharm | 5g | Fmoc-Cit-OH, 98% | 133174-15-9 | USD 6 | >5 | 3 | 1 |
| BLDPharm | 10g | Fmoc-Cit-OH, 98% | 133174-15-9 | USD 11 | >5 | Inquiry | >5 |
| BLDPharm | 25g | Fmoc-Cit-OH, 98% | 133174-15-9 | USD 26 | >5 | 1 | >5 |
| BLDPharm | 100g | Fmoc-Cit-OH, 98% | 133174-15-9 | USD 42 | >5 | 1 | 1 |
| BLDPharm | 500g | Fmoc-Cit-OH, 98% | 133174-15-9 | USD 209 | 1 | 1 | 1 |
| BLDPharm | 1kg | Fmoc-Cit-OH, 98% | 133174-15-9 | USD 417 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-D-Phg-OH, 98% | 111524-95-9 | USD 8 | >5 | 1 | 1 |
| BLDPharm | 5g | Fmoc-D-Phg-OH, 98% | 111524-95-9 | USD 10 | >5 | 1 | Inquiry |
| BLDPharm | 10g | Fmoc-D-Phg-OH, 98% | 111524-95-9 | USD 13 | >5 | Inquiry | 2 |
| BLDPharm | 25g | Fmoc-D-Phg-OH, 98% | 111524-95-9 | USD 31 | >5 | 5 | Inquiry |
| BLDPharm | 100g | Fmoc-D-Phg-OH, 98% | 111524-95-9 | USD 87 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, 95% Synonyms:Ethylene Glycol Tetraacetic Acid; Egtazic acid; Ethylene-bis(oxyethylenenitrilo)tetraacetic acid; Glycol ether diamine tetraacetic acid; Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid | 67-42-5 | USD 9 | >5 | 1 | 2 |
| BLDPharm | 25g | 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, 95% Synonyms:Ethylene Glycol Tetraacetic Acid; Egtazic acid; Ethylene-bis(oxyethylenenitrilo)tetraacetic acid; Glycol ether diamine tetraacetic acid; Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid | 67-42-5 | USD 20 | >5 | 3 | 3 |
| BLDPharm | 100g | 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, 95% Synonyms:Ethylene Glycol Tetraacetic Acid; Egtazic acid; Ethylene-bis(oxyethylenenitrilo)tetraacetic acid; Glycol ether diamine tetraacetic acid; Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid | 67-42-5 | USD 77 | >5 | 5 | 1 |
| BLDPharm | 500g | 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, 95% Synonyms:Ethylene Glycol Tetraacetic Acid; Egtazic acid; Ethylene-bis(oxyethylenenitrilo)tetraacetic acid; Glycol ether diamine tetraacetic acid; Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid | 67-42-5 | USD 171 | >5 | Inquiry | 1 |
| BLDPharm | 1kg | 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, 95% Synonyms:Ethylene Glycol Tetraacetic Acid; Egtazic acid; Ethylene-bis(oxyethylenenitrilo)tetraacetic acid; Glycol ether diamine tetraacetic acid; Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid | 67-42-5 | USD 341 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-18-4 | USD 87 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-18-4 | USD 147 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-18-4 | USD 397 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-D-Cys(Trt)-OH, 97% | 167015-11-4 | USD 8 | >5 | >5 | 1 |
| BLDPharm | 5g | Fmoc-D-Cys(Trt)-OH, 97% | 167015-11-4 | USD 10 | >5 | 5 | 1 |
| BLDPharm | 10g | Fmoc-D-Cys(Trt)-OH, 97% | 167015-11-4 | USD 13 | >5 | Inquiry | 2 |
| BLDPharm | 25g | Fmoc-D-Cys(Trt)-OH, 97% | 167015-11-4 | USD 31 | >5 | 5 | 4 |
| BLDPharm | 100g | Fmoc-D-Cys(Trt)-OH, 97% | 167015-11-4 | USD 123 | >5 | >5 | 5 |
| BLDPharm | 500g | Fmoc-D-Cys(Trt)-OH, 97% | 167015-11-4 | USD 479 | 5 | Inquiry | 1 |
| BLDPharm | 1g | Fmoc-Tyr-OH, 98% | 92954-90-0 | USD 5 | >5 | 2 | 2 |
| BLDPharm | 5g | Fmoc-Tyr-OH, 98% | 92954-90-0 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 10g | Fmoc-Tyr-OH, 98% | 92954-90-0 | USD 11 | >5 | 3 | 5 |
| BLDPharm | 25g | Fmoc-Tyr-OH, 98% | 92954-90-0 | USD 27 | 1 | Inquiry | 4 |
| BLDPharm | 100g | Fmoc-Tyr-OH, 98% | 92954-90-0 | USD 83 | 1 | Inquiry | Inquiry |
| BLDPharm | 500g | Fmoc-Tyr-OH, 98% | 92954-90-0 | USD 414 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | N2-Fmoc-D-lysine Hydrochloride, 98% | 201002-47-3 | USD 18 | >5 | 2 | 1 |
| BLDPharm | 5g | N2-Fmoc-D-lysine Hydrochloride, 98% | 201002-47-3 | USD 22 | >5 | 3 | Inquiry |
| BLDPharm | 25g | N2-Fmoc-D-lysine Hydrochloride, 98% | 201002-47-3 | USD 109 | >5 | 1 | 1 |
| BLDPharm | 100g | N2-Fmoc-D-lysine Hydrochloride, 98% | 201002-47-3 | USD 360 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-D-Ser(tBu)-OH, 97% | 128107-47-1 | USD 7 | >5 | >5 | 1 |
| BLDPharm | 1g | Fmoc-D-Ser(tBu)-OH, 97% | 128107-47-1 | USD 9 | >5 | >5 | 2 |
| BLDPharm | 5g | Fmoc-D-Ser(tBu)-OH, 97% | 128107-47-1 | USD 11 | >5 | 2 | 1 |
| BLDPharm | 10g | Fmoc-D-Ser(tBu)-OH, 97% | 128107-47-1 | USD 14 | >5 | 4 | 1 |
| BLDPharm | 25g | Fmoc-D-Ser(tBu)-OH, 97% | 128107-47-1 | USD 30 | >5 | >5 | 1 |
| BLDPharm | 100g | Fmoc-D-Ser(tBu)-OH, 97% | 128107-47-1 | USD 119 | >5 | 5 | 1 |
| BLDPharm | 500g | Fmoc-D-Ser(tBu)-OH, 97% | 128107-47-1 | USD 594 | 4 | Inquiry | 1 |
| BLDPharm | 250mg | Fmoc-D-Gln(Trt)-OH, 97% | 200623-62-7 | USD 9 | Inquiry | 5 | 1 |
| BLDPharm | 1g | Fmoc-D-Gln(Trt)-OH, 97% | 200623-62-7 | USD 15 | Inquiry | Inquiry | 5 |
| BLDPharm | 5g | Fmoc-D-Gln(Trt)-OH, 97% | 200623-62-7 | USD 45 | Inquiry | Inquiry | 2 |
| BLDPharm | 10g | Fmoc-D-Gln(Trt)-OH, 97% | 200623-62-7 | USD 54 | Inquiry | Inquiry | 2 |
| BLDPharm | 25g | Fmoc-D-Gln(Trt)-OH, 97% | 200623-62-7 | USD 134 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | Fmoc-D-Gln(Trt)-OH, 97% | 200623-62-7 | USD 535 | Inquiry | Inquiry | 1 |
| BLDPharm | 5g | (S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-19-5 | USD 20 | 1 | Inquiry | Inquiry |
| BLDPharm | 10g | (S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-19-5 | USD 24 | 5 | Inquiry | Inquiry |
| BLDPharm | 25g | (S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-19-5 | USD 45 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | (S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-19-5 | USD 154 | 3 | Inquiry | Inquiry |
| BLDPharm | 500g | (S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 95% | 141109-19-5 | USD 328 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | Ac-Asn(Trt)-OH, 97% | 163277-78-9 | USD 5 | 2 | Inquiry | 1 |
| BLDPharm | 250mg | Ac-Asn(Trt)-OH, 97% | 163277-78-9 | USD 12 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Ac-Asn(Trt)-OH, 97% | 163277-78-9 | USD 32 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | Ac-Asn(Trt)-OH, 97% | 163277-78-9 | USD 153 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid, 97% | 138797-71-4 | USD 5 | >5 | 1 | 1 |
| BLDPharm | 1g | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid, 97% | 138797-71-4 | USD 7 | >5 | 2 | 2 |
| BLDPharm | 5g | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid, 97% | 138797-71-4 | USD 32 | >5 | 2 | 1 |
| BLDPharm | 10g | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid, 97% | 138797-71-4 | USD 48 | >5 | 1 | 1 |
| BLDPharm | 25g | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid, 97% | 138797-71-4 | USD 72 | >5 | 2 | 2 |
| BLDPharm | 100g | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid, 97% | 138797-71-4 | USD 287 | 3 | 2 | Inquiry |
| BLDPharm | 250mg | Fmoc-D-Tyr(tBu)-OH, 96% | 118488-18-9 | USD 6 | >5 | 5 | 2 |
| BLDPharm | 1g | Fmoc-D-Tyr(tBu)-OH, 96% | 118488-18-9 | USD 9 | >5 | Inquiry | 1 |
| BLDPharm | 5g | Fmoc-D-Tyr(tBu)-OH, 96% | 118488-18-9 | USD 21 | >5 | 1 | 1 |
| BLDPharm | 10g | Fmoc-D-Tyr(tBu)-OH, 96% | 118488-18-9 | USD 29 | >5 | 1 | 2 |
| BLDPharm | 25g | Fmoc-D-Tyr(tBu)-OH, 96% | 118488-18-9 | USD 71 | >5 | 4 | 4 |
| BLDPharm | 100g | Fmoc-D-Tyr(tBu)-OH, 96% | 118488-18-9 | USD 283 | >5 | 3 | 1 |
| BLDPharm | 500g | Fmoc-D-Tyr(tBu)-OH, 96% | 118488-18-9 | USD 1414 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | H-Gln(Trt)-OH, 97% | 102747-84-2 | USD 9 | >5 | 2 | 2 |
| BLDPharm | 5g | H-Gln(Trt)-OH, 97% | 102747-84-2 | USD 44 | >5 | 3 | 5 |
| BLDPharm | 25g | H-Gln(Trt)-OH, 97% | 102747-84-2 | USD 219 | >5 | 2 | 1 |
| BLDPharm | 100g | H-Gln(Trt)-OH, 97% | 102747-84-2 | USD 875 | >5 | Inquiry | 1 |
| BLDPharm | 500g | H-Gln(Trt)-OH, 97% | 102747-84-2 | USD 3063 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylacetic acid, 97% | 102410-65-1 | USD 6 | >5 | 3 | Inquiry |
| BLDPharm | 10g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylacetic acid, 97% | 102410-65-1 | USD 10 | >5 | 1 | 1 |
| BLDPharm | 25g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylacetic acid, 97% | 102410-65-1 | USD 15 | >5 | Inquiry | 1 |
| BLDPharm | 100g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylacetic acid, 97% | 102410-65-1 | USD 44 | >5 | 2 | 1 |
| BLDPharm | 500g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylacetic acid, 97% | 102410-65-1 | USD 219 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | Fmoc-Ile-OH, 98% | 71989-23-6 | USD 5 | >5 | >5 | 2 |
| BLDPharm | 10g | Fmoc-Ile-OH, 98% | 71989-23-6 | USD 7 | >5 | >5 | 1 |
| BLDPharm | 25g | Fmoc-Ile-OH, 98% | 71989-23-6 | USD 9 | >5 | Inquiry | 3 |
| BLDPharm | 100g | Fmoc-Ile-OH, 98% | 71989-23-6 | USD 34 | >5 | >5 | 5 |
| BLDPharm | 500g | Fmoc-Ile-OH, 98% | 71989-23-6 | USD 169 | >5 | 3 | 2 |
| BLDPharm | 1kg | Fmoc-Ile-OH, 98% | 71989-23-6 | USD 337 | >5 | 3 | 1 |
| BLDPharm | 5g | Fmoc-Arg(Pbf)-OH, 98% | 154445-77-9 | USD 7 | >5 | 1 | 2 |
| BLDPharm | 10g | Fmoc-Arg(Pbf)-OH, 98% | 154445-77-9 | USD 12 | >5 | 5 | 3 |
| BLDPharm | 25g | Fmoc-Arg(Pbf)-OH, 98% | 154445-77-9 | USD 27 | >5 | >5 | >5 |
| BLDPharm | 100g | Fmoc-Arg(Pbf)-OH, 98% | 154445-77-9 | USD 96 | >5 | >5 | >5 |
| BLDPharm | 500g | Fmoc-Arg(Pbf)-OH, 98% | 154445-77-9 | USD 470 | 4 | 2 | 3 |
| BLDPharm | 1kg | Fmoc-Arg(Pbf)-OH, 98% | 154445-77-9 | USD 939 | >5 | 2 | 5 |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid, 97% | 104091-08-9 | USD 8 | >5 | 2 | 3 |
| BLDPharm | 5g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid, 97% | 104091-08-9 | USD 10 | >5 | 1 | 1 |
| BLDPharm | 10g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid, 97% | 104091-08-9 | USD 12 | >5 | 1 | 3 |
| BLDPharm | 25g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid, 97% | 104091-08-9 | USD 29 | >5 | >5 | 5 |
| BLDPharm | 100g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid, 97% | 104091-08-9 | USD 115 | >5 | 2 | Inquiry |
| BLDPharm | 500g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid, 97% | 104091-08-9 | USD 574 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | H-Asn(Trt)-OH, 95% | 132388-58-0 | USD 9 | Inquiry | 3 | 2 |
| BLDPharm | 5g | H-Asn(Trt)-OH, 95% | 132388-58-0 | USD 11 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | H-Asn(Trt)-OH, 95% | 132388-58-0 | USD 21 | Inquiry | Inquiry | 1 |
| BLDPharm | 25g | H-Asn(Trt)-OH, 95% | 132388-58-0 | USD 37 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | H-Asn(Trt)-OH, 95% | 132388-58-0 | USD 147 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Fmoc-Tyr(tBu)-OH, 98% | 71989-38-3 | USD 5 | >5 | 5 | 3 |
| BLDPharm | 10g | Fmoc-Tyr(tBu)-OH, 98% | 71989-38-3 | USD 7 | >5 | >5 | 1 |
| BLDPharm | 25g | Fmoc-Tyr(tBu)-OH, 98% | 71989-38-3 | USD 16 | >5 | >5 | >5 |
| BLDPharm | 100g | Fmoc-Tyr(tBu)-OH, 98% | 71989-38-3 | USD 58 | >5 | >5 | 4 |
| BLDPharm | 500g | Fmoc-Tyr(tBu)-OH, 98% | 71989-38-3 | USD 289 | >5 | >5 | 1 |
| BLDPharm | 1kg | Fmoc-Tyr(tBu)-OH, 98% | 71989-38-3 | USD 577 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-2-yl)propanoic acid, 95% | 130309-35-2 | USD 13 | >5 | 2 | 1 |
| BLDPharm | 1g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-2-yl)propanoic acid, 95% | 130309-35-2 | USD 46 | >5 | 2 | 3 |
| BLDPharm | 5g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-2-yl)propanoic acid, 95% | 130309-35-2 | USD 61 | 5 | 4 | 3 |
| BLDPharm | 10g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-2-yl)propanoic acid, 95% | 130309-35-2 | USD 120 | 4 | 1 | Inquiry |
| BLDPharm | 25g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-2-yl)propanoic acid, 95% | 130309-35-2 | USD 299 | 5 | 1 | 1 |
| BLDPharm | 250mg | Fmoc-D-Asn(Trt)-OH, 97% | 180570-71-2 | USD 7 | 4 | 3 | 2 |
| BLDPharm | 1g | Fmoc-D-Asn(Trt)-OH, 97% | 180570-71-2 | USD 9 | 5 | Inquiry | 3 |
| BLDPharm | 5g | Fmoc-D-Asn(Trt)-OH, 97% | 180570-71-2 | USD 27 | >5 | Inquiry | 2 |
| BLDPharm | 10g | Fmoc-D-Asn(Trt)-OH, 97% | 180570-71-2 | USD 38 | >5 | Inquiry | 3 |
| BLDPharm | 25g | Fmoc-D-Asn(Trt)-OH, 97% | 180570-71-2 | USD 94 | >5 | 3 | 2 |
| BLDPharm | 100g | Fmoc-D-Asn(Trt)-OH, 97% | 180570-71-2 | USD 304 | >5 | >5 | 1 |
| BLDPharm | 500g | Fmoc-D-Asn(Trt)-OH, 97% | 180570-71-2 | USD 1122 | 1 | Inquiry | Inquiry |
| BLDPharm | 1mg | (2S,2'S)-2,2'-(Carbonylbis(azanediyl))dipentanedioic acid, 98% | 302941-52-2 | USD 135 | >5 | Inquiry | Inquiry |
| BLDPharm | 5mg | (2S,2'S)-2,2'-(Carbonylbis(azanediyl))dipentanedioic acid, 98% | 302941-52-2 | USD 403 | 4 | Inquiry | Inquiry |
| BLDPharm | 10mg | (2S,2'S)-2,2'-(Carbonylbis(azanediyl))dipentanedioic acid, 98% | 302941-52-2 | USD 604 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-chlorophenyl)propanoic acid, 95% | 511272-52-9 | USD 58 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-chlorophenyl)propanoic acid, 95% | 511272-52-9 | USD 98 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-chlorophenyl)propanoic acid, 95% | 511272-52-9 | USD 264 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-chlorophenyl)propanoic acid, 95% | 507472-15-3 | USD 39 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-chlorophenyl)propanoic acid, 95% | 507472-15-3 | USD 66 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-chlorophenyl)propanoic acid, 95% | 507472-15-3 | USD 177 | 4 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid, 95% | 507472-13-1 | USD 25 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid, 95% | 507472-13-1 | USD 42 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid, 95% | 507472-13-1 | USD 58 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95% | 507472-09-5 | USD 64 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95% | 507472-09-5 | USD 77 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95% | 507472-09-5 | USD 209 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-amino-4-oxobutanoic acid, 98% | 200335-41-7 | USD 196 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 98% | 136555-16-3 | USD 13 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 98% | 136555-16-3 | USD 20 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 98% | 136555-16-3 | USD 52 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 98% | 136555-16-3 | USD 169 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 98% | 136555-16-3 | USD 289 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopropylacetic acid, 98% | 923012-40-2 | USD 174 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-acetylphenyl)propanoic acid, 95% | 204716-07-4 | USD 1395 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 98% | 284492-06-4 | USD 11 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 98% | 284492-06-4 | USD 18 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 98% | 284492-06-4 | USD 48 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 98% | 284492-06-4 | USD 131 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-oxocyclohexanecarboxylic acid, 95% | 285996-74-9 | USD 475 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | 1-(Fmoc-amino)indane-1-carboxylic Acid, 95% | 214139-28-3 | USD 1730 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2-(trifluoromethyl)phenyl)butanoic acid, 95% | 270065-75-3 | USD 483 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 95% | 167993-23-9 | USD 93 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 95% | 167993-23-9 | USD 157 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 95% | 167993-23-9 | USD 421 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 95% | 167993-07-9 | USD 67 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 95% | 167993-07-9 | USD 113 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 95% | 167993-07-9 | USD 303 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,4R)-4-(4-Bromobenzyl)pyrrolidine-2-carboxylic acid hydrochloride, 95% | 1049734-21-5 | USD 131 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,4R)-4-(4-Bromobenzyl)pyrrolidine-2-carboxylic acid hydrochloride, 95% | 1049734-21-5 | USD 235 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | (2S,4R)-4-(4-Bromobenzyl)pyrrolidine-2-carboxylic acid hydrochloride, 95% | 1049734-21-5 | USD 938 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(2-methoxyphenyl)acetic acid, 98% | 1176648-58-0 | USD 450 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 3-((tert-Butoxycarbonyl)amino)-3-(pyridin-3-yl)propanoic acid, 98% | 166194-68-9 | USD 33 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3-((tert-Butoxycarbonyl)amino)-3-(pyridin-3-yl)propanoic acid, 98% | 166194-68-9 | USD 61 | 5 | Inquiry | Inquiry |
| BLDPharm | 5g | 3-((tert-Butoxycarbonyl)amino)-3-(pyridin-3-yl)propanoic acid, 98% | 166194-68-9 | USD 259 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | Methyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate oxalate(2:1), 97% | 1788043-91-3 | USD 65 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | Methyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate oxalate(2:1), 97% | 1788043-91-3 | USD 225 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | Methyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate oxalate(2:1), 97% | 1788043-91-3 | USD 574 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpentanoic acid, 95% | 269078-74-2 | USD 218 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(naphthalen-2-yl)propanoic acid, 95% | 269078-81-1 | USD 236 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-(1-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexyl)acetic acid, 95% | 282524-98-5 | USD 48 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-(1-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexyl)acetic acid, 95% | 282524-98-5 | USD 80 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(1-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexyl)acetic acid, 95% | 282524-98-5 | USD 214 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-carbamoylphenyl)propanoic acid, 95% | 1217759-04-0 | USD 302 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(methylsulfonyl)butanoic acid, 96% | 1247791-23-6 | USD 295 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclopropane-1-carboxylic acid, 95% | 1263045-62-0 | USD 59 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclopropane-1-carboxylic acid, 95% | 1263045-62-0 | USD 145 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclopropane-1-carboxylic acid, 95% | 1263045-62-0 | USD 577 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | 1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclopropane-1-carboxylic acid, 95% | 1263045-62-0 | USD 2882 | 1 | Inquiry | Inquiry |
| BLDPharm | 10mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3,5-dimethylisoxazol-4-yl)phenyl)propanoic acid, 98% | 1381790-25-5 | USD 50 | 4 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3,5-dimethylisoxazol-4-yl)phenyl)propanoic acid, 98% | 1381790-25-5 | USD 83 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3,5-dimethylisoxazol-4-yl)phenyl)propanoic acid, 98% | 1381790-25-5 | USD 142 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dimethoxyphenyl)propanoic acid, 95% | 381222-51-1 | USD 483 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid, 98% | 175452-89-8 | USD 125 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-(tritylthio)butanoic acid, 97% | 526210-71-9 | USD 106 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-(tritylthio)butanoic acid, 97% | 526210-71-9 | USD 180 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-(tritylthio)butanoic acid, 97% | 526210-71-9 | USD 484 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | Ethyl 3-amino-2-methylpropanoate hydrochloride, 95% | 187886-03-9 | USD 114 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Ethyl 3-amino-2-methylpropanoate hydrochloride, 95% | 187886-03-9 | USD 193 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Ethyl 3-amino-2-methylpropanoate hydrochloride, 95% | 187886-03-9 | USD 519 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-Benzyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95% | 706806-61-3 | USD 127 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-Benzyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95% | 706806-61-3 | USD 258 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-Benzyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95% | 706806-61-3 | USD 557 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-(4-Acetamidophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95% | 114117-42-9 | USD 36 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-(4-Acetamidophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95% | 114117-42-9 | USD 78 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-(4-Acetamidophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95% | 114117-42-9 | USD 157 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-((2,4-Dinitrophenyl)amino)pentanedioic acid, 95% | 1655-48-7 | USD 43 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-((2,4-Dinitrophenyl)amino)pentanedioic acid, 95% | 1655-48-7 | USD 71 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-((2,4-Dinitrophenyl)amino)pentanedioic acid, 95% | 1655-48-7 | USD 191 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethoxyphenyl)propanoic acid, 90% | 511272-39-2 | USD 50 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethoxyphenyl)propanoic acid, 90% | 511272-39-2 | USD 84 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethoxyphenyl)propanoic acid, 90% | 511272-39-2 | USD 226 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 511272-40-5 | USD 54 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 511272-40-5 | USD 91 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 511272-40-5 | USD 242 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 95% | 507472-28-8 | USD 51 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 95% | 507472-28-8 | USD 85 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 95% | 507472-28-8 | USD 227 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethoxyphenyl)propanoic acid, 95% | 501015-36-7 | USD 56 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethoxyphenyl)propanoic acid, 95% | 501015-36-7 | USD 95 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethoxyphenyl)propanoic acid, 95% | 501015-36-7 | USD 254 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 501015-37-8 | USD 41 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 501015-37-8 | USD 69 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 501015-37-8 | USD 185 | 5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-3-yl)propanoic acid, 95% | 507472-06-2 | USD 1521 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid sulfuric acid salt, 95% | 16055-80-4 | USD 126 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid sulfuric acid salt, 95% | 16055-80-4 | USD 213 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid sulfuric acid salt, 95% | 16055-80-4 | USD 575 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,2'-((2-((2,6-Diisopropylphenyl)amino)-2-oxoethyl)azanediyl)diacetic acid, 95% | 65717-97-7 | USD 106 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2,2'-((2-((2,6-Diisopropylphenyl)amino)-2-oxoethyl)azanediyl)diacetic acid, 95% | 65717-97-7 | USD 285 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 2,2'-((2-((2,6-Diisopropylphenyl)amino)-2-oxoethyl)azanediyl)diacetic acid, 95% | 65717-97-7 | USD 996 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid, 95% | 270063-49-5 | USD 208 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 284492-37-1 | USD 31 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 284492-37-1 | USD 52 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 284492-37-1 | USD 136 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-Palmitamidopropanoic acid, 97% | 56255-31-3 | USD 62 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-Palmitamidopropanoic acid, 97% | 56255-31-3 | USD 105 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-Palmitamidopropanoic acid, 97% | 56255-31-3 | USD 282 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid xsulfuric acid salt, 95% | 19185-26-3 | USD 115 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid xsulfuric acid salt, 95% | 19185-26-3 | USD 195 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid xsulfuric acid salt, 95% | 19185-26-3 | USD 525 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid, 95% | 1279032-69-7 | USD 36 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid, 95% | 1279032-69-7 | USD 143 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid, 95% | 1279032-69-7 | USD 679 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 500788-93-2 | USD 51 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 500788-93-2 | USD 86 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 500788-93-2 | USD 229 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-(4-(2-Amino-6-chloropyrimidin-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95% | 1033804-86-2 | USD 167 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-(4-(2-Amino-6-chloropyrimidin-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95% | 1033804-86-2 | USD 285 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-(4-(2-Amino-6-chloropyrimidin-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95% | 1033804-86-2 | USD 768 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-methylheptanoic acid, 97% | 269078-75-3 | USD 109 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-methylheptanoic acid, 97% | 269078-75-3 | USD 217 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-methylheptanoic acid, 97% | 269078-75-3 | USD 479 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-Dibenzyl 2-aminosuccinate, 95% * Cold-chain transportation | 2791-79-9 | USD 27 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-Dibenzyl 2-aminosuccinate, 95% * Cold-chain transportation | 2791-79-9 | USD 72 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-Dibenzyl 2-aminosuccinate, 95% * Cold-chain transportation | 2791-79-9 | USD 250 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-4-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)butanoic acid, 95% | 150009-60-2 | USD 48 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-4-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)butanoic acid, 95% | 150009-60-2 | USD 58 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-4-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)butanoic acid, 95% | 150009-60-2 | USD 175 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylnon-8-enoic acid, 95% | 1311933-84-2 | USD 184 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylnon-8-enoic acid, 95% | 1311933-84-2 | USD 495 | >5 | >5 | Inquiry |
| BLDPharm | 5g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylnon-8-enoic acid, 95% | 1311933-84-2 | USD 1733 | 2 | 4 | Inquiry |
| BLDPharm | 100mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid, 95% | 251317-00-7 | USD 30 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid, 95% | 251317-00-7 | USD 45 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid, 95% | 251317-00-7 | USD 135 | >5 | 2 | 2 |
| BLDPharm | 5g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid, 95% | 251317-00-7 | USD 415 | 5 | 1 | Inquiry |
| BLDPharm | 1g | (2S,3R)-tert-Butyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoate, 98% | 120791-76-6 | USD 133 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (2S,3R)-tert-Butyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoate, 98% | 120791-76-6 | USD 160 | 5 | Inquiry | Inquiry |
| BLDPharm | 10g | (2S,3R)-tert-Butyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoate, 98% | 120791-76-6 | USD 193 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | (2S,3R)-tert-Butyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoate, 98% | 120791-76-6 | USD 361 | 2 | 1 | Inquiry |
| BLDPharm | 100g | (2S,3R)-tert-Butyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoate, 98% | 120791-76-6 | USD 1085 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-(1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid, 95% | 882847-19-0 | USD 93 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-(1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid, 95% | 882847-19-0 | USD 176 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid, 95% | 882847-19-0 | USD 403 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 2-(1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid, 95% | 882847-19-0 | USD 1558 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | 2-(1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid, 95% | 882847-19-0 | USD 1951 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-1-tert-Butyl 5-methyl 2-((tert-butoxycarbonyl)amino)pentanedioate, 98% | 24277-38-1 | USD 20 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-1-tert-Butyl 5-methyl 2-((tert-butoxycarbonyl)amino)pentanedioate, 98% | 24277-38-1 | USD 64 | >5 | 4 | Inquiry |
| BLDPharm | 25g | (S)-1-tert-Butyl 5-methyl 2-((tert-butoxycarbonyl)amino)pentanedioate, 98% | 24277-38-1 | USD 219 | >5 | Inquiry | 1 |
| BLDPharm | 100mg | 3-(1-Benzyl-1H-imidazol-4-yl)-2-(3-(diethylamino)propanamido)propanoic acid, 97% | 2055839-74-0 | USD 113 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 3-(1-Benzyl-1H-imidazol-4-yl)-2-(3-(diethylamino)propanamido)propanoic acid, 97% | 2055839-74-0 | USD 191 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | 3-(1-Benzyl-1H-imidazol-4-yl)-2-(3-(diethylamino)propanamido)propanoic acid, 97% | 2055839-74-0 | USD 514 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-(2-Chloroacetamido)-3-phenylpropanoic acid, 95% | 137503-97-0 | USD 75 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-(2-Chloroacetamido)-3-phenylpropanoic acid, 95% | 137503-97-0 | USD 201 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (R)-2-(2-Chloroacetamido)-3-phenylpropanoic acid, 95% | 137503-97-0 | USD 701 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid sulfuric acid salt, 95% | 2126-91-2 | USD 176 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid sulfuric acid salt, 95% | 2126-91-2 | USD 298 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid sulfuric acid salt, 95% | 2126-91-2 | USD 802 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95% | 507472-25-5 | USD 34 | >5 | 1 | 1 |
| BLDPharm | 250mg | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95% | 507472-25-5 | USD 50 | >5 | 2 | 2 |
| BLDPharm | 1g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95% | 507472-25-5 | USD 61 | 3 | Inquiry | 4 |
| BLDPharm | 5g | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95% | 507472-25-5 | USD 274 | 2 | Inquiry | 2 |
| BLDPharm | 100mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-hydroxyethyl)thio)propanoic acid, 95% | 200354-35-4 | USD 130 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-hydroxyethyl)thio)propanoic acid, 95% | 200354-35-4 | USD 229 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((2-hydroxyethyl)thio)propanoic acid, 95% | 200354-35-4 | USD 520 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)acetamide hydrobromide, 98% | 113728-13-5 | USD 110 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)acetamide hydrobromide, 98% | 113728-13-5 | USD 196 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)acetamide hydrobromide, 98% | 113728-13-5 | USD 410 | 1 | 1 | 1 |
| BLDPharm | 5g | 2,2'-((2-Hydroxyethyl)azanediyl)diacetic acid, 98% | 93-62-9 | USD 22 | >5 | 1 | 1 |
| BLDPharm | 25g | 2,2'-((2-Hydroxyethyl)azanediyl)diacetic acid, 98% | 93-62-9 | USD 75 | >5 | 2 | 1 |
| BLDPharm | 100g | 2,2'-((2-Hydroxyethyl)azanediyl)diacetic acid, 98% | 93-62-9 | USD 125 | >5 | 2 | 1 |
| BLDPharm | 500g | 2,2'-((2-Hydroxyethyl)azanediyl)diacetic acid, 98% | 93-62-9 | USD 375 | 3 | 1 | 1 |
| BLDPharm | 250mg | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid, 95% | 220498-02-2 | USD 36 | >5 | 1 | 1 |
| BLDPharm | 1g | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid, 95% | 220498-02-2 | USD 46 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid, 95% | 220498-02-2 | USD 149 | 2 | Inquiry | 1 |
| BLDPharm | 250mg | Methyl 4-(((benzyloxy)carbonyl)amino)-3-oxobutanoate, 97% | 82961-77-1 | USD 39 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Methyl 4-(((benzyloxy)carbonyl)amino)-3-oxobutanoate, 97% | 82961-77-1 | USD 117 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Methyl 4-(((benzyloxy)carbonyl)amino)-3-oxobutanoate, 97% | 82961-77-1 | USD 452 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-Amino-4-phenylbutanoic acid, 95% | 1011-60-5 | USD 56 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4-Amino-4-phenylbutanoic acid, 95% | 1011-60-5 | USD 95 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 4-Amino-4-phenylbutanoic acid, 95% | 1011-60-5 | USD 256 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)decanoic acid, 95% | 220497-96-1 | USD 74 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)decanoic acid, 95% | 220497-96-1 | USD 124 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)decanoic acid, 95% | 220497-96-1 | USD 335 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 499995-84-5 | USD 65 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 499995-84-5 | USD 109 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((tert-Butoxycarbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 95% | 499995-84-5 | USD 231 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2S,4R)-4-(3,4-Difluorobenzyl)pyrrolidine-2-carboxylic acid, 97% | 1049981-46-5 | USD 211 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (2S,4R)-4-(3,4-Difluorobenzyl)pyrrolidine-2-carboxylic acid, 97% | 1049981-46-5 | USD 735 | 1 | Inquiry | Inquiry |
| BLDPharm | 10g | (2S,4R)-4-(3,4-Difluorobenzyl)pyrrolidine-2-carboxylic acid, 97% | 1049981-46-5 | USD 1249 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | (R)-Methyl 2-(methylamino)propanoate hydrochloride, 97% | 19914-41-1 | USD 16 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | (R)-Methyl 2-(methylamino)propanoate hydrochloride, 97% | 19914-41-1 | USD 26 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-3-Amino-2-phenylpropanoic acid hydrochloride, 95% | 1392090-21-9 | USD 146 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-Amino-2-phenylpropanoic acid hydrochloride, 95% | 1392090-21-9 | USD 246 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-Amino-2-phenylpropanoic acid hydrochloride, 95% | 1392090-21-9 | USD 661 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | H-D-Tyr(3-I)-OH, 97% | 25799-58-0 | USD 33 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | H-D-Tyr(3-I)-OH, 97% | 25799-58-0 | USD 56 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | H-D-Tyr(3-I)-OH, 97% | 25799-58-0 | USD 112 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | H-D-Tyr(3-I)-OH, 97% | 25799-58-0 | USD 335 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-3-(4-(Benzyloxy)phenyl)-2-((tert-butoxycarbonyl)(methyl)amino)propanoic acid, 98% | 138774-98-8 | USD 100 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-3-(4-(Benzyloxy)phenyl)-2-((tert-butoxycarbonyl)(methyl)amino)propanoic acid, 98% | 138774-98-8 | USD 210 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (R)-3-(4-(Benzyloxy)phenyl)-2-((tert-butoxycarbonyl)(methyl)amino)propanoic acid, 98% | 138774-98-8 | USD 794 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Methyl (R)-2-aminohexanoate hydrochloride, 98% | 60687-33-4 | USD 90 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((tert-Butoxycarbonyl)amino)-3,3-difluorocyclobutanecarboxylic acid, 95% | 1363380-83-9 | USD 117 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((tert-Butoxycarbonyl)amino)-3,3-difluorocyclobutanecarboxylic acid, 95% | 1363380-83-9 | USD 198 | 2 | 2 | 1 |
| BLDPharm | 1g | 1-((tert-Butoxycarbonyl)amino)-3,3-difluorocyclobutanecarboxylic acid, 95% | 1363380-83-9 | USD 291 | 2 | 1 | Inquiry |
| BLDPharm | 1g | 1-(((tert-Butoxycarbonyl)amino)methyl)cyclobutane-1-carboxylic acid, 95% | 220145-21-1 | USD 246 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-2-((((Benzyloxy)carbonyl)amino)methyl)-3-methylbutanoic acid, 98% | 1138323-75-7 | USD 39 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-((((Benzyloxy)carbonyl)amino)methyl)-3-methylbutanoic acid, 98% | 1138323-75-7 | USD 60 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-((((Benzyloxy)carbonyl)amino)methyl)-3-methylbutanoic acid, 98% | 1138323-75-7 | USD 239 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N,N-Dimethyl-2-(methylamino)acetamide, 95% | 1857-20-1 | USD 30 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | N,N-Dimethyl-2-(methylamino)acetamide, 95% | 1857-20-1 | USD 80 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | N,N-Dimethyl-2-(methylamino)acetamide, 95% | 1857-20-1 | USD 316 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-((4-methoxyphenyl)diphenylmethyl)-D-lysine, 97% | 2044710-18-9 | USD 122 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-((4-methoxyphenyl)diphenylmethyl)-D-lysine, 97% | 2044710-18-9 | USD 300 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-((4-methoxyphenyl)diphenylmethyl)-D-lysine, 97% | 2044710-18-9 | USD 1316 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-3-Aminohexanoic acid, 97% | 91298-66-7 | USD 111 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-Aminohexanoic acid, 97% | 91298-66-7 | USD 188 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-Aminohexanoic acid, 97% | 91298-66-7 | USD 504 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-(Aminomethyl)butanoic acid, 97% | 538368-15-9 | USD 143 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-(Aminomethyl)butanoic acid, 97% | 538368-15-9 | USD 241 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-(Aminomethyl)butanoic acid, 97% | 538368-15-9 | USD 651 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-Aminohexanedioic acid, 97% | 32908-48-8 | USD 71 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-Aminohexanedioic acid, 97% | 32908-48-8 | USD 192 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-Aminohexanedioic acid, 97% | 32908-48-8 | USD 672 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-3-(2,5-difluorophenyl)propanoic acid, 97% | 32133-38-3 | USD 34 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-3-(2,5-difluorophenyl)propanoic acid, 97% | 32133-38-3 | USD 67 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 2-Amino-3-(2,5-difluorophenyl)propanoic acid, 97% | 32133-38-3 | USD 178 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,3R,4R,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-Pyrrolidine-2-carboxylic acid, 98% | 951382-34-6 | USD 41 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,3R,4R,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-Pyrrolidine-2-carboxylic acid, 98% | 951382-34-6 | USD 50 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (2S,3R,4R,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-Pyrrolidine-2-carboxylic acid, 98% | 951382-34-6 | USD 124 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Fmoc-(S)-2-amino-hept-6-ynoic acid, 95% | 1097192-05-6 | USD 147 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-(S)-2-amino-hept-6-ynoic acid, 95% | 1097192-05-6 | USD 260 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-(S)-2-amino-hept-6-ynoic acid, 95% | 1097192-05-6 | USD 413 | Inquiry | Inquiry | 1 |
| BLDPharm | 5mg | (S)-2-Amino-3-(3-hydroxy-4-methoxy-5-methylphenyl)propanoic acid, 98+% | 699536-22-6 | USD 886 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-5,5,5-trifluoropentanoic acid hcl, 95% | 1443979-43-8 | USD 657 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | (R)-2-Amino-5,5,5-trifluoropentanoic acid, 95% | 122565-29-1 | USD 81 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-2-Amino-5,5,5-trifluoropentanoic acid, 95% | 122565-29-1 | USD 161 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (R)-2-Amino-5,5,5-trifluoropentanoic acid, 95% | 122565-29-1 | USD 297 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | (R)-2-Amino-5,5,5-trifluoropentanoic acid, 95% | 122565-29-1 | USD 598 | 5 | Inquiry | Inquiry |
| BLDPharm | 5g | (R)-2-Amino-5,5,5-trifluoropentanoic acid, 95% | 122565-29-1 | USD 2242 | 1 | Inquiry | Inquiry |
| BLDPharm | 100g | Z-D-Asp(OtBu)-OH, 98% | 71449-08-6 | USD 223 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-D-Leu-OH, 97% | 114360-54-2 | USD 5 | >5 | 2 | 1 |
| BLDPharm | 5g | Fmoc-D-Leu-OH, 97% | 114360-54-2 | USD 7 | >5 | 1 | 2 |
| BLDPharm | 10g | Fmoc-D-Leu-OH, 97% | 114360-54-2 | USD 9 | >5 | 1 | 3 |
| BLDPharm | 25g | Fmoc-D-Leu-OH, 97% | 114360-54-2 | USD 13 | >5 | 4 | 1 |
| BLDPharm | 100g | Fmoc-D-Leu-OH, 97% | 114360-54-2 | USD 51 | >5 | 4 | 3 |
| BLDPharm | 500g | Fmoc-D-Leu-OH, 97% | 114360-54-2 | USD 254 | >5 | Inquiry | 1 |
| BLDPharm | 5g | Fmoc-Leu-OH, 98% | 35661-60-0 | USD 5 | >5 | 5 | 3 |
| BLDPharm | 10g | Fmoc-Leu-OH, 98% | 35661-60-0 | USD 6 | >5 | >5 | 1 |
| BLDPharm | 25g | Fmoc-Leu-OH, 98% | 35661-60-0 | USD 13 | >5 | >5 | >5 |
| BLDPharm | 100g | Fmoc-Leu-OH, 98% | 35661-60-0 | USD 46 | >5 | >5 | >5 |
| BLDPharm | 500g | Fmoc-Leu-OH, 98% | 35661-60-0 | USD 157 | >5 | 3 | 2 |
| BLDPharm | 1kg | Fmoc-Leu-OH, 98% | 35661-60-0 | USD 222 | >5 | 2 | 3 |
| BLDPharm | 1g | Boc-His(Trt)-OH, 98% | 32926-43-5 | USD 6 | 5 | 2 | 1 |
| BLDPharm | 5g | Boc-His(Trt)-OH, 98% | 32926-43-5 | USD 15 | >5 | 1 | 1 |
| BLDPharm | 10g | Boc-His(Trt)-OH, 98% | 32926-43-5 | USD 21 | 1 | 2 | Inquiry |
| BLDPharm | 25g | Boc-His(Trt)-OH, 98% | 32926-43-5 | USD 27 | >5 | Inquiry | 1 |
| BLDPharm | 100g | Boc-His(Trt)-OH, 98% | 32926-43-5 | USD 96 | >5 | 2 | 3 |
| BLDPharm | 500g | Boc-His(Trt)-OH, 98% | 32926-43-5 | USD 479 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | Fmoc-Asp-OH, 98% | 119062-05-4 | USD 9 | >5 | 1 | Inquiry |
| BLDPharm | 100g | Fmoc-Asp-OH, 98% | 119062-05-4 | USD 35 | >5 | 1 | 1 |
| BLDPharm | 500g | Fmoc-Asp-OH, 98% | 119062-05-4 | USD 174 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-cycloleucine, 97% | 117322-30-2 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 1g | Fmoc-cycloleucine, 97% | 117322-30-2 | USD 10 | >5 | >5 | 3 |
| BLDPharm | 5g | Fmoc-cycloleucine, 97% | 117322-30-2 | USD 13 | >5 | Inquiry | 1 |
| BLDPharm | 10g | Fmoc-cycloleucine, 97% | 117322-30-2 | USD 25 | 5 | 1 | 1 |
| BLDPharm | 25g | Fmoc-cycloleucine, 97% | 117322-30-2 | USD 60 | >5 | 3 | 1 |
| BLDPharm | 100g | Fmoc-cycloleucine, 97% | 117322-30-2 | USD 239 | 5 | Inquiry | 1 |
| BLDPharm | 250mg | Boc-Phe-Phe-OH, 97% | 13122-90-2 | USD 5 | >5 | 3 | 1 |
| BLDPharm | 1g | Boc-Phe-Phe-OH, 97% | 13122-90-2 | USD 7 | >5 | 5 | 1 |
| BLDPharm | 5g | Boc-Phe-Phe-OH, 97% | 13122-90-2 | USD 29 | >5 | 3 | 2 |
| BLDPharm | 25g | Boc-Phe-Phe-OH, 97% | 13122-90-2 | USD 91 | 1 | 2 | 2 |
| BLDPharm | 100g | Boc-Phe-Phe-OH, 97% | 13122-90-2 | USD 299 | 4 | Inquiry | 2 |
| BLDPharm | 1g | Boc-Gln(Trt)-OH, 98% | 132388-69-3 | USD 6 | Inquiry | 4 | 1 |
| BLDPharm | 5g | Boc-Gln(Trt)-OH, 98% | 132388-69-3 | USD 10 | Inquiry | 2 | Inquiry |
| BLDPharm | 10g | Boc-Gln(Trt)-OH, 98% | 132388-69-3 | USD 18 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | Boc-Gln(Trt)-OH, 98% | 132388-69-3 | USD 25 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | Boc-Gln(Trt)-OH, 98% | 132388-69-3 | USD 97 | Inquiry | 1 | Inquiry |
| BLDPharm | 250mg | Fmoc-Phe-Gly, 95% | 169624-67-3 | USD 24 | >5 | 1 | 1 |
| BLDPharm | 1g | Fmoc-Phe-Gly, 95% | 169624-67-3 | USD 58 | >5 | Inquiry | 1 |
| BLDPharm | 5g | Fmoc-Phe-Gly, 95% | 169624-67-3 | USD 203 | 4 | 2 | Inquiry |
| BLDPharm | 25g | Fmoc-Phe-Gly, 95% | 169624-67-3 | USD 708 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Boc-Gln(Xan)-OH, 97% | 55260-24-7 | USD 13 | 4 | Inquiry | Inquiry |
| BLDPharm | 5g | Boc-Gln(Xan)-OH, 97% | 55260-24-7 | USD 28 | 3 | 2 | 1 |
| BLDPharm | 10g | Boc-Gln(Xan)-OH, 97% | 55260-24-7 | USD 34 | 5 | 2 | Inquiry |
| BLDPharm | 25g | Boc-Gln(Xan)-OH, 97% | 55260-24-7 | USD 82 | >5 | 2 | 1 |
| BLDPharm | 100mg | Boc-D-PHE-PRO-OH, 98% | 38675-10-4 | USD 16 | Inquiry | 1 | Inquiry |
| BLDPharm | 250mg | Boc-D-PHE-PRO-OH, 98% | 38675-10-4 | USD 24 | Inquiry | 1 | Inquiry |
| BLDPharm | 1g | Boc-D-PHE-PRO-OH, 98% | 38675-10-4 | USD 43 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((tert-Butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid, 98% | 35899-43-5 | USD 8 | 2 | 2 | 1 |
| BLDPharm | 5g | (S)-2-((tert-Butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid, 98% | 35899-43-5 | USD 17 | 1 | 1 | 1 |
| BLDPharm | 10g | (S)-2-((tert-Butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid, 98% | 35899-43-5 | USD 31 | 2 | 1 | 2 |
| BLDPharm | 25g | (S)-2-((tert-Butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid, 98% | 35899-43-5 | USD 71 | 4 | 2 | Inquiry |
| BLDPharm | 100g | (S)-2-((tert-Butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid, 98% | 35899-43-5 | USD 261 | 2 | Inquiry | 1 |
| BLDPharm | 1g | Z-Glu-OBzl, 97% | 3705-42-8 | USD 6 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Z-Glu-OBzl, 97% | 3705-42-8 | USD 10 | >5 | 1 | 1 |
| BLDPharm | 10g | Z-Glu-OBzl, 97% | 3705-42-8 | USD 19 | >5 | 1 | Inquiry |
| BLDPharm | 25g | Z-Glu-OBzl, 97% | 3705-42-8 | USD 38 | >5 | Inquiry | 1 |
| BLDPharm | 100g | Z-Glu-OBzl, 97% | 3705-42-8 | USD 80 | >5 | 1 | 1 |
| BLDPharm | 500g | Z-Glu-OBzl, 97% | 3705-42-8 | USD 399 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (Methyl-d3)boronic acid, 98% 98%atom%D | 1332481-37-4 | USD 1993 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | D8-mmae, 98% 98%atom%D | 2070009-72-0 | USD 3472 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | Azilsartan D5, 98% 98%atom%D | 1346599-45-8 | USD 553 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8, 98% 98%atom%D | 1126621-86-0 | USD 87 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8, 98% 98%atom%D | 1126621-86-0 | USD 174 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8, 98% 98%atom%D | 1126621-86-0 | USD 606 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | L-Leucine-5,5,5-d3, 98% 98%atom%D | 87828-86-2 | USD 164 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 121067-66-1 | USD 158 | 5 | Inquiry | Inquiry |
| BLDPharm | 10mg | (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 121067-66-1 | USD 267 | 2 | Inquiry | Inquiry |
| BLDPharm | 25mg | (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 121067-66-1 | USD 454 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 121067-66-1 | USD 770 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 121067-66-1 | USD 1309 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Methoxyl-d3-amine Hydrochloride, 97% | 110220-55-8 | USD 492 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | 1,1,1,3,3,3-Hexafluoropropan-2-ol-d, 98% 98%atom%D * Cold-chain transportation | 38701-73-4 | USD 668 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | 3-((Bis(methyl-d3)carbamoyl)oxy)-1-methylpyridin-1-ium bromide, 98% 98%atom%D | 2375858-08-3 | USD 100 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide-2,3,5,6-d4, 98% 98%atom%D | 1134803-16-9 | USD 310 | >5 | Inquiry | Inquiry |
| BLDPharm | 5mg | N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide-2,3,5,6-d4, 98% 98%atom%D | 1134803-16-9 | USD 775 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2R,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 110187-42-3 | USD 57 | >5 | 3 | Inquiry |
| BLDPharm | 100mg | (2R,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 110187-42-3 | USD 93 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | (2R,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 110187-42-3 | USD 175 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal-1,2,3,4,5,6-13C6, 98% 98%atom%13C | 110187-42-3 | USD 473 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1kg | Methyl-d3-triphenylphosphoniumbromide, 98% 98%atom%D | 1787-44-6 | USD 56 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 1,1,1,3,3,3-Hexafluoropropan-2-d-2-ol-d, 98% 98%atom%D * Cold-chain transportation | 38701-74-5 | USD 71 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1,1,1,3,3,3-Hexafluoropropan-2-d-2-ol-d, 98% 98%atom%D * Cold-chain transportation | 38701-74-5 | USD 186 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 1,1,1,3,3,3-Hexafluoropropan-2-d-2-ol-d, 98% 98%atom%D * Cold-chain transportation | 38701-74-5 | USD 714 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | 3-Ethyl 5-methyl 2-((2-aminoethoxy-1,1,2,2-d4)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate, 98% 98%atom%D | 1185246-14-3 | USD 271 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-(methyl-d3)propanoic-3,3,3-d3 acid, 98% 98%atom%D | 548783-71-7 | USD 903 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | TRIMETHYLAMINE N-OXIDE (D9), 98% 98%atom%D | 1161070-49-0 | USD 290 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | 4,4'-((Propane-2,2-diyl-13C3)bis(sulfanediyl))bis(2,6-di-tert-butylphenol), 98% +98%atom%13C | 1173019-29-8 | USD 1707 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | Rel-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidine-2,4(1H,3H)-dione-2-13C-1,3-15N2, 98% | 1217728-33-0 | USD 276 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 2,3-Dihydroxypropanal-1-13C, 98% | 70849-18-2 | USD 217 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | P-Toluenesulfonamide-15N, 98% | 287476-18-0 | USD 443 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Propan-1-amine-15N hydrochloride, 98% | 84050-99-7 | USD 412 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10mg | 5-Fluorodihydropyrimidine-2,4(1H,3H)-dione-2-13C-1,3-15N2, 98% | 1189492-99-6 | USD 7856 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 500g | 7-Hydroxy-4-methyl-2H-chromen-2-one-2,3,4,4a-13C4, 98% | 1569304-40-0 | USD 58 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl-2,2,3,3,5,5,6,6-d8)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one, 98% +98%atom%D | 1628752-83-9 | USD 372 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | 6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide, 99% | 1609392-27-9 | USD 141 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide, 99% | 1609392-27-9 | USD 375 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | 6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide, 99% | 1609392-27-9 | USD 563 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | 6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide, 99% | 1609392-27-9 | USD 1127 | 3 | Inquiry | Inquiry |
| BLDPharm | 10mg | 2-Amino-1-(methyl-d3)-1,5-dihydro-4H-imidazol-4-one, 98% 98atom%D | 143827-20-7 | USD 429 | 5 | Inquiry | Inquiry |
| BLDPharm | 25mg | 2-Amino-1-(methyl-d3)-1,5-dihydro-4H-imidazol-4-one, 98% 98atom%D | 143827-20-7 | USD 729 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | 2-Amino-1-(methyl-d3)-1,5-dihydro-4H-imidazol-4-one, 98% 98atom%D | 143827-20-7 | USD 1240 | 1 | Inquiry | Inquiry |
| BLDPharm | 1mg | Propan-2-yl-1,1,1,3,3,3-d6 ((((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate, 98% +98%atom%D | 1868135-06-1 | USD 372 | >5 | Inquiry | Inquiry |
| BLDPharm | 5mg | Propan-2-yl-1,1,1,3,3,3-d6 ((((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate, 98% +98%atom%D | 1868135-06-1 | USD 819 | 2 | Inquiry | Inquiry |
| BLDPharm | 1mg | 4-(7-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl-1,1,3,3-d4)-2-fluoro-N-methylbenzamide, 98% +98%atom%D | 1638885-65-0 | USD 372 | 5 | Inquiry | Inquiry |
| BLDPharm | 1mg | N4-(7-Chloroquinolin-4-yl)-N1-ethyl-N1-(ethyl-d5)pentane-1,4-diamine, 98% +98%atom%D | 1854126-41-2 | USD 282 | 5 | Inquiry | Inquiry |
| BLDPharm | 1mg | N-(2-((2-(Bis(methyl-d3)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide, 98% +98%atom%D | 1638281-44-3 | USD 259 | 5 | Inquiry | Inquiry |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl-2,4,5,6-13C4-1,3-15N2)-3,4-dihydroxytetrahydrofuran-2-yl-2,3,4,5-13C4)methyl-13C tetrahydrogen triphosphate xsodium salt, 98% | 285978-18-9 | USD 299 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Leucomalachite green-methyl-13C4, 98% 98%atom%13C | 1415676-19-5 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(Octanoyloxy)propane-1,3-diyl dipalmitate-Octanoic-1-13C, 98% 98%atom%13C | 1246935-55-6 | USD 432 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Methacetin-methoxy-13c, 98% 98%atom%13C | 72156-70-8 | USD 575 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Glyceryl 1,2-dioctadecanoate-3-octanoate-1-13C, 98% 98%atom%13C | 121043-30-9 | USD 432 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Urea-13C, 98% 99atom%13C | 58069-82-2 | USD 118 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Urea-13C, 98% 99atom%13C | 58069-82-2 | USD 200 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Urea-13C, 98% 99atom%13C | 58069-82-2 | USD 540 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1,4-Dibromobutane-1,1,2,2,3,3,4,4-d8, 98% 98atom%D | 68375-92-8 | USD 66 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1,4-Dibromobutane-1,1,2,2,3,3,4,4-d8, 98% 98atom%D | 68375-92-8 | USD 138 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 1,4-Dibromobutane-1,1,2,2,3,3,4,4-d8, 98% 98atom%D | 68375-92-8 | USD 413 | 3 | 1 | Inquiry |
| BLDPharm | 100mg | Succinic-d4 acid-d2, 98% 98atom%D | 21668-90-6 | USD 72 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Succinic-d4 acid-d2, 98% 98atom%D | 21668-90-6 | USD 121 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | Succinic-d4 acid-d2, 98% 98atom%D | 21668-90-6 | USD 327 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Ethane-d4-1,2-diol, 98% 98atom%D | 2219-51-4 | USD 70 | 2 | 1 | Inquiry |
| BLDPharm | 250mg | Ethane-d4-1,2-diol, 98% 98atom%D | 2219-51-4 | USD 85 | >5 | 1 | Inquiry |
| BLDPharm | 1g | Ethane-d4-1,2-diol, 98% 98atom%D | 2219-51-4 | USD 195 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Ethane-d4-1,2-diol, 98% 98atom%D | 2219-51-4 | USD 974 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | Methyl-d3 trifluoromethanesulfonate, 98% +98%atom%D | 73900-07-9 | USD 12 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Methyl-d3 trifluoromethanesulfonate, 98% +98%atom%D | 73900-07-9 | USD 32 | 3 | Inquiry | Inquiry |
| BLDPharm | 5g | Methyl-d3 trifluoromethanesulfonate, 98% +98%atom%D | 73900-07-9 | USD 110 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | Kynurenic Acid-d5, 98% 98atom%D | 350820-13-2 | USD 2142 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Water-18O, 98atom%18O | 14314-42-2 | USD 53 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 250mg | Water-18O, 98atom%18O | 14314-42-2 | USD 79 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 1g | Water-18O, 98atom%18O | 14314-42-2 | USD 196 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 5g | Water-18O, 98atom%18O | 14314-42-2 | USD 587 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 25g | Water-18O, 98atom%18O | 14314-42-2 | USD 2055 | 1 | Inquiry | 0 1 |
| BLDPharm | 250mg | Naphthalen-d7-2-ol, 98% 98atom%D | 78832-54-9 | USD 467 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | Propan-d7-2-amine hydrochloride, 98% 98atom%D | 106658-10-0 | USD 101 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 50mg | Propan-d7-2-amine hydrochloride, 98% 98atom%D | 106658-10-0 | USD 144 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 100mg | Propan-d7-2-amine hydrochloride, 98% 98atom%D | 106658-10-0 | USD 217 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 250mg | Propan-d7-2-amine hydrochloride, 98% 98atom%D | 106658-10-0 | USD 377 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 1g | Propan-d7-2-amine hydrochloride, 98% 98atom%D | 106658-10-0 | USD 1019 | 5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 250mg | Ammonium sulfate-15N2, 99% 99%atom%15N | 43086-58-4 | USD 42 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 1g | Ammonium sulfate-15N2, 99% 99%atom%15N | 43086-58-4 | USD 137 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 5g | Ammonium sulfate-15N2, 99% 99%atom%15N | 43086-58-4 | USD 586 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 1g | Sodium L-lactate-13C3, 98% 98%atom%13C | 201595-71-3 | USD 1167 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Formamide-13C, 98% +98%atom%13C | 51284-91-4 | USD 874 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-NP-SCA-13C,15N3, 98% 98.5atom%15N,98.5atom%13C | 1958113-22-8 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Nitrofurazone-13C,15N3, 98% 98.5atom%15N,98.5atom%13C | 1958113-24-0 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1-Aminoimidazolidine-2,4-dione-5-13C hydrochloride, 98% 98.5atom%13C | 1958100-83-8 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(((5-Nitrofuran-2-yl)methylene)amino-15N)imidazolidine-2,4-dione-2-13C-1,3-15N2, 98% 99atom%15N,98.5atom%13C | 1516934-90-9 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Sodium octanoate-1-13C, 98% 98.5atom%13C | 201612-61-5 | USD 218 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Sodium octanoate-1-13C, 98% 98.5atom%13C | 201612-61-5 | USD 867 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Carbonic-13C acid, monosodium salt, 98% 98.7atom%13C | 87081-58-1 | USD 1174 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Carbonic-13C acid, calcium salt, 98% 98.8atom%13C | 287389-46-2 | USD 719 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | Iodobenzene-13C6, 97% 98atom%13C | 104130-35-0 | USD 965 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-NP-AHD-13C,15N3, 98% 98.5atom%15N,98.5atom%13C | 1958113-23-9 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Diethyl acetamidomalonate-15N, 98% 99atom%15N | 92877-34-4 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Ethyl 3-oxobutanoate-1,2,3,4-13C4, 99% 99%atom%13C | 84508-55-4 | USD 2992 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Sodiumbutyrate-1-13c, 98% 98.5atom%13C | 62601-04-1 | USD 771 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Urea-13C,-15N2, 98% 98.5atom%15N,98.5atom%13C | 58069-83-3 | USD 246 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Deuterium oxide-18O, 99% 99%atom%D,98%atom%18O | 14674-67-0 | USD 2018 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | L-Valine-2,3,4,4,4,4,4,4-d8, 95% | 35045-72-8 | USD 424 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | M-PHENYLENEDIAMINE-15N, 95% | 1958100-70-3 | USD 1165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | L-Aspartic acid-15N, 98% 98atom%15N | 3715-16-0 | USD 118 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | L-Aspartic acid-15N, 98% 98atom%15N | 3715-16-0 | USD 155 | 1 | 1 | 1 |
| BLDPharm | 250mg | L-Aspartic acid-15N, 98% 98atom%15N | 3715-16-0 | USD 384 | Inquiry | 1 | 1 |
| BLDPharm | 1g | L-Aspartic acid-15N, 98% 98atom%15N | 3715-16-0 | USD 1175 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | Glycine-13C2-15N, 97% | 211057-02-2 | USD 341 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-leucine-13C6-15N, 95% | 1163133-36-5 | USD 129 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-leucine-13C6-15N, 95% | 1163133-36-5 | USD 218 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-leucine-13C6-15N, 95% | 1163133-36-5 | USD 435 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-leucine-13C6-15N, 95% | 1163133-36-5 | USD 738 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-leucine-13C6-15N, 95% | 1163133-36-5 | USD 1253 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-leucine-13C6-15N, 95% | 1163133-36-5 | USD 2129 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | Acetyl-DL-valine-15N, 98% +98%atom%15N | 96817-44-6 | USD 321 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | L-Asparagine-15N2, 98% +98%atom%15N | 748757-99-5 | USD 918 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-alanine-13C3-15N, 97% | 865720-15-6 | USD 411 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-alanine-13C3-15N, 97% | 865720-15-6 | USD 698 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-alanine-13C3-15N, 97% | 865720-15-6 | USD 1185 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | N-(9-Fluorenylmethoxycarbonyl)-L-proline-13C5,15N, 97% | 1217452-48-6 | USD 279 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(9-Fluorenylmethoxycarbonyl)-L-proline-13C5,15N, 97% | 1217452-48-6 | USD 473 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(9-Fluorenylmethoxycarbonyl)-L-proline-13C5,15N, 97% | 1217452-48-6 | USD 804 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | N-(9-Fluorenylmethoxycarbonyl)-L-Phenylalanine-13C9,15N, 97% | 1217455-27-0 | USD 450 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(9-Fluorenylmethoxycarbonyl)-L-Phenylalanine-13C9,15N, 97% | 1217455-27-0 | USD 765 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(9-Fluorenylmethoxycarbonyl)-L-Phenylalanine-13C9,15N, 97% | 1217455-27-0 | USD 1300 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | L-leucine-1-13c, 98% 98%atom%13C | 74292-94-7 | USD 773 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-alanine-15N, 98% +98%atom%15N | 2714333-90-9 | USD 168 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-Asp-OH--15N, 98% 94atom%15N | 287484-33-7 | USD 2251 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | L-Arginine-13C6,15N4 hydrochloride, 98% +98%atom%13C,15N | 202468-25-5 | USD 55 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | L-Tryptophan-15N2, 98% 98atom%15N | 204634-20-8 | USD 406 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | L-Asparagine-N-15N, monohydrate, 98% +98%atom%15N | 204451-47-8 | USD 1021 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | L-lysine-N-15N hydrochloride, 98% 99atom%15N | 82783-00-4 | USD 2018 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10mg | L-Proline-15N, 98% 98atom%15N | 59681-31-1 | USD 98 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | L-Proline-15N, 98% 98atom%15N | 59681-31-1 | USD 195 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | L-Proline-15N, 98% 98atom%15N | 59681-31-1 | USD 331 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | L-Proline-15N, 98% 98atom%15N | 59681-31-1 | USD 563 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | L-Proline-15N, 98% 98atom%15N | 59681-31-1 | USD 956 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | L-Valine-15N, 98% 98atom%15N | 59935-29-4 | USD 1063 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-Glu-OH-15N, 98% 95atom%15N | 287484-34-8 | USD 1850 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-Ile-OH-15N, 98% 97atom%15N | 204633-89-6 | USD 1642 | Inquiry | Inquiry | |
| BLDPharm | 100mg | Fmoc-Pro-OH-15N, 98% 97atom%15N | 204523-24-0 | USD 773 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-Phe-OH-15N, 98% 95atom%15N | 125700-32-5 | USD 1096 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | N-Trifluoro acetyl-DL-tyrosine-15N, 98% 98atom%15N | USD 1150 | Inquiry | Inquiry | ||
| BLDPharm | 1g | N-Acetylglycine-15N, 98% 98atom%15N | 1449-79-2 | USD 432 | Inquiry | Inquiry | |
| BLDPharm | 1g | 2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide, 97% | 69-81-8 | USD 10 | 1 | 2 | Inquiry |
| BLDPharm | 5g | 2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide, 97% | 69-81-8 | USD 24 | 1 | 2 | Inquiry |
| BLDPharm | 10g | 2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide, 97% | 69-81-8 | USD 40 | 3 | 2 | Inquiry |
| BLDPharm | 25g | 2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide, 97% | 69-81-8 | USD 65 | 2 | 1 | Inquiry |
| BLDPharm | 100g | 2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide, 97% | 69-81-8 | USD 165 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97% | 171482-05-6 | USD 19 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97% | 171482-05-6 | USD 26 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97% | 171482-05-6 | USD 41 | >5 | 2 | 1 |
| BLDPharm | 5g | (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97% | 171482-05-6 | USD 111 | >5 | 1 | Inquiry |
| BLDPharm | 10g | (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97% | 171482-05-6 | USD 214 | >5 | 1 | 1 |
| BLDPharm | 25g | (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97% | 171482-05-6 | USD 322 | >5 | Inquiry | 1 |
| BLDPharm | 5g | 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine, 98% | 3159-07-07 00:00:00 | USD 8 | >5 | 2 | 1 |
| BLDPharm | 25g | 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine, 98% | 3159-07-07 00:00:00 | USD 25 | >5 | 1 | Inquiry |
| BLDPharm | 100g | 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine, 98% | 3159-07-07 00:00:00 | USD 92 | >5 | 3 | 1 |
| BLDPharm | 500g | 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine, 98% | 3159-07-07 00:00:00 | USD 321 | 5 | 1 | Inquiry |
| BLDPharm | 1kg | 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine, 98% | 3159-07-07 00:00:00 | USD 547 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | (2S,3R,4R,5R)-2-Acetoxy-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate, 98% | 6974-32-9 | USD 5 | >5 | 1 | 2 |
| BLDPharm | 10g | (2S,3R,4R,5R)-2-Acetoxy-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate, 98% | 6974-32-9 | USD 6 | >5 | >5 | 2 |
| BLDPharm | 25g | (2S,3R,4R,5R)-2-Acetoxy-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate, 98% | 6974-32-9 | USD 14 | >5 | >5 | 5 |
| BLDPharm | 100g | (2S,3R,4R,5R)-2-Acetoxy-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate, 98% | 6974-32-9 | USD 55 | >5 | 3 | 4 |
| BLDPharm | 500g | (2S,3R,4R,5R)-2-Acetoxy-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate, 98% | 6974-32-9 | USD 109 | >5 | 2 | 3 |
| BLDPharm | 250mg | Sodium ((4R)-4-((3R,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycinate, 95% | 863-57-0 | USD 7 | 4 | 2 | Inquiry |
| BLDPharm | 1g | Sodium ((4R)-4-((3R,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycinate, 95% | 863-57-0 | USD 23 | 3 | Inquiry | 1 |
| BLDPharm | 5g | Sodium ((4R)-4-((3R,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycinate, 95% | 863-57-0 | USD 42 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | Sodium ((4R)-4-((3R,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycinate, 95% | 863-57-0 | USD 51 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | Sodium ((4R)-4-((3R,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycinate, 95% | 863-57-0 | USD 106 | 2 | 1 | Inquiry |
| BLDPharm | 25g | (2R,3R,4S,5S,6R)-2-(((1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 60+% | 37248-47-8 | USD 9 | >5 | Inquiry | 1 |
| BLDPharm | 100g | (2R,3R,4S,5S,6R)-2-(((1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 60+% | 37248-47-8 | USD 29 | >5 | Inquiry | 1 |
| BLDPharm | 500g | (2R,3R,4S,5S,6R)-2-(((1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 60+% | 37248-47-8 | USD 95 | >5 | Inquiry | Inquiry |
| BLDPharm | 1kg | (2R,3R,4S,5S,6R)-2-(((1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 60+% | 37248-47-8 | USD 162 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one, 97% | 272778-12-8 | USD 6 | 3 | 2 | 1 |
| BLDPharm | 1g | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one, 97% | 272778-12-8 | USD 9 | 2 | Inquiry | 1 |
| BLDPharm | 5g | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one, 97% | 272778-12-8 | USD 26 | 4 | 2 | 1 |
| BLDPharm | 25g | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one, 97% | 272778-12-8 | USD 87 | 3 | Inquiry | 1 |
| BLDPharm | 100g | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one, 97% | 272778-12-8 | USD 284 | 3 | 1 | 1 |
| BLDPharm | 1g | (Z)-tert-Butyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)-2-methylpropanoate, 97% | 89604-92-2 | USD 6 | >5 | 1 | 2 |
| BLDPharm | 5g | (Z)-tert-Butyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)-2-methylpropanoate, 97% | 89604-92-2 | USD 8 | >5 | 1 | 1 |
| BLDPharm | 10g | (Z)-tert-Butyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)-2-methylpropanoate, 97% | 89604-92-2 | USD 13 | >5 | 1 | 1 |
| BLDPharm | 25g | (Z)-tert-Butyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)-2-methylpropanoate, 97% | 89604-92-2 | USD 16 | >5 | 1 | 1 |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97% | 817204-32-3 | USD 9 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97% | 817204-32-3 | USD 13 | 5 | Inquiry | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97% | 817204-32-3 | USD 16 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97% | 817204-32-3 | USD 21 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97% | 817204-32-3 | USD 42 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97% | 817204-32-3 | USD 136 | 2 | 2 | Inquiry |
| BLDPharm | 5g | Ethyl 2-aminothiazole-4-carboxylate, 98% | 5398-36-7 | USD 6 | >5 | 4 | 2 |
| BLDPharm | 10g | Ethyl 2-aminothiazole-4-carboxylate, 98% | 5398-36-7 | USD 9 | >5 | 2 | 4 |
| BLDPharm | 25g | Ethyl 2-aminothiazole-4-carboxylate, 98% | 5398-36-7 | USD 18 | >5 | 3 | 1 |
| BLDPharm | 100g | Ethyl 2-aminothiazole-4-carboxylate, 98% | 5398-36-7 | USD 65 | >5 | Inquiry | Inquiry |
| BLDPharm | 500g | Ethyl 2-aminothiazole-4-carboxylate, 98% | 5398-36-7 | USD 259 | 3 | 2 | 1 |
| BLDPharm | 1kg | Ethyl 2-aminothiazole-4-carboxylate, 98% | 5398-36-7 | USD 311 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1), 97% | 33818-15-4 | USD 5 | 1 | 1 | Inquiry |
| BLDPharm | 1g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1), 97% | 33818-15-4 | USD 9 | 4 | 1 | Inquiry |
| BLDPharm | 5g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1), 97% | 33818-15-4 | USD 29 | >5 | 1 | Inquiry |
| BLDPharm | 10g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1), 97% | 33818-15-4 | USD 45 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1), 97% | 33818-15-4 | USD 89 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1), 97% | 33818-15-4 | USD 314 | >5 | 1 | Inquiry |
| BLDPharm | 500g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1), 97% | 33818-15-4 | USD 1010 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium, 96% | 987-78-0 | USD 5 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium, 96% | 987-78-0 | USD 7 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium, 96% | 987-78-0 | USD 18 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium, 96% | 987-78-0 | USD 62 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | 2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium, 96% | 987-78-0 | USD 210 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Ammonium 2-((2R,3S,4S,5R,6S)-6-((R)-1-((2S,5R,7S,8R,9S)-2-((2S,2'R,3'S,5R,5'R)-3'-(((2R,4S,5S,6S)-4,5-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5'-((2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyltetrahydro-2H-pyran-2-yl)-2-methyloctahydro-[2,2'-bifuran]-5-yl)-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl)ethyl)-2-hydroxy-4,5-dimethoxy-3-methyltetrahydro-2H-pyran-2-yl)acetate, 98% Synonyms:Maduramycin ammonium | 84878-61-5 | USD 28 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Ammonium 2-((2R,3S,4S,5R,6S)-6-((R)-1-((2S,5R,7S,8R,9S)-2-((2S,2'R,3'S,5R,5'R)-3'-(((2R,4S,5S,6S)-4,5-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5'-((2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyltetrahydro-2H-pyran-2-yl)-2-methyloctahydro-[2,2'-bifuran]-5-yl)-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl)ethyl)-2-hydroxy-4,5-dimethoxy-3-methyltetrahydro-2H-pyran-2-yl)acetate, 98% Synonyms:Maduramycin ammonium | 84878-61-5 | USD 47 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | Ammonium 2-((2R,3S,4S,5R,6S)-6-((R)-1-((2S,5R,7S,8R,9S)-2-((2S,2'R,3'S,5R,5'R)-3'-(((2R,4S,5S,6S)-4,5-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5'-((2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyltetrahydro-2H-pyran-2-yl)-2-methyloctahydro-[2,2'-bifuran]-5-yl)-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl)ethyl)-2-hydroxy-4,5-dimethoxy-3-methyltetrahydro-2H-pyran-2-yl)acetate, 98% Synonyms:Maduramycin ammonium | 84878-61-5 | USD 122 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Sodium 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 98+% | 95510-70-6 | USD 10 | >5 | 1 | 1 |
| BLDPharm | 5g | Sodium 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 98+% | 95510-70-6 | USD 27 | >5 | 1 | 1 |
| BLDPharm | 25g | Sodium 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 98+% | 95510-70-6 | USD 64 | >5 | 2 | 1 |
| BLDPharm | 100g | Sodium 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 98+% | 95510-70-6 | USD 184 | 3 | 1 | 2 |
| BLDPharm | 5g | Calcium 2-oxo-3-phenylpropanoate, 95+% | 51828-93-4 | USD 378 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 3-((2S,4S)-4-Mercapto-1-(((4-nitrobenzyl)oxy)carbonyl)pyrrolidine-2-carboxamido)benzoic acid, 97% | 202467-69-4 | USD 334 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | N-(2-Oxo-1,2-dihydropyrimidin-4-yl)benzamide, 97% | 26661-13-2 | USD 11 | >5 | 3 | 1 |
| BLDPharm | 100g | N-(2-Oxo-1,2-dihydropyrimidin-4-yl)benzamide, 97% | 26661-13-2 | USD 14 | >5 | 2 | 1 |
| BLDPharm | 500g | N-(2-Oxo-1,2-dihydropyrimidin-4-yl)benzamide, 97% | 26661-13-2 | USD 65 | 3 | Inquiry | 1 |
| BLDPharm | 1kg | N-(2-Oxo-1,2-dihydropyrimidin-4-yl)benzamide, 97% | 26661-13-2 | USD 111 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | 5-Thiazolamine, 98% * Cold-chain transportation | 17721-00-5 | USD 59 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 5-Thiazolamine, 98% * Cold-chain transportation | 17721-00-5 | USD 83 | 5 | 1 | Inquiry |
| BLDPharm | 1g | 5-Thiazolamine, 98% * Cold-chain transportation | 17721-00-5 | USD 209 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | 5-Thiazolamine, 98% * Cold-chain transportation | 17721-00-5 | USD 731 | 2 | 1 | Inquiry |
| BLDPharm | 250mg | (2S,4S)-4-Nitrobenzyl 4-(acetylthio)-2-(((tert-butoxycarbonyl)(sulfamoyl)amino)methyl)pyrrolidine-1-carboxylate, 98% | 491878-06-9 | USD 5 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2S,4S)-4-Nitrobenzyl 4-(acetylthio)-2-(((tert-butoxycarbonyl)(sulfamoyl)amino)methyl)pyrrolidine-1-carboxylate, 98% | 491878-06-9 | USD 12 | 5 | Inquiry | 1 |
| BLDPharm | 5g | (2S,4S)-4-Nitrobenzyl 4-(acetylthio)-2-(((tert-butoxycarbonyl)(sulfamoyl)amino)methyl)pyrrolidine-1-carboxylate, 98% | 491878-06-9 | USD 36 | 1 | 1 | Inquiry |
| BLDPharm | 10g | (2S,4S)-4-Nitrobenzyl 4-(acetylthio)-2-(((tert-butoxycarbonyl)(sulfamoyl)amino)methyl)pyrrolidine-1-carboxylate, 98% | 491878-06-9 | USD 59 | 1 | 1 | Inquiry |
| BLDPharm | 1g | 5,5'-(Methylenebis(azanediyl))bis(1,3,4-thiadiazole-2(3H)-thione), 90% | 79319-85-0 | USD 7 | 3 | Inquiry | Inquiry |
| BLDPharm | 5g | 5,5'-(Methylenebis(azanediyl))bis(1,3,4-thiadiazole-2(3H)-thione), 90% | 79319-85-0 | USD 16 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | 5,5'-(Methylenebis(azanediyl))bis(1,3,4-thiadiazole-2(3H)-thione), 90% | 79319-85-0 | USD 51 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 7-Chloro-2-methylquinoline, 97% | 4965-33-7 | USD 6 | >5 | 2 | 1 |
| BLDPharm | 10g | 7-Chloro-2-methylquinoline, 97% | 4965-33-7 | USD 9 | >5 | 2 | 1 |
| BLDPharm | 25g | 7-Chloro-2-methylquinoline, 97% | 4965-33-7 | USD 15 | >5 | 4 | >5 |
| BLDPharm | 100g | 7-Chloro-2-methylquinoline, 97% | 4965-33-7 | USD 34 | >5 | 1 | 2 |
| BLDPharm | 500g | 7-Chloro-2-methylquinoline, 97% | 4965-33-7 | USD 155 | >5 | 1 | 1 |
| BLDPharm | 1kg | 7-Chloro-2-methylquinoline, 97% | 4965-33-7 | USD 186 | >5 | 1 | 1 |
| BLDPharm | 25g | 1-(2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole sulfate, 98+% | 58594-72-2 | USD 5 | 4 | 2 | 1 |
| BLDPharm | 100g | 1-(2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole sulfate, 98+% | 58594-72-2 | USD 17 | >5 | Inquiry | Inquiry |
| BLDPharm | 500g | 1-(2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole sulfate, 98+% | 58594-72-2 | USD 60 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid, 95% | 17745-04-9 | USD 20 | >5 | 2 | 3 |
| BLDPharm | 250mg | 2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid, 95% | 17745-04-9 | USD 30 | >5 | 1 | 2 |
| BLDPharm | 1g | 2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid, 95% | 17745-04-9 | USD 42 | 5 | Inquiry | 3 |
| BLDPharm | 5g | 2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid, 95% | 17745-04-9 | USD 167 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 67% | 135-16-0 | USD 102 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 67% | 135-16-0 | USD 139 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | (2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 67% | 135-16-0 | USD 325 | >5 | 3 | 2 |
| BLDPharm | 1g | (2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 67% | 135-16-0 | USD 736 | >5 | 1 | Inquiry |
| BLDPharm | 5g | (2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 67% | 135-16-0 | USD 2208 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate, 98% | 97614-43-2 | USD 5 | >5 | Inquiry | 2 |
| BLDPharm | 1g | (2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate, 98% | 97614-43-2 | USD 11 | >5 | >5 | 2 |
| BLDPharm | 5g | (2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate, 98% | 97614-43-2 | USD 14 | >5 | >5 | 2 |
| BLDPharm | 10g | (2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate, 98% | 97614-43-2 | USD 17 | >5 | 5 | 2 |
| BLDPharm | 25g | (2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate, 98% | 97614-43-2 | USD 32 | >5 | >5 | 4 |
| BLDPharm | 100g | (2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate, 98% | 97614-43-2 | USD 127 | >5 | 4 | 1 |
| BLDPharm | 500g | (2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate, 98% | 97614-43-2 | USD 634 | 3 | Inquiry | 1 |
| BLDPharm | 250mg | Methyl 3-sulfamoylthiophene-2-carboxylate, 95% | 59337-93-8 | USD 8 | 1 | Inquiry | 1 |
| BLDPharm | 1g | Methyl 3-sulfamoylthiophene-2-carboxylate, 95% | 59337-93-8 | USD 21 | >5 | 2 | 2 |
| BLDPharm | 5g | Methyl 3-sulfamoylthiophene-2-carboxylate, 95% | 59337-93-8 | USD 36 | >5 | 1 | 1 |
| BLDPharm | 25g | Methyl 3-sulfamoylthiophene-2-carboxylate, 95% | 59337-93-8 | USD 142 | >5 | Inquiry | 1 |
| BLDPharm | 100g | Methyl 3-sulfamoylthiophene-2-carboxylate, 95% | 59337-93-8 | USD 437 | 3 | 1 | 1 |
| BLDPharm | 100mg | tert-Butyl (1R,5S,6s)-rel-3-azabicyclo[3.1.0]hexan-6-ylcarbamate, 98% | 134575-17-0 | USD 34 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | tert-Butyl (1R,5S,6s)-rel-3-azabicyclo[3.1.0]hexan-6-ylcarbamate, 98% | 134575-17-0 | USD 57 | 1 | Inquiry | 1 |
| BLDPharm | 1g | tert-Butyl (1R,5S,6s)-rel-3-azabicyclo[3.1.0]hexan-6-ylcarbamate, 98% | 134575-17-0 | USD 130 | Inquiry | 1 | 1 |
| BLDPharm | 5g | tert-Butyl (1R,5S,6s)-rel-3-azabicyclo[3.1.0]hexan-6-ylcarbamate, 98% | 134575-17-0 | USD 649 | Inquiry | 4 | Inquiry |
| BLDPharm | 1g | (2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone, 98% | 141627-42-1 | USD 37 | >5 | 3 | 1 |
| BLDPharm | 5g | (2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone, 98% | 141627-42-1 | USD 92 | >5 | 4 | 1 |
| BLDPharm | 25g | (2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone, 98% | 141627-42-1 | USD 111 | >5 | 3 | 1 |
| BLDPharm | 100g | (2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone, 98% | 141627-42-1 | USD 435 | 3 | 1 | Inquiry |
| BLDPharm | 1g | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate, 98% | 96034-64-9 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 5g | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate, 98% | 96034-64-9 | USD 9 | >5 | 2 | 1 |
| BLDPharm | 25g | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate, 98% | 96034-64-9 | USD 28 | >5 | Inquiry | 2 |
| BLDPharm | 100g | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate, 98% | 96034-64-9 | USD 111 | >5 | Inquiry | 1 |
| BLDPharm | 500g | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate, 98% | 96034-64-9 | USD 554 | 1 | Inquiry | 1 |
| BLDPharm | 1g | (1S,3aR,6aS)-2-((S)-2-((S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid, 95+% | 402958-98-9 | USD 2127 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Dimethyl 7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate, 99+% Synonyms:DDB | 73536-69-3 | USD 6 | 2 | 5 | Inquiry |
| BLDPharm | 5g | Dimethyl 7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate, 99+% Synonyms:DDB | 73536-69-3 | USD 22 | 4 | 2 | Inquiry |
| BLDPharm | 10g | Dimethyl 7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate, 99+% Synonyms:DDB | 73536-69-3 | USD 41 | 5 | 2 | Inquiry |
| BLDPharm | 25g | Dimethyl 7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate, 99+% Synonyms:DDB | 73536-69-3 | USD 88 | 2 | 2 | Inquiry |
| BLDPharm | 100g | Dimethyl 7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate, 99+% Synonyms:DDB | 73536-69-3 | USD 255 | 1 | 2 | Inquiry |
| BLDPharm | 1g | Policresulen, 50% | 101418-00-2 | USD 5 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Policresulen, 50% | 101418-00-2 | USD 7 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | Policresulen, 50% | 101418-00-2 | USD 10 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | Policresulen, 50% | 101418-00-2 | USD 13 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | Policresulen, 50% | 101418-00-2 | USD 42 | >5 | 1 | Inquiry |
| BLDPharm | 500g | Policresulen, 50% | 101418-00-2 | USD 149 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 95% | 196404-55-4 | USD 7 | >5 | 1 | 1 |
| BLDPharm | 1g | (4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 95% | 196404-55-4 | USD 11 | >5 | Inquiry | 1 |
| BLDPharm | 5g | (4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 95% | 196404-55-4 | USD 45 | >5 | 2 | 1 |
| BLDPharm | 10g | (4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 95% | 196404-55-4 | USD 89 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | (4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 95% | 196404-55-4 | USD 185 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Butoconazole, 98% | 64872-76-0 | USD 290 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | Tak-778, 98% | 180185-61-9 | USD 2605 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | 5-Fluoroimidazo[1,2-a]pyridine hydrochloride, 95+% | 198896-14-9 | USD 2362 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)docosanamide, 97% * Cold-chain transportation | 55726-47-1 | USD 988 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-(((2S,6R)-4-(Carboxymethyl)-5-oxo-2-(thiophen-2-yl)-1,4-thiazepan-6-yl)amino)-4-phenylbutanoic acid, 95% | 110221-53-9 | USD 1015 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | N-(2-Butylbenzofuran-5-yl)methanesulfonamide, 98% | 437652-07-8 | USD 2750 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | (Z)-S-Benzo[d]thiazol-2-yl 2-(acetoxyimino)-2-(2-aminothiazol-4-yl)ethanethioate, 95% | 104797-47-9 | USD 122 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S,E)-tert-Butyl 7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-5-hydroxy-3-oxohept-6-enoate, 95+% | 194934-95-7 | USD 1824 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | 4-(3-(Dibutylamino)propoxy)benzoic acid hydrochloride, 98% | 437651-44-0 | USD 110 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (6R,7R)-Benzhydryl 3-(chloromethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 95% | 64308-63-0 | USD 83 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | trans-5-(4-Chlorophenyl)-4-methylthiazolidin-2-one, 95+% | 78587-59-4 | USD 402 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100g | (6R,7R)-Benzhydryl 7-amino-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride, 95% mix TBC as stabilizer | 79349-67-0 | USD 255 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine, 95+% | 196597-81-6 | USD 620 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | 5-Amino-2-butylbenzofuran-3-yl (4-(3-(dibutylamino)propoxy)phenyl) oxalate, 95+% | 851014-95-4 | USD 828 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(4,5-Dihydrothiazol-2-yl)azetidin-3-ol, 95+% | 161715-27-1 | USD 522 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Isopentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate, 97% | 162204-30-0 | USD 188 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2-(4-Chlorophenyl)-2-methylpropoxy)methyl)-3-phenoxybenzene, 95+% | 80844-01-5 | USD 372 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | (S)-N1-(2-Aminoethyl)-3-(4-ethoxyphenyl)propane-1,2-diamine trihydrochloride, 95+% | 221640-06-8 | USD 593 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | ((1R,4S)-4-((2,5-Diamino-6-chloropyrimidin-4-yl)amino)cyclopent-2-en-1-yl)methanol, 95+% | 896716-96-4 | USD 1094 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 4-((5-(((Cyclopentyloxy)carbonyl)amino)-1-methyl-1H-indol-3-yl)methyl)-3-methoxybenzoic acid, 95+% | 107754-20-1 | USD 1824 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Methyl 4-(1-(5-amino-1H-indol-3-yl)ethyl)-3-methoxybenzoate, 95+% | 107754-14-3 | USD 465 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Diplacine, 95+% | 19918-85-5 | USD 233 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | [(2R,3R,4R,5R)-3-Benzoyloxy-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-4-methyl-tetrahydrofuran-2-yl]methyl benzoate, 98% | 863329-65-1 | USD 341 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(2-Amino-3-benzoylphenyl)-2-(methylthio)acetamide, 97% | 78281-61-5 | USD 117 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 4-Amino-1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 26524-60-7 | USD 37 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | 4-Amino-1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 26524-60-7 | USD 61 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | 4-Amino-1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 26524-60-7 | USD 170 | 1 | 2 | Inquiry |
| BLDPharm | 5g | 4-Amino-1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 26524-60-7 | USD 766 | 3 | 2 | Inquiry |
| BLDPharm | 25g | 4-Amino-1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 26524-60-7 | USD 3296 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 98% | 5988-19-2 | USD 5 | >5 | 2 | 2 |
| BLDPharm | 1g | (S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 98% | 5988-19-2 | USD 19 | >5 | 2 | 1 |
| BLDPharm | 5g | (S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 98% | 5988-19-2 | USD 94 | >5 | 2 | 3 |
| BLDPharm | 25g | (S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 98% | 5988-19-2 | USD 132 | >5 | 1 | 2 |
| BLDPharm | 100g | (S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 98% | 5988-19-2 | USD 159 | 4 | Inquiry | 1 |
| BLDPharm | 1g | Sodium ((2R,3S,4R,5R)-5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 98% | 25899-70-1 | USD 348 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | Sodium ((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl diphosphate, 98% * Cold-chain transportation | 95648-78-5 | USD 174 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Sodium ((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl diphosphate, 98% * Cold-chain transportation | 95648-78-5 | USD 209 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Sodium ((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl diphosphate, 98% * Cold-chain transportation | 95648-78-5 | USD 380 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | Sodium ((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl diphosphate, 98% * Cold-chain transportation | 95648-78-5 | USD 1101 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 97% | 6757-06-08 00:00:00 | USD 5 | 3 | Inquiry | 1 |
| BLDPharm | 10g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 97% | 6757-06-08 00:00:00 | USD 6 | 3 | 1 | Inquiry |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 97% | 6757-06-08 00:00:00 | USD 8 | >5 | 4 | 1 |
| BLDPharm | 100g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 97% | 6757-06-08 00:00:00 | USD 29 | >5 | 1 | 1 |
| BLDPharm | 500g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate, 97% | 6757-06-08 00:00:00 | USD 142 | >5 | 3 | 1 |
| BLDPharm | 100mg | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 26287-69-4 | USD 31 | >5 | 2 | 1 |
| BLDPharm | 250mg | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 26287-69-4 | USD 54 | >5 | 1 | 1 |
| BLDPharm | 1g | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 26287-69-4 | USD 129 | >5 | 5 | Inquiry |
| BLDPharm | 5g | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 26287-69-4 | USD 479 | 3 | 4 | 1 |
| BLDPharm | 25g | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 26287-69-4 | USD 1660 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, 99% | 60-92-4 | USD 5 | 2 | 1 | Inquiry |
| BLDPharm | 250mg | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, 99% | 60-92-4 | USD 6 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, 99% | 60-92-4 | USD 23 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, 99% | 60-92-4 | USD 114 | >5 | Inquiry | 2 |
| BLDPharm | 25g | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, 99% | 60-92-4 | USD 569 | >5 | Inquiry | 1 |
| BLDPharm | 100mg | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one, 95% | 13957-31-8 | USD 77 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one, 95% | 13957-31-8 | USD 93 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one, 95% | 13957-31-8 | USD 297 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate dihydrate, 97% Synonyms:CTP Disodium Salt | 81012-87-5 | USD 6 | >5 | 1 | Inquiry |
| BLDPharm | 1g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate dihydrate, 97% Synonyms:CTP Disodium Salt | 81012-87-5 | USD 16 | >5 | 1 | Inquiry |
| BLDPharm | 5g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate dihydrate, 97% Synonyms:CTP Disodium Salt | 81012-87-5 | USD 56 | >5 | Inquiry | 1 |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate dihydrate, 97% Synonyms:CTP Disodium Salt | 81012-87-5 | USD 190 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 95% | 4494-26-2 | USD 146 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 95% | 4494-26-2 | USD 292 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 95% | 4494-26-2 | USD 962 | 1 | Inquiry | 1 |
| BLDPharm | 250mg | 1-((2R,4S,5R)-4-Hydroxy-5-((trityloxy)methyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 14270-73-6 | USD 143 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2R,4S,5R)-4-Hydroxy-5-((trityloxy)methyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 14270-73-6 | USD 241 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 1-((2R,4S,5R)-4-Hydroxy-5-((trityloxy)methyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 14270-73-6 | USD 652 | 3 | Inquiry | Inquiry |
| BLDPharm | 50mg | N-((E)-3-(1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)allyl)-2,2,2-trifluoroacetamide, 95+% | 869222-68-4 | USD 43 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-((E)-3-(1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)allyl)-2,2,2-trifluoroacetamide, 95+% | 869222-68-4 | USD 68 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-((E)-3-(1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)allyl)-2,2,2-trifluoroacetamide, 95+% | 869222-68-4 | USD 112 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | N-((E)-3-(1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)allyl)-2,2,2-trifluoroacetamide, 95+% | 869222-68-4 | USD 306 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 223777-15-9 | USD 10 | 2 | 2 | 1 |
| BLDPharm | 250mg | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 223777-15-9 | USD 12 | >5 | 3 | 1 |
| BLDPharm | 1g | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 223777-15-9 | USD 47 | >5 | 2 | 1 |
| BLDPharm | 5g | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 223777-15-9 | USD 221 | 3 | 2 | Inquiry |
| BLDPharm | 1g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt xhydrate, 98% | 34369-07-8 | USD 5 | 3 | Inquiry | Inquiry |
| BLDPharm | 5g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt xhydrate, 98% | 34369-07-8 | USD 8 | >5 | 5 | Inquiry |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt xhydrate, 98% | 34369-07-8 | USD 15 | 5 | 1 | Inquiry |
| BLDPharm | 100g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt xhydrate, 98% | 34369-07-8 | USD 46 | >5 | 1 | Inquiry |
| BLDPharm | 500g | ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt xhydrate, 98% | 34369-07-8 | USD 221 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)isobutyramide, 95% | 110522-75-3 | USD 37 | 1 | 1 | 1 |
| BLDPharm | 5g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)isobutyramide, 95% | 110522-75-3 | USD 45 | 1 | 1 | 1 |
| BLDPharm | 10g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)isobutyramide, 95% | 110522-75-3 | USD 54 | 3 | 1 | 1 |
| BLDPharm | 25g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)isobutyramide, 95% | 110522-75-3 | USD 124 | 2 | 1 | 1 |
| BLDPharm | 1g | Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 54735-61-4 | USD 10 | >5 | 2 | 2 |
| BLDPharm | 5g | Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 54735-61-4 | USD 48 | 2 | 2 | Inquiry |
| BLDPharm | 10g | Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 54735-61-4 | USD 84 | 3 | 1 | Inquiry |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 54735-61-4 | USD 151 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | N4-Acetyl-2'-deoxycytidine, 97% HPLC | 32909-05-0 | USD 15 | >5 | 1 | Inquiry |
| BLDPharm | 5g | N4-Acetyl-2'-deoxycytidine, 97% HPLC | 32909-05-0 | USD 62 | 5 | 2 | 1 |
| BLDPharm | 25g | N4-Acetyl-2'-deoxycytidine, 97% HPLC | 32909-05-0 | USD 268 | 1 | 1 | Inquiry |
| BLDPharm | 250mg | 4-Amino-5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 99% | 1022-79-3 | USD 49 | >5 | 2 | 1 |
| BLDPharm | 1g | 4-Amino-5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 99% | 1022-79-3 | USD 59 | >5 | 3 | 2 |
| BLDPharm | 5g | 4-Amino-5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 99% | 1022-79-3 | USD 71 | >5 | 2 | 1 |
| BLDPharm | 25g | 4-Amino-5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 99% | 1022-79-3 | USD 354 | 2 | 1 | 1 |
| BLDPharm | 250mg | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 16178-48-6 | USD 5 | >5 | 1 | 1 |
| BLDPharm | 1g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 16178-48-6 | USD 6 | >5 | 2 | 1 |
| BLDPharm | 5g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 16178-48-6 | USD 20 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 16178-48-6 | USD 39 | 4 | Inquiry | Inquiry |
| BLDPharm | 25g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 16178-48-6 | USD 70 | 2 | 3 | Inquiry |
| BLDPharm | 100g | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate, 97% | 16178-48-6 | USD 276 | 1 | 1 | Inquiry |
| BLDPharm | 100mg | 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione, 95% | 5116-24-5 | USD 225 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione, 95% | 5116-24-5 | USD 275 | 1 | Inquiry | 1 |
| BLDPharm | 1g | 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione, 95% | 5116-24-5 | USD 741 | 2 | Inquiry | 1 |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-(5-Fluoro-2-oxo-4-(((pentyloxy)carbonyl)amino)pyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate, 97% | 162204-20-8 | USD 6 | 3 | Inquiry | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-(5-Fluoro-2-oxo-4-(((pentyloxy)carbonyl)amino)pyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate, 97% | 162204-20-8 | USD 16 | 1 | 1 | Inquiry |
| BLDPharm | 10g | (2R,3R,4R,5R)-2-(5-Fluoro-2-oxo-4-(((pentyloxy)carbonyl)amino)pyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate, 97% | 162204-20-8 | USD 30 | 4 | Inquiry | 1 |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-(5-Fluoro-2-oxo-4-(((pentyloxy)carbonyl)amino)pyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate, 97% | 162204-20-8 | USD 59 | 1 | Inquiry | Inquiry |
| BLDPharm | 100g | (2R,3R,4R,5R)-2-(5-Fluoro-2-oxo-4-(((pentyloxy)carbonyl)amino)pyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate, 97% | 162204-20-8 | USD 84 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% * Cold-chain transportation | 110764-72-2 | USD 19 | >5 | 1 | 1 |
| BLDPharm | 250mg | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% * Cold-chain transportation | 110764-72-2 | USD 27 | >5 | 3 | 1 |
| BLDPharm | 1g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% * Cold-chain transportation | 110764-72-2 | USD 49 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% * Cold-chain transportation | 110764-72-2 | USD 198 | >5 | 2 | 2 |
| BLDPharm | 25g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% * Cold-chain transportation | 110764-72-2 | USD 898 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% * Cold-chain transportation | 110764-72-2 | USD 2996 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 136834-21-4 | USD 9 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 136834-21-4 | USD 20 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 136834-21-4 | USD 74 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 64325-78-6 | USD 17 | >5 | 2 | 2 |
| BLDPharm | 5g | N-(9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 64325-78-6 | USD 61 | >5 | 2 | 1 |
| BLDPharm | 10g | N-(9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 64325-78-6 | USD 74 | 3 | 1 | Inquiry |
| BLDPharm | 25g | N-(9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 64325-78-6 | USD 89 | >5 | 2 | 3 |
| BLDPharm | 100g | N-(9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 64325-78-6 | USD 349 | 3 | 3 | Inquiry |
| BLDPharm | 25mg | 5-Methyl-2'-deoxycytidine 5'-monophosphate, 95% | 2498-41-1 | USD 130 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 5-Methyl-2'-deoxycytidine 5'-monophosphate, 95% | 2498-41-1 | USD 255 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 5-Methyl-2'-deoxycytidine 5'-monophosphate, 95% | 2498-41-1 | USD 415 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 5-Methyl-2'-deoxycytidine 5'-monophosphate, 95% | 2498-41-1 | USD 781 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 81246-81-3 | USD 32 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 81246-81-3 | USD 54 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 81246-81-3 | USD 138 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81246-82-4 | USD 5 | 3 | Inquiry | 1 |
| BLDPharm | 1g | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81246-82-4 | USD 8 | >5 | 3 | 1 |
| BLDPharm | 5g | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81246-82-4 | USD 18 | >5 | 4 | 1 |
| BLDPharm | 25g | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81246-82-4 | USD 77 | 5 | 2 | Inquiry |
| BLDPharm | 100g | N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95% | 81246-82-4 | USD 303 | >5 | 3 | 2 |
| BLDPharm | 5g | Inosine 5'-monophosphate disodium salt xhydrate, 97% | 352195-40-5 | USD 7 | >5 | 1 | Inquiry |
| BLDPharm | 25g | Inosine 5'-monophosphate disodium salt xhydrate, 97% | 352195-40-5 | USD 21 | >5 | 2 | 1 |
| BLDPharm | 100g | Inosine 5'-monophosphate disodium salt xhydrate, 97% | 352195-40-5 | USD 54 | >5 | 1 | 1 |
| BLDPharm | 500g | Inosine 5'-monophosphate disodium salt xhydrate, 97% | 352195-40-5 | USD 266 | 3 | Inquiry | 1 |
| BLDPharm | 1g | 1-((2R,4S,5R)-4-Hydroxy-5-((trityloxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 98% (contains <10%DCM) | 7791-71-1 | USD 11 | >5 | 2 | 1 |
| BLDPharm | 5g | 1-((2R,4S,5R)-4-Hydroxy-5-((trityloxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 98% (contains <10%DCM) | 7791-71-1 | USD 41 | >5 | 2 | 1 |
| BLDPharm | 10g | 1-((2R,4S,5R)-4-Hydroxy-5-((trityloxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 98% (contains <10%DCM) | 7791-71-1 | USD 77 | >5 | 2 | 1 |
| BLDPharm | 25g | 1-((2R,4S,5R)-4-Hydroxy-5-((trityloxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 98% (contains <10%DCM) | 7791-71-1 | USD 142 | >5 | 2 | Inquiry |
| BLDPharm | 100mg | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione, 95+% | 34218-84-3 | USD 34 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione, 95+% | 34218-84-3 | USD 77 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione, 95+% | 34218-84-3 | USD 229 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | Guanosine 5'-phosphate disodium salt hydrate, 97% | 146894-16-8 | USD 7 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | Guanosine 5'-phosphate disodium salt hydrate, 97% | 146894-16-8 | USD 15 | >5 | 1 | 1 |
| BLDPharm | 100g | Guanosine 5'-phosphate disodium salt hydrate, 97% | 146894-16-8 | USD 38 | >5 | 2 | 1 |
| BLDPharm | 500g | Guanosine 5'-phosphate disodium salt hydrate, 97% | 146894-16-8 | USD 139 | 2 | 2 | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 104992-55-4 | USD 5 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 104992-55-4 | USD 10 | >5 | 2 | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 104992-55-4 | USD 28 | >5 | 3 | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 104992-55-4 | USD 78 | >5 | 2 | Inquiry |
| BLDPharm | 10g | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 104992-55-4 | USD 150 | >5 | 1 | Inquiry |
| BLDPharm | 25g | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 104992-55-4 | USD 374 | >5 | 2 | Inquiry |
| BLDPharm | 100mg | (2R,3S,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 98% | 60129-59-1 | USD 56 | 1 | 2 | Inquiry |
| BLDPharm | 250mg | (2R,3S,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 98% | 60129-59-1 | USD 139 | 3 | 2 | Inquiry |
| BLDPharm | 1g | (2R,3S,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 98% | 60129-59-1 | USD 517 | 1 | Inquiry | 1 |
| BLDPharm | 1g | N6-Benzoyladenosine, 95% | 4546-55-8 | USD 5 | >5 | >5 | 1 |
| BLDPharm | 5g | N6-Benzoyladenosine, 95% | 4546-55-8 | USD 7 | >5 | 2 | 2 |
| BLDPharm | 10g | N6-Benzoyladenosine, 95% | 4546-55-8 | USD 13 | >5 | 3 | 1 |
| BLDPharm | 25g | N6-Benzoyladenosine, 95% | 4546-55-8 | USD 18 | >5 | 2 | 3 |
| BLDPharm | 100g | N6-Benzoyladenosine, 95% | 4546-55-8 | USD 71 | >5 | >5 | 3 |
| BLDPharm | 500g | N6-Benzoyladenosine, 95% | 4546-55-8 | USD 354 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 23669-79-6 | USD 8 | >5 | 1 | 1 |
| BLDPharm | 1g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 23669-79-6 | USD 15 | >5 | 1 | 1 |
| BLDPharm | 5g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 23669-79-6 | USD 55 | 5 | 1 | 1 |
| BLDPharm | 25g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98% | 23669-79-6 | USD 195 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95% | 40615-39-2 | USD 9 | >5 | 1 | 2 |
| BLDPharm | 5g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95% | 40615-39-2 | USD 21 | 1 | 2 | 2 |
| BLDPharm | 10g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95% | 40615-39-2 | USD 37 | 2 | Inquiry | 2 |
| BLDPharm | 25g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95% | 40615-39-2 | USD 67 | >5 | 2 | 3 |
| BLDPharm | 100g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95% | 40615-39-2 | USD 215 | >5 | 3 | 3 |
| BLDPharm | 500g | 1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95% | 40615-39-2 | USD 877 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98% | 4546-72-9 | USD 20 | >5 | 3 | 1 |
| BLDPharm | 5g | N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98% | 4546-72-9 | USD 47 | >5 | 1 | 1 |
| BLDPharm | 10g | N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98% | 4546-72-9 | USD 57 | >5 | 1 | Inquiry |
| BLDPharm | 25g | N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98% | 4546-72-9 | USD 141 | >5 | 2 | Inquiry |
| BLDPharm | 100g | N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98% | 4546-72-9 | USD 563 | 5 | 1 | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 147201-04-5 | USD 7 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 147201-04-5 | USD 12 | >5 | 2 | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 147201-04-5 | USD 25 | >5 | 1 | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 147201-04-5 | USD 124 | >5 | Inquiry | Inquiry |
| BLDPharm | 10g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 147201-04-5 | USD 247 | 3 | 1 | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 118362-03-1 | USD 16 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 118362-03-1 | USD 29 | >5 | 1 | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 118362-03-1 | USD 119 | >5 | 3 | Inquiry |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 118362-03-1 | USD 594 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 110782-31-5 | USD 13 | >5 | 1 | 2 |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 110782-31-5 | USD 37 | >5 | 2 | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 110782-31-5 | USD 184 | >5 | Inquiry | >5 |
| BLDPharm | 25g | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 110782-31-5 | USD 775 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 150780-67-9 | USD 10 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 150780-67-9 | USD 23 | >5 | 2 | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 150780-67-9 | USD 88 | >5 | 2 | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 150780-67-9 | USD 368 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 146954-75-8 | USD 20 | >5 | 2 | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 146954-75-8 | USD 81 | >5 | 2 | Inquiry |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 146954-75-8 | USD 404 | >5 | 1 | 1 |
| BLDPharm | 100g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 146954-75-8 | USD 1615 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 97% | 81246-80-2 | USD 24 | >5 | Inquiry | 1 |
| BLDPharm | 1g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 97% | 81246-80-2 | USD 63 | >5 | 4 | Inquiry |
| BLDPharm | 5g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 97% | 81246-80-2 | USD 218 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 114745-26-5 | USD 16 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 114745-26-5 | USD 49 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 114745-26-5 | USD 193 | 3 | Inquiry | Inquiry |
| BLDPharm | 25g | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide, 95% | 114745-26-5 | USD 579 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 103285-22-9 | USD 5 | >5 | 1 | 1 |
| BLDPharm | 250mg | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 103285-22-9 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 1g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 103285-22-9 | USD 12 | >5 | 3 | 2 |
| BLDPharm | 5g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 103285-22-9 | USD 50 | 5 | 2 | 2 |
| BLDPharm | 10g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 103285-22-9 | USD 96 | 5 | 5 | 1 |
| BLDPharm | 25g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 103285-22-9 | USD 239 | >5 | 4 | 2 |
| BLDPharm | 100g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95% | 103285-22-9 | USD 840 | 1 | 1 | 1 |
| BLDPharm | 100mg | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 96% | 146954-74-7 | USD 12 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 96% | 146954-74-7 | USD 15 | 4 | Inquiry | 1 |
| BLDPharm | 1g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 96% | 146954-74-7 | USD 35 | >5 | >5 | 1 |
| BLDPharm | 5g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 96% | 146954-74-7 | USD 100 | >5 | >5 | 1 |
| BLDPharm | 25g | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 96% | 146954-74-7 | USD 360 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine, 95% | 68892-41-1 | USD 5 | 1 | Inquiry | 1 |
| BLDPharm | 1g | N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine, 95% | 68892-41-1 | USD 7 | >5 | 2 | 1 |
| BLDPharm | 5g | N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine, 95% | 68892-41-1 | USD 16 | >5 | 1 | Inquiry |
| BLDPharm | 10g | N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine, 95% | 68892-41-1 | USD 29 | >5 | 1 | 1 |
| BLDPharm | 25g | N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine, 95% | 68892-41-1 | USD 72 | >5 | 4 | 2 |
| BLDPharm | 100g | N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine, 95% | 68892-41-1 | USD 287 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 98796-51-1 | USD 5 | >5 | 2 | 1 |
| BLDPharm | 1g | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 98796-51-1 | USD 12 | >5 | 2 | 2 |
| BLDPharm | 5g | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 98796-51-1 | USD 56 | 4 | Inquiry | 1 |
| BLDPharm | 10g | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 98796-51-1 | USD 89 | 4 | 1 | 2 |
| BLDPharm | 25g | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 98796-51-1 | USD 184 | 2 | Inquiry | 2 |
| BLDPharm | 100g | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 97% | 98796-51-1 | USD 685 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 98796-53-3 | USD 6 | >5 | 2 | 1 |
| BLDPharm | 1g | (2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 98796-53-3 | USD 13 | >5 | 1 | 1 |
| BLDPharm | 5g | (2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 98796-53-3 | USD 45 | >5 | 1 | 1 |
| BLDPharm | 10g | (2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 98796-53-3 | USD 75 | 5 | 1 | 2 |
| BLDPharm | 25g | (2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 98796-53-3 | USD 180 | 1 | 1 | Inquiry |
| BLDPharm | 100g | (2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 98796-53-3 | USD 630 | 1 | Inquiry | 1 |
| BLDPharm | 10mg | (2R,3R,4R,5R)-2-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95% | 443642-29-3 | USD 58 | 4 | Inquiry | Inquiry |
| BLDPharm | 25mg | (2R,3R,4R,5R)-2-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95% | 443642-29-3 | USD 116 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | (2R,3R,4R,5R)-2-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95% | 443642-29-3 | USD 217 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5R)-2-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95% | 443642-29-3 | USD 261 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95% | 443642-29-3 | USD 446 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 110764-79-9 | USD 31 | >5 | 2 | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 110764-79-9 | USD 106 | >5 | Inquiry | 1 |
| BLDPharm | 10g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 110764-79-9 | USD 187 | >5 | 3 | 2 |
| BLDPharm | 25g | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 110764-79-9 | USD 371 | >5 | Inquiry | 2 |
| BLDPharm | 50mg | (2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95+% | 104291-17-0 | USD 44 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95+% | 104291-17-0 | USD 67 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95+% | 104291-17-0 | USD 113 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95+% | 104291-17-0 | USD 311 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | (2R,3S,5R)-5-(4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 97% | 187479-00-1 | USD 78 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | (2R,3S,5R)-5-(4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 97% | 187479-00-1 | USD 132 | >5 | 2 | 1 |
| BLDPharm | 250mg | (2R,3S,5R)-5-(4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 97% | 187479-00-1 | USD 224 | 3 | 2 | Inquiry |
| BLDPharm | 1g | (2R,3S,5R)-5-(4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 97% | 187479-00-1 | USD 604 | 1 | 1 | 1 |
| BLDPharm | 100mg | 2'-Deoxyguanosine-5'-triphosphate trisodium salt, 99% | 93919-41-6 | USD 137 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2'-Deoxyguanosine-5'-triphosphate trisodium salt, 99% | 93919-41-6 | USD 224 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 2'-Deoxyguanosine-5'-triphosphate trisodium salt, 99% | 93919-41-6 | USD 549 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 2'-Deoxyguanosine-5'-triphosphate trisodium salt, 99% | 93919-41-6 | USD 2260 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10mg | Guanosine 5'-(trihydrogen diphosphate) P'-D-mannopyranosyl ester disodium salt, 98% | 103301-73-1 | USD 93 | >5 | 3 | Inquiry |
| BLDPharm | 25mg | Guanosine 5'-(trihydrogen diphosphate) P'-D-mannopyranosyl ester disodium salt, 98% | 103301-73-1 | USD 166 | >5 | 3 | Inquiry |
| BLDPharm | 50mg | Guanosine 5'-(trihydrogen diphosphate) P'-D-mannopyranosyl ester disodium salt, 98% | 103301-73-1 | USD 248 | 4 | 1 | Inquiry |
| BLDPharm | 100mg | Guanosine 5'-(trihydrogen diphosphate) P'-D-mannopyranosyl ester disodium salt, 98% | 103301-73-1 | USD 392 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | Guanosine 5'-(trihydrogen diphosphate) P'-D-mannopyranosyl ester disodium salt, 98% | 103301-73-1 | USD 775 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | Guanosine 5'-(trihydrogen diphosphate) P'-D-mannopyranosyl ester disodium salt, 98% | 103301-73-1 | USD 2703 | 1 | Inquiry | Inquiry |
| BLDPharm | 10mg | Udp-alpha-d-n-acetylgalactosamine,disodiumsalt, 98% | 108320-87-2 | USD 96 | >5 | 3 | 2 |
| BLDPharm | 25mg | Udp-alpha-d-n-acetylgalactosamine,disodiumsalt, 98% | 108320-87-2 | USD 163 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | Udp-alpha-d-n-acetylgalactosamine,disodiumsalt, 98% | 108320-87-2 | USD 420 | >5 | 1 | Inquiry |
| BLDPharm | 1g | Udp-alpha-d-n-acetylgalactosamine,disodiumsalt, 98% | 108320-87-2 | USD 1931 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | Inosine-5'-triphosphate trisodium salt, 98% | 35908-31-7 | USD 17 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Inosine-5'-triphosphate trisodium salt, 98% | 35908-31-7 | USD 36 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Inosine-5'-triphosphate trisodium salt, 98% | 35908-31-7 | USD 107 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Inosine-5'-triphosphate trisodium salt, 98% | 35908-31-7 | USD 400 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 102212-98-6 | USD 6 | >5 | 1 | 1 |
| BLDPharm | 1g | (2R,3S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 102212-98-6 | USD 19 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (2R,3S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 102212-98-6 | USD 80 | >5 | 1 | 1 |
| BLDPharm | 25g | (2R,3S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 102212-98-6 | USD 270 | 4 | 1 | 2 |
| BLDPharm | 100g | (2R,3S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 102212-98-6 | USD 840 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3S,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 154110-40-4 | USD 21 | >5 | 1 | Inquiry |
| BLDPharm | 5g | (2R,3S,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 154110-40-4 | USD 81 | >5 | Inquiry | 1 |
| BLDPharm | 25g | (2R,3S,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 154110-40-4 | USD 297 | >5 | 2 | 1 |
| BLDPharm | 100g | (2R,3S,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 154110-40-4 | USD 968 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Ac-rC Phosphoramidite, 95% | 121058-88-6 | USD 31 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Ac-rC Phosphoramidite, 95% | 121058-88-6 | USD 38 | >5 | 2 | Inquiry |
| BLDPharm | 1g | Ac-rC Phosphoramidite, 95% | 121058-88-6 | USD 93 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Ac-rC Phosphoramidite, 95% | 121058-88-6 | USD 324 | 3 | 2 | Inquiry |
| BLDPharm | 25g | Ac-rC Phosphoramidite, 95% | 121058-88-6 | USD 972 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% (Drying loss 4%max) | 110764-78-8 | USD 19 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% (Drying loss 4%max) | 110764-78-8 | USD 57 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% (Drying loss 4%max) | 110764-78-8 | USD 230 | >5 | 5 | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 199593-09-4 | USD 14 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 199593-09-4 | USD 34 | >5 | Inquiry | 2 |
| BLDPharm | 5g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 199593-09-4 | USD 94 | >5 | Inquiry | 1 |
| BLDPharm | 10g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 199593-09-4 | USD 154 | >5 | Inquiry | 1 |
| BLDPharm | 25g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 199593-09-4 | USD 343 | >5 | Inquiry | Inquiry |
| BLDPharm | 100g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 95% | 199593-09-4 | USD 1371 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 159414-99-0 | USD 36 | >5 | 1 | 1 |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 159414-99-0 | USD 96 | >5 | 3 | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 159414-99-0 | USD 288 | >5 | 1 | 1 |
| BLDPharm | 25g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 159414-99-0 | USD 1008 | 1 | Inquiry | Inquiry |
| BLDPharm | 100g | (2R,3R,4R,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 159414-99-0 | USD 3327 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | N-(1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 96% | 100898-63-3 | USD 20 | >5 | 2 | 1 |
| BLDPharm | 5g | N-(1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 96% | 100898-63-3 | USD 42 | >5 | 1 | 1 |
| BLDPharm | 25g | N-(1-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 96% | 100898-63-3 | USD 95 | 3 | 2 | 2 |
| BLDPharm | 1g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95% | 121058-85-3 | USD 37 | 1 | 2 | Inquiry |
| BLDPharm | 5g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95% | 121058-85-3 | USD 130 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95% | 121058-85-3 | USD 453 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 1-((2R,3R,4S,5R)-5-((((((((2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, disodium salt, 99% | 24292-60-2 | USD 12 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 1-((2R,3R,4S,5R)-5-((((((((2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, disodium salt, 99% | 24292-60-2 | USD 20 | >5 | 4 | 1 |
| BLDPharm | 5g | 1-((2R,3R,4S,5R)-5-((((((((2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, disodium salt, 99% | 24292-60-2 | USD 70 | 5 | Inquiry | 2 |
| BLDPharm | 25g | 1-((2R,3R,4S,5R)-5-((((((((2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium, disodium salt, 99% | 24292-60-2 | USD 240 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate hydrochloride, 95% | 63639-21-4 | USD 71 | 2 | Inquiry | 1 |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate hydrochloride, 95% | 63639-21-4 | USD 120 | >5 | Inquiry | 1 |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate hydrochloride, 95% | 63639-21-4 | USD 323 | 2 | Inquiry | 2 |
| BLDPharm | 50mg | Thymidine 5′-(tetrahydrogen triphosphate) xsodium salt, 97% | 18423-43-3 | USD 65 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | Thymidine 5′-(tetrahydrogen triphosphate) xsodium salt, 97% | 18423-43-3 | USD 110 | 4 | 2 | Inquiry |
| BLDPharm | 250mg | Thymidine 5′-(tetrahydrogen triphosphate) xsodium salt, 97% | 18423-43-3 | USD 230 | 4 | 2 | Inquiry |
| BLDPharm | 1g | Thymidine 5′-(tetrahydrogen triphosphate) xsodium salt, 97% | 18423-43-3 | USD 680 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2'-Deoxycytidine-5'-triphosphoric acid disodium salt, 98% | 102783-51-7 | USD 83 | 4 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2'-Deoxycytidine-5'-triphosphoric acid disodium salt, 98% | 102783-51-7 | USD 140 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | 2'-Deoxycytidine-5'-triphosphoric acid disodium salt, 98% | 102783-51-7 | USD 378 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], 95% | 105931-57-5 | USD 24 | >5 | 1 | 1 |
| BLDPharm | 1g | Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], 95% | 105931-57-5 | USD 65 | >5 | 2 | 2 |
| BLDPharm | 5g | Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], 95% | 105931-57-5 | USD 229 | >5 | 1 | 1 |
| BLDPharm | 25g | Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], 95% | 105931-57-5 | USD 801 | 5 | 1 | Inquiry |
| BLDPharm | 100mg | ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate, 97% | 63-38-7 | USD 197 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 105931-58-6 | USD 114 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 105931-58-6 | USD 170 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 105931-58-6 | USD 255 | >5 | Inquiry | 1 |
| BLDPharm | 1g | (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 105931-58-6 | USD 635 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-Amino-7-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 97% | 86392-75-8 | USD 59 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-7-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 97% | 86392-75-8 | USD 100 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-Amino-7-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 97% | 86392-75-8 | USD 260 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | 2-Amino-8-bromo-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 98% | 13389-03-2 | USD 8 | >5 | 2 | 1 |
| BLDPharm | 250mg | 2-Amino-8-bromo-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 98% | 13389-03-2 | USD 19 | >5 | 1 | 1 |
| BLDPharm | 1g | 2-Amino-8-bromo-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 98% | 13389-03-2 | USD 29 | >5 | >5 | 3 |
| BLDPharm | 5g | 2-Amino-8-bromo-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 98% | 13389-03-2 | USD 108 | >5 | 2 | Inquiry |
| BLDPharm | 25g | 2-Amino-8-bromo-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 98% | 13389-03-2 | USD 539 | 2 | Inquiry | Inquiry |
| BLDPharm | 50mg | (((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)methyl)phosphonic acid disodium salt, 97% | 7414-56-4 | USD 139 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)methyl)phosphonic acid disodium salt, 97% | 7414-56-4 | USD 257 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)methyl)phosphonic acid disodium salt, 97% | 7414-56-4 | USD 514 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)methyl)phosphonic acid disodium salt, 97% | 7414-56-4 | USD 1026 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Chloroadenosine hemihydrate, 97% | 81012-94-4 | USD 5 | >5 | Inquiry | 1 |
| BLDPharm | 1g | 2-Chloroadenosine hemihydrate, 97% | 81012-94-4 | USD 11 | 3 | Inquiry | 2 |
| BLDPharm | 5g | 2-Chloroadenosine hemihydrate, 97% | 81012-94-4 | USD 34 | >5 | Inquiry | 1 |
| BLDPharm | 10g | 2-Chloroadenosine hemihydrate, 97% | 81012-94-4 | USD 64 | >5 | Inquiry | 1 |
| BLDPharm | 25g | 2-Chloroadenosine hemihydrate, 97% | 81012-94-4 | USD 130 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt, 95% | 37839-81-9 | USD 36 | 1 | 1 | Inquiry |
| BLDPharm | 1g | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt, 95% | 37839-81-9 | USD 143 | 3 | 1 | Inquiry |
| BLDPharm | 5g | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt, 95% | 37839-81-9 | USD 213 | 1 | Inquiry | Inquiry |
| BLDPharm | 10g | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt, 95% | 37839-81-9 | USD 256 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt, 95% | 37839-81-9 | USD 616 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | 2-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1,9-dihydro-6H-purin-6-one, 95% | 7665-99-8 | USD 156 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | 2-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1,9-dihydro-6H-purin-6-one, 95% | 7665-99-8 | USD 216 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1,9-dihydro-6H-purin-6-one, 95% | 7665-99-8 | USD 346 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1,9-dihydro-6H-purin-6-one, 95% | 7665-99-8 | USD 632 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 52571-45-6 | USD 13 | >5 | 4 | 1 |
| BLDPharm | 250mg | N-(1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 52571-45-6 | USD 22 | >5 | 1 | Inquiry |
| BLDPharm | 1g | N-(1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 52571-45-6 | USD 66 | 5 | Inquiry | 1 |
| BLDPharm | 5g | N-(1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 52571-45-6 | USD 246 | 1 | Inquiry | Inquiry |
| BLDPharm | 10g | N-(1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 52571-45-6 | USD 391 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97% | 132628-16-1 | USD 45 | >5 | 2 | 1 |
| BLDPharm | 10g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97% | 132628-16-1 | USD 54 | >5 | 3 | 1 |
| BLDPharm | 25g | N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97% | 132628-16-1 | USD 134 | >5 | 2 | 1 |
| BLDPharm | 250mg | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose, 98% | 22224-41-5 | USD 5 | 4 | 1 | 2 |
| BLDPharm | 1g | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose, 98% | 22224-41-5 | USD 6 | 1 | 4 | Inquiry |
| BLDPharm | 5g | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose, 98% | 22224-41-5 | USD 23 | >5 | 1 | 1 |
| BLDPharm | 10g | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose, 98% | 22224-41-5 | USD 29 | 5 | 2 | Inquiry |
| BLDPharm | 25g | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose, 98% | 22224-41-5 | USD 65 | >5 | 2 | Inquiry |
| BLDPharm | 100g | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose, 98% | 22224-41-5 | USD 82 | >5 | 5 | 1 |
| BLDPharm | 500g | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose, 98% | 22224-41-5 | USD 409 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 4836-13-9 | USD 19 | >5 | 3 | 1 |
| BLDPharm | 5g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 4836-13-9 | USD 23 | >5 | 4 | Inquiry |
| BLDPharm | 25g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 4836-13-9 | USD 114 | >5 | 1 | Inquiry |
| BLDPharm | 100g | N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 4836-13-9 | USD 377 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 161442-19-9 | USD 64 | >5 | 1 | 1 |
| BLDPharm | 1g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 161442-19-9 | USD 128 | >5 | 2 | 1 |
| BLDPharm | 5g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 161442-19-9 | USD 396 | 5 | 2 | Inquiry |
| BLDPharm | 25g | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98% | 161442-19-9 | USD 1187 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 110764-74-4 | USD 17 | >5 | 2 | 1 |
| BLDPharm | 1g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 110764-74-4 | USD 48 | >5 | 1 | Inquiry |
| BLDPharm | 5g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 110764-74-4 | USD 122 | >5 | 3 | 1 |
| BLDPharm | 25g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98% | 110764-74-4 | USD 532 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95% | 199593-08-3 | USD 17 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95% | 199593-08-3 | USD 24 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95% | 199593-08-3 | USD 33 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95% | 199593-08-3 | USD 97 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 97% | 85-32-5 | USD 14 | >5 | 1 | 0 1 2 3 4 5 |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 97% | 85-32-5 | USD 26 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 100g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 97% | 85-32-5 | USD 38 | >5 | Inquiry | 0 1 2 3 4 5 |
| BLDPharm | 500g | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 97% | 85-32-5 | USD 147 | 1 | Inquiry | 0 1 |
| BLDPharm | 1kg | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 97% | 85-32-5 | USD 200 | 1 | Inquiry | 0 1 |
| BLDPharm | 100mg | 4-Amino-1-((2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95% | 123402-20-0 | USD 389 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine, 95% | 81352-25-2 | USD 7 | >5 | 1 | Inquiry |
| BLDPharm | 1g | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine, 95% | 81352-25-2 | USD 23 | >5 | 1 | Inquiry |
| BLDPharm | 5g | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine, 95% | 81352-25-2 | USD 110 | >5 | 1 | Inquiry |
| BLDPharm | 250mg | 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)uridine, 95% | 69304-38-7 | USD 10 | >5 | 2 | Inquiry |
| BLDPharm | 1g | 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)uridine, 95% | 69304-38-7 | USD 28 | >5 | 3 | 1 |
| BLDPharm | 5g | 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)uridine, 95% | 69304-38-7 | USD 112 | >5 | 3 | >5 |
| BLDPharm | 25g | 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)uridine, 95% | 69304-38-7 | USD 392 | >5 | 1 | Inquiry |
| BLDPharm | 50mg | 1-(a-D-ribofuranosyl)uracil, 95% | 3258-07-09 00:00:00 | USD 35 | 4 | 1 | Inquiry |
| BLDPharm | 100mg | 1-(a-D-ribofuranosyl)uracil, 95% | 3258-07-09 00:00:00 | USD 42 | 4 | 2 | 1 |
| BLDPharm | 250mg | 1-(a-D-ribofuranosyl)uracil, 95% | 3258-07-09 00:00:00 | USD 74 | 4 | 1 | Inquiry |
| BLDPharm | 1g | 1-(a-D-ribofuranosyl)uracil, 95% | 3258-07-09 00:00:00 | USD 293 | >5 | 1 | 1 |
| BLDPharm | 5g | 1-(a-D-ribofuranosyl)uracil, 95% | 3258-07-09 00:00:00 | USD 1461 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,3R,5S)-5-(4-Amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95+% | 908130-61-0 | USD 10 | 4 | Inquiry | 1 |
| BLDPharm | 250mg | (2S,3R,5S)-5-(4-Amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95+% | 908130-61-0 | USD 16 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2S,3R,5S)-5-(4-Amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95+% | 908130-61-0 | USD 24 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-Amino-7-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodo-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 95% | 172163-62-1 | USD 57 | >5 | 1 | 1 |
| BLDPharm | 250mg | 2-Amino-7-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodo-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 95% | 172163-62-1 | USD 94 | >5 | 2 | 1 |
| BLDPharm | 1g | 2-Amino-7-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodo-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 95% | 172163-62-1 | USD 200 | >5 | >5 | 5 |
| BLDPharm | 5g | 2-Amino-7-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodo-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 95% | 172163-62-1 | USD 700 | 3 | 5 | 1 |
| BLDPharm | 100mg | N-(1-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95+% | 123956-65-0 | USD 31 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | N-(1-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95+% | 123956-65-0 | USD 49 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | N-(1-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95+% | 123956-65-0 | USD 140 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | (2R,3R,4R,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95+% | 205171-06-8 | USD 128 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2R,3R,4R,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95+% | 205171-06-8 | USD 214 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2R,3R,4R,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95+% | 205171-06-8 | USD 374 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | (2R,3R,4R,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 95+% | 205171-06-8 | USD 864 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol, 98% | 93778-57-5 | USD 7 | 3 | 1 | Inquiry |
| BLDPharm | 1g | 9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol, 98% | 93778-57-5 | USD 30 | 3 | 2 | Inquiry |
| BLDPharm | 5g | 9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol, 98% | 93778-57-5 | USD 75 | >5 | 1 | 1 |
| BLDPharm | 25g | 9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol, 98% | 93778-57-5 | USD 284 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-isobutyrylguanosine 2'-CE phosphoramidite, 98% | 1445905-51-0 | USD 41 | >5 | 1 | 1 |
| BLDPharm | 250mg | 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-isobutyrylguanosine 2'-CE phosphoramidite, 98% | 1445905-51-0 | USD 63 | 3 | 1 | 1 |
| BLDPharm | 1g | 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-isobutyrylguanosine 2'-CE phosphoramidite, 98% | 1445905-51-0 | USD 174 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-isobutyrylguanosine 2'-CE phosphoramidite, 98% | 1445905-51-0 | USD 657 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | Polyinosinic Polycytidylic acid sodium salt, 99% 聚肌苷:聚胞苷酸组分比约为1:1 | 42424-50-0 | USD 427 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Sodium ((2R,3S,5R)-3-hydroxy-5-(6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-2-yl)methyl phosphate, 98% | 14999-52-1 | USD 50 | 2 | Inquiry | 2 |
| BLDPharm | 250mg | Sodium ((2R,3S,5R)-3-hydroxy-5-(6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-2-yl)methyl phosphate, 98% | 14999-52-1 | USD 60 | >5 | Inquiry | 1 |
| BLDPharm | 1g | Sodium ((2R,3S,5R)-3-hydroxy-5-(6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-2-yl)methyl phosphate, 98% | 14999-52-1 | USD 128 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)(hydroxy)phosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl hydrogen phosphate, 99% | 1184-16-3 | USD 73 | >5 | 5 | 1 |
| BLDPharm | 1g | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)(hydroxy)phosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl hydrogen phosphate, 99% | 1184-16-3 | USD 88 | >5 | >5 | 1 |
| BLDPharm | 5g | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)(hydroxy)phosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl hydrogen phosphate, 99% | 1184-16-3 | USD 106 | >5 | 2 | 2 |
| BLDPharm | 10g | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)(hydroxy)phosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl hydrogen phosphate, 99% | 1184-16-3 | USD 201 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)(hydroxy)phosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl hydrogen phosphate, 99% | 1184-16-3 | USD 381 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | ((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid disodium salt, 98% | 606-68-8 | USD 5 | >5 | 4 | 1 |
| BLDPharm | 250mg | ((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid disodium salt, 98% | 606-68-8 | USD 6 | >5 | 1 | 3 |
| BLDPharm | 1g | ((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid disodium salt, 98% | 606-68-8 | USD 23 | >5 | 2 | Inquiry |
| BLDPharm | 5g | ((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid disodium salt, 98% | 606-68-8 | USD 80 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | ((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid disodium salt, 98% | 606-68-8 | USD 240 | 3 | 1 | Inquiry |
| BLDPharm | 100g | ((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid disodium salt, 98% | 606-68-8 | USD 720 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate, 98% | 2646-71-1 | USD 48 | >5 | >5 | 3 |
| BLDPharm | 250mg | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate, 98% | 2646-71-1 | USD 118 | >5 | 3 | 1 |
| BLDPharm | 1g | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate, 98% | 2646-71-1 | USD 340 | >5 | >5 | 2 |
| BLDPharm | 5g | Sodium (2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-((((((((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)-4-hydroxytetrahydrofuran-3-yl phosphate, 98% | 2646-71-1 | USD 991 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,3R,4S,5R,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 98% | 7240-90-6 | USD 9 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,3R,4S,5R,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 98% | 7240-90-6 | USD 14 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (2S,3R,4S,5R,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 98% | 7240-90-6 | USD 49 | >5 | 1 | 1 |
| BLDPharm | 5g | (2S,3R,4S,5R,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 98% | 7240-90-6 | USD 172 | >5 | 1 | Inquiry |
| BLDPharm | 100mg | Acetylcoenzymeatrilithiumsalt, 97% | 75520-41-1 | USD 299 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | S-(2-(3-((2R)-4-(((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)oxy)-2-hydroxy-3,3-dimethylbutanamido)propanamido)ethyl) ethanethioate, lithium salt (1:x), 98+% | 32140-51-5 | USD 1093 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, 99% (contains <5%H2O) | 165450-17-9 | USD 5 | >5 | 4 | 2 |
| BLDPharm | 10g | (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, 99% (contains <5%H2O) | 165450-17-9 | USD 8 | 1 | Inquiry | Inquiry |
| BLDPharm | 25g | (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, 99% (contains <5%H2O) | 165450-17-9 | USD 12 | 1 | Inquiry | 1 |
| BLDPharm | 100g | (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, 99% (contains <5%H2O) | 165450-17-9 | USD 36 | 2 | 2 | 1 |
| BLDPharm | 500g | (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, 99% (contains <5%H2O) | 165450-17-9 | USD 150 | 1 | 1 | Inquiry |
| BLDPharm | 1kg | (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, 99% (contains <5%H2O) | 165450-17-9 | USD 268 | 2 | 1 | Inquiry |
| BLDPharm | 250mg | Fmoc-Pro-Pro-OH, 98% | 129223-22-9 | USD 8 | 2 | 1 | 1 |
| BLDPharm | 1g | Fmoc-Pro-Pro-OH, 98% | 129223-22-9 | USD 11 | 3 | 3 | 2 |
| BLDPharm | 5g | Fmoc-Pro-Pro-OH, 98% | 129223-22-9 | USD 24 | 3 | 2 | 1 |
| BLDPharm | 10g | Fmoc-Pro-Pro-OH, 98% | 129223-22-9 | USD 47 | >5 | 4 | 2 |
| BLDPharm | 25g | Fmoc-Pro-Pro-OH, 98% | 129223-22-9 | USD 116 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95% | 84889-09-8 | USD 5 | >5 | 1 | 1 |
| BLDPharm | 1g | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95% | 84889-09-8 | USD 13 | >5 | 1 | 2 |
| BLDPharm | 5g | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95% | 84889-09-8 | USD 41 | 1 | Inquiry | Inquiry |
| BLDPharm | 10g | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95% | 84889-09-8 | USD 72 | >5 | 1 | 3 |
| BLDPharm | 25g | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95% | 84889-09-8 | USD 161 | 2 | 2 | 1 |
| BLDPharm | 100mg | (R)-2-((R)-2-Amino-3-(1H-indol-3-yl)propanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 58607-72-0 | USD 102 | >5 | Inquiry | 1 |
| BLDPharm | 250mg | (R)-2-((R)-2-Amino-3-(1H-indol-3-yl)propanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 58607-72-0 | USD 191 | >5 | 1 | Inquiry |
| BLDPharm | 1g | (R)-2-((R)-2-Amino-3-(1H-indol-3-yl)propanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 58607-72-0 | USD 481 | 5 | Inquiry | Inquiry |
| BLDPharm | 25mg | Gly-Gly-Tyr-Arg, 99+% | 70195-20-9 | USD 75 | 1 | Inquiry | Inquiry |
| BLDPharm | 50mg | Gly-Gly-Tyr-Arg, 99+% | 70195-20-9 | USD 127 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Gly-Gly-Tyr-Arg, 99+% | 70195-20-9 | USD 215 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Gly-Gly-Tyr-Arg, 99+% | 70195-20-9 | USD 322 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-Gly-Gly-Gly-OH, 97% | 170941-79-4 | USD 6 | >5 | 2 | 1 |
| BLDPharm | 1g | Fmoc-Gly-Gly-Gly-OH, 97% | 170941-79-4 | USD 12 | >5 | 1 | 1 |
| BLDPharm | 5g | Fmoc-Gly-Gly-Gly-OH, 97% | 170941-79-4 | USD 22 | >5 | 4 | 5 |
| BLDPharm | 10g | Fmoc-Gly-Gly-Gly-OH, 97% | 170941-79-4 | USD 43 | >5 | 1 | 1 |
| BLDPharm | 25g | Fmoc-Gly-Gly-Gly-OH, 97% | 170941-79-4 | USD 90 | >5 | 1 | 1 |
| BLDPharm | 100g | Fmoc-Gly-Gly-Gly-OH, 97% | 170941-79-4 | USD 293 | >5 | 1 | Inquiry |
| BLDPharm | 25mg | (S)-2-((S)-2-Amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid, 97% | 1050-28-8 | USD 96 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((S)-2-Amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid, 97% | 1050-28-8 | USD 163 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((S)-2-Amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid, 97% | 1050-28-8 | USD 276 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-((S)-2-Amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid, 97% | 1050-28-8 | USD 470 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((S)-2-Amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid, 97% | 1050-28-8 | USD 798 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (R)-2-(2-((tert-Butoxycarbonyl)amino)-2-methylpropanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 159634-94-3 | USD 9 | >5 | 1 | 1 |
| BLDPharm | 250mg | (R)-2-(2-((tert-Butoxycarbonyl)amino)-2-methylpropanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 159634-94-3 | USD 12 | >5 | 1 | 1 |
| BLDPharm | 1g | (R)-2-(2-((tert-Butoxycarbonyl)amino)-2-methylpropanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 159634-94-3 | USD 30 | >5 | 2 | Inquiry |
| BLDPharm | 5g | (R)-2-(2-((tert-Butoxycarbonyl)amino)-2-methylpropanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 159634-94-3 | USD 99 | 1 | 1 | 1 |
| BLDPharm | 100mg | L-Histidyl-L-lysine hydrobromide, 97% | 151151-29-0 | USD 91 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | L-Histidyl-L-lysine hydrobromide, 97% | 151151-29-0 | USD 155 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | L-Histidyl-L-lysine hydrobromide, 97% | 151151-29-0 | USD 417 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Z-Phe-Ala-OH, 95% | 21881-18-5 | USD 8 | >5 | Inquiry | 1 |
| BLDPharm | 1g | Z-Phe-Ala-OH, 95% | 21881-18-5 | USD 31 | >5 | 1 | 1 |
| BLDPharm | 5g | Z-Phe-Ala-OH, 95% | 21881-18-5 | USD 83 | >5 | 1 | Inquiry |
| BLDPharm | 10g | Z-Phe-Ala-OH, 95% | 21881-18-5 | USD 100 | 5 | 1 | 1 |
| BLDPharm | 25g | Z-Phe-Ala-OH, 95% | 21881-18-5 | USD 249 | 4 | 1 | Inquiry |
| BLDPharm | 250mg | Z-Phe-Leu-OH, 95% | 4313-73-9 | USD 6 | 1 | 1 | Inquiry |
| BLDPharm | 1g | Z-Phe-Leu-OH, 95% | 4313-73-9 | USD 23 | 2 | 1 | Inquiry |
| BLDPharm | 5g | Z-Phe-Leu-OH, 95% | 4313-73-9 | USD 31 | 4 | 1 | Inquiry |
| BLDPharm | 10g | Z-Phe-Leu-OH, 95% | 4313-73-9 | USD 61 | 2 | 1 | Inquiry |
| BLDPharm | 25g | Z-Phe-Leu-OH, 95% | 4313-73-9 | USD 151 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-Val-Cit-OH, 95% | 159858-21-6 | USD 7 | >5 | 2 | 1 |
| BLDPharm | 1g | Fmoc-Val-Cit-OH, 95% | 159858-21-6 | USD 15 | >5 | 3 | 2 |
| BLDPharm | 5g | Fmoc-Val-Cit-OH, 95% | 159858-21-6 | USD 32 | >5 | 5 | >5 |
| BLDPharm | 25g | Fmoc-Val-Cit-OH, 95% | 159858-21-6 | USD 117 | >5 | 2 | 2 |
| BLDPharm | 100g | Fmoc-Val-Cit-OH, 95% | 159858-21-6 | USD 467 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH, 97% | 1000164-43-1 | USD 23 | >5 | 1 | 1 |
| BLDPharm | 250mg | Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH, 97% | 1000164-43-1 | USD 35 | >5 | 2 | Inquiry |
| BLDPharm | 1g | Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH, 97% | 1000164-43-1 | USD 83 | >5 | 1 | Inquiry |
| BLDPharm | 5g | Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH, 97% | 1000164-43-1 | USD 340 | >5 | 3 | 4 |
| BLDPharm | 25g | Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH, 97% | 1000164-43-1 | USD 1089 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 98% | 909115-33-9 | USD 36 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 98% | 909115-33-9 | USD 78 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 98% | 909115-33-9 | USD 323 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 95% | 920519-32-0 | USD 32 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 95% | 920519-32-0 | USD 61 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 95% | 920519-32-0 | USD 277 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-β-Ala-Leu-OH, 97% | 848691-83-8 | USD 110 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | Fmoc-Lys(Boc)-Lys(Boc)-OH, 97% | 169151-00-2 | USD 353 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-Amino-4-oxo-4-(((R)-1-oxo-1-((2,2,4,4-tetramethylthietan-3-yl)amino)propan-2-yl)amino)butanoic acid, 98% | 80863-62-3 | USD 1016 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | (3-(Furan-2-yl)acryloyl)-L-leucylglycyl-L-prolyl-L-alanine, 97% * Cold-chain transportation | 78832-65-2 | USD 92 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | (3-(Furan-2-yl)acryloyl)-L-leucylglycyl-L-prolyl-L-alanine, 97% * Cold-chain transportation | 78832-65-2 | USD 156 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | (3-(Furan-2-yl)acryloyl)-L-leucylglycyl-L-prolyl-L-alanine, 97% * Cold-chain transportation | 78832-65-2 | USD 312 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (3-(Furan-2-yl)acryloyl)-L-leucylglycyl-L-prolyl-L-alanine, 97% * Cold-chain transportation | 78832-65-2 | USD 562 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (3-(Furan-2-yl)acryloyl)-L-leucylglycyl-L-prolyl-L-alanine, 97% * Cold-chain transportation | 78832-65-2 | USD 955 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (3-(Furan-2-yl)acryloyl)-L-leucylglycyl-L-prolyl-L-alanine, 97% * Cold-chain transportation | 78832-65-2 | USD 1624 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-Ala-Ala-OH, 98% | 87512-31-0 | USD 5 | >5 | 4 | 2 |
| BLDPharm | 1g | Fmoc-Ala-Ala-OH, 98% | 87512-31-0 | USD 7 | >5 | 2 | 5 |
| BLDPharm | 5g | Fmoc-Ala-Ala-OH, 98% | 87512-31-0 | USD 34 | >5 | >5 | 2 |
| BLDPharm | 10g | Fmoc-Ala-Ala-OH, 98% | 87512-31-0 | USD 67 | >5 | 3 | 3 |
| BLDPharm | 25g | Fmoc-Ala-Ala-OH, 98% | 87512-31-0 | USD 167 | 4 | 2 | 1 |
| BLDPharm | 100g | Fmoc-Ala-Ala-OH, 98% | 87512-31-0 | USD 667 | >5 | Inquiry | 1 |
| BLDPharm | 1g | Glycylglycine Benzyl Ester p-Toluenesulfonate, 97% | 1738-82-5 | USD 18 | 2 | 2 | 1 |
| BLDPharm | 5g | Glycylglycine Benzyl Ester p-Toluenesulfonate, 97% | 1738-82-5 | USD 60 | 1 | 3 | 1 |
| BLDPharm | 25g | Glycylglycine Benzyl Ester p-Toluenesulfonate, 97% | 1738-82-5 | USD 201 | 3 | Inquiry | 1 |
| BLDPharm | 100g | Glycylglycine Benzyl Ester p-Toluenesulfonate, 97% | 1738-82-5 | USD 663 | 4 | 3 | 1 |
| BLDPharm | 100mg | H-Gly-Gly-Phe-OH, 98% | 6234-26-0 | USD 26 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | H-Gly-Gly-Phe-OH, 98% | 6234-26-0 | USD 49 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | H-Gly-Gly-Phe-OH, 98% | 6234-26-0 | USD 93 | 2 | 2 | Inquiry |
| BLDPharm | 5g | H-Gly-Gly-Phe-OH, 98% | 6234-26-0 | USD 375 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10g | H-Gly-Gly-Phe-OH, 98% | 6234-26-0 | USD 580 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25g | H-Gly-Gly-Phe-OH, 98% | 6234-26-0 | USD 1160 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | L-Histidyl-L-phenylalanine, 97% | 16874-81-0 | USD 72 | 1 | Inquiry | 1 |
| BLDPharm | 250mg | L-Histidyl-L-phenylalanine, 97% | 16874-81-0 | USD 117 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | L-Histidyl-L-phenylalanine, 97% | 16874-81-0 | USD 320 | 3 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-((S)-2-Amino-4-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 5156-22-9 | USD 60 | 3 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((S)-2-Amino-4-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 5156-22-9 | USD 102 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((S)-2-Amino-4-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 5156-22-9 | USD 173 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | Methyl L-phenylalanyl-L-phenylalaninate hydrochloride, 97% | 38017-65-1 | USD 14 | >5 | 5 | 1 |
| BLDPharm | 1g | Methyl L-phenylalanyl-L-phenylalaninate hydrochloride, 97% | 38017-65-1 | USD 50 | >5 | 2 | 1 |
| BLDPharm | 5g | Methyl L-phenylalanyl-L-phenylalaninate hydrochloride, 97% | 38017-65-1 | USD 222 | >5 | 2 | 1 |
| BLDPharm | 25g | Methyl L-phenylalanyl-L-phenylalaninate hydrochloride, 97% | 38017-65-1 | USD 777 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | Allyl L-valinate 4-methylbenzenesulfonate, 97% | 88224-02-6 | USD 17 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Allyl L-valinate 4-methylbenzenesulfonate, 97% | 88224-02-6 | USD 59 | >5 | Inquiry | Inquiry |
| BLDPharm | 25g | Allyl L-valinate 4-methylbenzenesulfonate, 97% | 88224-02-6 | USD 205 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((S)-2-((S)-2-Formamido-4-(methylthio)butanamido)-4-methylpentanamido)-3-phenylpropanoic acid, 98% | 59880-97-6 | USD 303 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-((S)-2-((S)-2-Formamido-4-(methylthio)butanamido)-4-methylpentanamido)-3-phenylpropanoic acid, 98% | 59880-97-6 | USD 513 | 3 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((S)-2-((S)-2-Formamido-4-(methylthio)butanamido)-4-methylpentanamido)-3-phenylpropanoic acid, 98% | 59880-97-6 | USD 1385 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1mg | (S)-2-Amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid, 98% | 52809-07-1 | USD 90 | >5 | Inquiry | Inquiry |
| BLDPharm | 2mg | (S)-2-Amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid, 98% | 52809-07-1 | USD 153 | >5 | Inquiry | Inquiry |
| BLDPharm | 5mg | (S)-2-Amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid, 98% | 52809-07-1 | USD 260 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | (S)-2-Amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid, 98% | 52809-07-1 | USD 442 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-Amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid, 98% | 52809-07-1 | USD 752 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-Amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid, 98% | 52809-07-1 | USD 1278 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-Amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid, 98% | 52809-07-1 | USD 2172 | 2 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-2-(2-(((Benzyloxy)carbonyl)amino)acetamido)-3-phenylpropanoic acid, 95% | 1170-76-9 | USD 24 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-(2-(((Benzyloxy)carbonyl)amino)acetamido)-3-phenylpropanoic acid, 95% | 1170-76-9 | USD 29 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-2-(2-(((Benzyloxy)carbonyl)amino)acetamido)-3-phenylpropanoic acid, 95% | 1170-76-9 | USD 93 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | (2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95% | 42538-01-2 | USD 8 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95% | 42538-01-2 | USD 12 | >5 | 1 | Inquiry |
| BLDPharm | 1g | (2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95% | 42538-01-2 | USD 25 | >5 | 4 | 1 |
| BLDPharm | 5g | (2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95% | 42538-01-2 | USD 92 | >5 | 3 | 1 |
| BLDPharm | 25g | (2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95% | 42538-01-2 | USD 303 | >5 | 2 | 1 |
| BLDPharm | 100g | (2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95% | 42538-01-2 | USD 1122 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)acetyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% | 1095952-22-9 | USD 27 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)acetyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% | 1095952-22-9 | USD 46 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)acetyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% | 1095952-22-9 | USD 205 | >5 | 5 | Inquiry |
| BLDPharm | 25g | (S)-3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)acetyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% | 1095952-22-9 | USD 680 | 3 | Inquiry | Inquiry |
| BLDPharm | 100mg | Fmoc-Gly-Thr[Psi(Me,Me)Pro]-OH, 97% | 1262308-49-5 | USD 22 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | Fmoc-Gly-Thr[Psi(Me,Me)Pro]-OH, 97% | 1262308-49-5 | USD 35 | >5 | 2 | Inquiry |
| BLDPharm | 1g | Fmoc-Gly-Thr[Psi(Me,Me)Pro]-OH, 97% | 1262308-49-5 | USD 70 | >5 | 1 | Inquiry |
| BLDPharm | 5g | Fmoc-Gly-Thr[Psi(Me,Me)Pro]-OH, 97% | 1262308-49-5 | USD 288 | >5 | 1 | Inquiry |
| BLDPharm | 10g | Fmoc-Gly-Thr[Psi(Me,Me)Pro]-OH, 97% | 1262308-49-5 | USD 558 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 99% | 878797-01-4 | USD 47 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 99% | 878797-01-4 | USD 67 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 99% | 878797-01-4 | USD 305 | 3 | Inquiry | Inquiry |
| BLDPharm | 250mg | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 98% | 920519-31-9 | USD 25 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 98% | 920519-31-9 | USD 59 | 2 | Inquiry | Inquiry |
| BLDPharm | 5g | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 98% | 920519-31-9 | USD 244 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-(N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N4-trityl-L-asparaginyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% HPLC | 920519-33-1 | USD 24 | 3 | Inquiry | 1 |
| BLDPharm | 1g | (S)-3-(N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N4-trityl-L-asparaginyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% HPLC | 920519-33-1 | USD 61 | >5 | Inquiry | 1 |
| BLDPharm | 5g | (S)-3-(N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N4-trityl-L-asparaginyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% HPLC | 920519-33-1 | USD 275 | 4 | 2 | 1 |
| BLDPharm | 1g | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 98% | 936707-21-0 | USD 68 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 98% | 936707-21-0 | USD 290 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | (6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate, 95% | 868540-15-2 | USD 16 | 1 | Inquiry | Inquiry |
| BLDPharm | 1g | (6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate, 95% | 868540-15-2 | USD 20 | >5 | 3 | 1 |
| BLDPharm | 5g | (6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate, 95% | 868540-15-2 | USD 99 | >5 | 1 | 2 |
| BLDPharm | 1g | 3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid, 97% | 2566-20-3 | USD 39 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid, 97% | 2566-20-3 | USD 145 | 5 | Inquiry | Inquiry |
| BLDPharm | 25g | 3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid, 97% | 2566-20-3 | USD 551 | 1 | Inquiry | Inquiry |
| BLDPharm | 250mg | Fmoc-Ala-Ala-Pro-OH, 95% | 161220-53-7 | USD 50 | 4 | Inquiry | Inquiry |
| BLDPharm | 1g | Fmoc-Ala-Ala-Pro-OH, 95% | 161220-53-7 | USD 114 | 1 | Inquiry | Inquiry |
| BLDPharm | 5g | Fmoc-Ala-Ala-Pro-OH, 95% | 161220-53-7 | USD 424 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | H-Leu-Lys(Z)-OH, 97% | 34990-61-9 | USD 15 | Inquiry | 1 | Inquiry |
| BLDPharm | 1g | H-Leu-Lys(Z)-OH, 97% | 34990-61-9 | USD 45 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 97% | 1572725-72-4 | USD 25 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 97% | 1572725-72-4 | USD 42 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 97% | 1572725-72-4 | USD 52 | 5 | Inquiry | Inquiry |
| BLDPharm | 250mg | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 97% | 1821378-64-6 | USD 25 | 3 | 1 | Inquiry |
| BLDPharm | 1g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 97% | 1821378-64-6 | USD 66 | >5 | 3 | Inquiry |
| BLDPharm | 5g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 97% | 1821378-64-6 | USD 304 | >5 | 3 | Inquiry |
| BLDPharm | 250mg | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% | 955048-92-7 | USD 30 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% | 955048-92-7 | USD 76 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid, 95% | 955048-92-7 | USD 323 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | H-Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2, 98% | 158563-45-2 | USD 125 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate, 97% | 868539-99-5 | USD 338 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | (S)-2-((2S,3S)-2-Amino-3-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 13589-06-5 | USD 67 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-2-((2S,3S)-2-Amino-3-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 13589-06-5 | USD 106 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | (S)-2-((2S,3S)-2-Amino-3-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid, 97% | 13589-06-5 | USD 178 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | (S)-6-Amino-2-((S)-2-((S)-2,6-diaminohexanamido)-3-(1H-indol-3-yl)propanamido)hexanoic acid, 98+% | 38579-27-0 | USD 158 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-Amino-N-((S)-1-amino-5-guanidino-1-oxopentan-2-yl)-5-guanidinopentanamide trihydrochloride, 97% * Cold-chain transportation | 114736-11-7 | USD 577 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (2S)-Methyl 2-(2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate, 98% | 402958-95-6 | USD 300 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | L-Alanyl-L-alanyl-L-alanyl-L-alanyl-L-alanyl-L-alanyl-L-alaninamide, 97% | 669051-31-4 | USD 210 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-6-Amino-2-((S)-6-amino-2-((S)-6-amino-2-((S)-2,6-diaminohexanamido)hexanamido)hexanamido)hexanoic acid, 95+% | 997-20-6 | USD 1227 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-(2-(((Benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanamido)acetic acid, 95+% | 17388-70-4 | USD 81 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | (S)-2-(2-(((Benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanamido)acetic acid, 95+% | 17388-70-4 | USD 325 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((S)-2-Amino-3-(1H-indol-3-yl)propanamido)-5-guanidinopentanoic acid, 97% | 88831-09-8 | USD 1219 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-2-((S)-2-(2-Benzamidoacetamido)-3-(1H-imidazol-4-yl)propanamido)-4-methylpentanoic acid, 98+% | 31373-65-6 | USD 398 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-6-Amino-2-(2-((S)-2,6-diaminohexanamido)acetamido)hexanoic acid, 97% | 57625-90-8 | USD 1219 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 250mg | 2-(tert-Butylimino)-3-isopropyl-5-phenyl-1,3,5-thiadiazinan-4-one, 98% | 69327-76-0 | USD 64 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(tert-Butylimino)-3-isopropyl-5-phenyl-1,3,5-thiadiazinan-4-one, 98% | 69327-76-0 | USD 128 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | 2-(tert-Butylimino)-3-isopropyl-5-phenyl-1,3,5-thiadiazinan-4-one, 98% | 69327-76-0 | USD 384 | 2 | Inquiry | Inquiry |
| BLDPharm | 25g | 2-(tert-Butylimino)-3-isopropyl-5-phenyl-1,3,5-thiadiazinan-4-one, 98% | 69327-76-0 | USD 919 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | Methyl 7-chloro-2-((methoxycarbonyl)(4-(trifluoromethoxy)phenyl)carbamoyl)-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate, 98% | 144171-61-9 | USD 29 | >5 | 2 | Inquiry |
| BLDPharm | 250mg | Methyl 7-chloro-2-((methoxycarbonyl)(4-(trifluoromethoxy)phenyl)carbamoyl)-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate, 98% | 144171-61-9 | USD 43 | >5 | 3 | Inquiry |
| BLDPharm | 1g | Methyl 7-chloro-2-((methoxycarbonyl)(4-(trifluoromethoxy)phenyl)carbamoyl)-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate, 98% | 144171-61-9 | USD 106 | >5 | 2 | 2 |
| BLDPharm | 5g | Methyl 7-chloro-2-((methoxycarbonyl)(4-(trifluoromethoxy)phenyl)carbamoyl)-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate, 98% | 144171-61-9 | USD 372 | >5 | 3 | Inquiry |
| BLDPharm | 25g | Methyl 7-chloro-2-((methoxycarbonyl)(4-(trifluoromethoxy)phenyl)carbamoyl)-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate, 98% | 144171-61-9 | USD 1303 | >5 | 3 | Inquiry |
| BLDPharm | 1g | (R)-2-(4-(4-Cyano-2-fluorophenoxy)phenoxy)propanoic acid, 98% | 122008-78-0 | USD 1741 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Fasudil n-hydroxy impurity, 95% | 1350827-92-7 | USD 869 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 25mg | N-(6-(2-Hydroxypropan-2-yl)-1-(2-(methylsulfonyl)ethyl)-1H-indazol-5-yl)-6-(trifluoromethyl)picolinamide, 98% | 2751749-06-9 | USD 370 | 5 | Inquiry | Inquiry |
| BLDPharm | 50mg | N-(6-(2-Hydroxypropan-2-yl)-1-(2-(methylsulfonyl)ethyl)-1H-indazol-5-yl)-6-(trifluoromethyl)picolinamide, 98% | 2751749-06-9 | USD 550 | 2 | Inquiry | Inquiry |
| BLDPharm | 100mg | N-(6-(2-Hydroxypropan-2-yl)-1-(2-(methylsulfonyl)ethyl)-1H-indazol-5-yl)-6-(trifluoromethyl)picolinamide, 98% | 2751749-06-9 | USD 785 | 1 | Inquiry | Inquiry |
| BLDPharm | 100mg | Methyl 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate, 98% | 15307-78-5 | USD 46 | >5 | Inquiry | Inquiry |
| BLDPharm | 250mg | Methyl 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate, 98% | 15307-78-5 | USD 78 | >5 | Inquiry | Inquiry |
| BLDPharm | 1g | Methyl 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate, 98% | 15307-78-5 | USD 210 | 5 | Inquiry | Inquiry |
| BLDPharm | 1g | 2-(4-(2,3-Dihydroxypropoxy)phenyl)acetamide, 95+% | 61698-76-8 | USD 980 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | 4-Hydroxy-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one, 95+% | 1672-63-5 | USD 143 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Alimemazine Hemitartrate, 98% Synonyms:Trimeprazine hemitartrate | 4330-99-8 | USD 127 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Alimemazine Hemitartrate, 98% Synonyms:Trimeprazine hemitartrate | 4330-99-8 | USD 378 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5g | Sodium 9,10-dimethoxyanthracene-2-sulfonate, 98% | 67580-39-6 | USD 868 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole, 98% | 88546-55-8 | USD 109 | 2 | 2 | Inquiry |
| BLDPharm | 250mg | 5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole, 98% | 88546-55-8 | USD 184 | 4 | 1 | Inquiry |
| BLDPharm | 1g | 5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole, 98% | 88546-55-8 | USD 498 | 4 | Inquiry | Inquiry |
| BLDPharm | 100mg | Sodium 5-bromo-4-chloro-1H-indol-3-yl phosphate, 97% | 102185-33-1 | USD 29 | 4 | 1 | Inquiry |
| BLDPharm | 250mg | Sodium 5-bromo-4-chloro-1H-indol-3-yl phosphate, 97% | 102185-33-1 | USD 35 | 3 | 1 | Inquiry |
| BLDPharm | 1g | Sodium 5-bromo-4-chloro-1H-indol-3-yl phosphate, 97% | 102185-33-1 | USD 71 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | Sodium 5-bromo-4-chloro-1H-indol-3-yl phosphate, 97% | 102185-33-1 | USD 247 | 2 | Inquiry | Inquiry |
| BLDPharm | 5mg | (2R,3R,4R,5R,6R)-5-Hydroxy-6-(4-hydroxy-3-methoxyphenethoxy)-2-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl (E)-3-(3,4-dihydroxyphenyl)acrylate, 98% | 93236-42-1 | USD 51 | >5 | Inquiry | Inquiry |
| BLDPharm | 10mg | (2R,3R,4R,5R,6R)-5-Hydroxy-6-(4-hydroxy-3-methoxyphenethoxy)-2-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl (E)-3-(3,4-dihydroxyphenyl)acrylate, 98% | 93236-42-1 | USD 86 | >5 | Inquiry | Inquiry |
| BLDPharm | 100mg | rel-(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, 98% | 87-78-5 | USD 5 | >5 | Inquiry | Inquiry |
| BLDPharm | 5g | rel-(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, 98% | 87-78-5 | USD 13 | >5 | Inquiry | 3 |
| BLDPharm | 25g | rel-(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, 98% | 87-78-5 | USD 45 | >5 | 2 | 1 |
| BLDPharm | 100g | rel-(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, 98% | 87-78-5 | USD 135 | >5 | 1 | 1 |
| BLDPharm | 500g | rel-(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, 98% | 87-78-5 | USD 404 | >5 | 2 | 1 |
| BLDPharm | 1kg | rel-(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, 98% | 87-78-5 | USD 598 | 1 | Inquiry | Inquiry |
| BLDPharm | 1kg | rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexayl hexakis(dihydrogen phosphate), calcium magnesium salt, 98% | 3615-82-5 | USD 169 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 50mg | 2-((R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid, sodium salt, 98% | 6042-32-6 | USD 104 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 100mg | 2-((R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid, sodium salt, 98% | 6042-32-6 | USD 176 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | (S)-Benzyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate, 96% | 26049-94-5 | USD 55 | 1 | Inquiry | 0 1 |
| BLDPharm | 5g | (S)-Benzyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate, 96% | 26049-94-5 | USD 240 | Inquiry | Inquiry | |
| BLDPharm | 1g | ((1R,4S)-4-Aminocyclopent-2-en-1-yl)methanol hydrochloride, 98+% | 287717-44-6 | USD 318 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | Methyl 4-(3-(dibutylamino)propoxy)benzoate, 95+% | 437651-42-8 | USD 255 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 5mg | 2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol, 95+% | 183321-86-0 | USD 144 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 10mg | Methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate, 95% * Cold-chain transportation | 1192224-24-0 | USD 88 | >5 | Inquiry | Inquiry |
| BLDPharm | 25mg | Methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate, 95% * Cold-chain transportation | 1192224-24-0 | USD 175 | >5 | Inquiry | Inquiry |
| BLDPharm | 50mg | Methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate, 95% * Cold-chain transportation | 1192224-24-0 | USD 298 | 5 | Inquiry | Inquiry |
| BLDPharm | 100mg | Methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate, 95% * Cold-chain transportation | 1192224-24-0 | USD 508 | 2 | Inquiry | Inquiry |
| BLDPharm | 1g | 2,2-Dimethyl-3-oxo-2,3-dihydrobenzofuran-7-yl methylcarbamate, 95+% | 16709-30-1 | USD 1978 | Inquiry | Inquiry | Inquiry |
| BLDPharm | 1g | 1-(Carboxymethyl)cyclohexanecarboxylic acid, 95% | 67950-95-2 | USD 691 | Inquiry | Inquiry | Inquiry |